Datasets:

ZixuanKe
/

nickmuchi-trade-the-event

Dataset card Viewer Files Files and versions Community

Split (2)

train · 258k rows

messages listlengths 2 2
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, June 16, 2020 /PRNewswire/ -- The \"Aircraft Maintenance, Repair and Overhauling Services Global Market Report 2020-30: COVID- 19 Impact and Recovery\" report has been added to ResearchAndMarkets.com's offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global aircraft maintenance, repair and overhauling services market as it emerges from the COVID-19 shut down.The global aircraft maintenance, repair and overhauling services market is expected to decline from $70.2 billion in 2019 to $68 billion in 2020 at a compound annual growth rate (CAGR) of -3.1%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $78.5 billion in 2023.Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market research findings. Benchmark performance against key competitors. Utilize the relationships between key data sets for superior strategizing. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Report will be updated with the latest data and delivered to you within 3 working days of order. Where is the largest and fastest growing market for the aircraft maintenance, repair and overhauling services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Aircraft Maintenance, Repair and Overhauling Services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider aircraft maintenance, repair and overhauling services market, and compares it with other markets. The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery. Market segmentations break down market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets. Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. The aircraft maintenance, repair and overhauling services market section of the report gives context. It compares the aircraft maintenance, repair and overhauling services market with other segments of the aerospace market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, aircraft maintenance, repair and overhauling services indicators comparison. The Asia Pacific was the largest region in the global aircraft maintenance, repair and overhauling services market, accounting for 37% of the market in 2019. North America was the second largest region accounting for 23% of the global aircraft maintenance, repair and overhauling services market. Africa was the smallest region in the global aircraft maintenance, repair and overhauling services market.Aircraft manufacturers are using machine-learning techniques such as artificial intelligence (AI) to improve safety, productivity and quality of aircrafts. Machine learning algorithms collect data from machine-to-machine and machine-to-human interfaces and use data analytics to drive effective decision making. These technologies optimize manufacturing operations and costs. For example, GE Aviation uses machine learning and data analytics to identify faults in engines, which increases lifecycle of parts and reduces maintenance costs. Boeing has successfully built machine-learning algorithms for aircraft designing and to automate factory operations. The aircraft maintenance, repair and overhauling services market consists of sales of aircraft maintenance, repair and overhauling services by entities (organizations, sole traders and partnerships) that maintain, repair and overhaul military and commercial aircraft.Key Topics Covered: 1. Executive Summary 2. Report Structure 3. Aircraft Maintenance, Repair and Overhauling Services Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Aircraft Maintenance, Repair and Overhauling Services Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Aircraft Maintenance, Repair and Overhauling Services Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Aircraft Maintenance, Repair and Overhauling Services Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Aircraft Maintenance, Repair and Overhauling Services Market Trends And Strategies 8. Aircraft Maintenance, Repair and Overhauling Services Market Size And Growth 8.1. Market Size 8.2. Historic Market Growth, Value ($ Billion) 8.2.1. Drivers Of The Market 8.2.2. Restraints On The Market 8.3. Forecast Market Growth, Value ($ Billion) 8.3.1. Drivers Of The Market 8.3.2. Restraints On The Market 9. Aircraft Maintenance, Repair and Overhauling Services Market Regional Analysis 9.1. Global Aircraft Maintenance, Repair and Overhauling Services Market, 2019, By Region, Value ($ Billion) 9.2. Global Aircraft Maintenance, Repair and Overhauling Services Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 9.3. Global Aircraft Maintenance, Repair and Overhauling Services Market, Growth And Market Share Comparison, By Region 10. Aircraft Maintenance, Repair and Overhauling Services Market Segmentation 10.1. Global Aircraft Maintenance, Repair and Overhauling Services Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion10.2. Global Aircraft Maintenance, Repair and Overhauling Services Market, Segmentation By Aircraft Division, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion10.3. Global Aircraft Maintenance, Repair and Overhauling Services Market, Segmentation By Size, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion10.4. Global Aircraft Maintenance, Repair and Overhauling Services Market, Segmentation By Service Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion11. Aircraft Maintenance, Repair and Overhauling Services Market Metrics 11.1. Aircraft Maintenance, Repair and Overhauling Services Market Size, Percentage Of GDP, 2015-2023, Global 11.2. Per Capita Average Aircraft Maintenance, Repair and Overhauling Services Market Expenditure, 2015-2023, Global 12. Asia-Pacific Aircraft Maintenance, Repair and Overhauling Services Market13. Western Europe Aircraft Maintenance, Repair and Overhauling Services Market14. Eastern Europe Aircraft Maintenance, Repair and Overhauling Services Market15. North America Aircraft Maintenance, Repair and Overhauling Services Market16. South America Aircraft Maintenance, Repair and Overhauling Services Market17. Middle East Aircraft Maintenance, Repair and Overhauling Services Market18. Africa Aircraft Maintenance, Repair and Overhauling Services Market19. Aircraft Maintenance, Repair and Overhauling Services Market Competitive Landscape 19.1. Competitive Market Overview 19.2. Market Shares 19.3. Company Profiles 19.3.1. Honeywell Aerospace 19.3.1.1. Company Overview 19.3.1.2. Products And Services 19.3.1.3. Strategy 19.3.1.4. Financial Performance 19.3.2. AAR Corporation 19.3.2.1. Company Overview 19.3.2.2. Products And Services 19.3.2.3. Strategy 19.3.2.4. Financial Performance 19.3.3. Air France Industries KLM Engineering & Maintenance 19.3.3.1. Company Overview 19.3.3.2. Products And Services 19.3.3.3. Strategy 19.3.3.4. Financial Performance 19.3.4. Airbus SAS 19.3.4.1. Company Overview 19.3.4.2. Products And Services 19.3.4.3. Strategy 19.3.4.4. Financial Performance 19.3.5. The Boeing Company 19.3.5.1. Company Overview 19.3.5.2. Products And Services 19.3.5.3. Strategy 19.3.5.4. Financial Performance 20. Key Mergers And Acquisitions In The Aircraft Maintenance, Repair and Overhauling Services Market 21. Market Background: Aerospace Market 21.1. Aerospace Market Characteristics 21.2. Aerospace Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global 21.3. Global Aerospace Market, 2019, By Region, Value ($ Billion) 21.4. Global Aerospace Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 21.5. Global Aerospace Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion) 22. Recommendations 22.1. Global Aircraft Maintenance, Repair and Overhauling Services Market In 2023- Growth Countries 22.2. Global Aircraft Maintenance, Repair and Overhauling Services Market In 2023- Growth Segments 22.3. Global Aircraft Maintenance, Repair and Overhauling Services Market In 2023- Growth Strategies 23. Appendix 23.1. NAICS Definitions Of Industry Covered In This Report 23.2. Abbreviations 23.3. Currencies 23.4. Research Inquiries 23.5. About the Publisher24. Copyright And Disclaimer Companies Mentioned Honeywell Aerospace AAR Corporation Air France Industries KLM Engineering & Maintenance Airbus SAS The Boeing Company For more information about this report visit https://www.researchandmarkets.com/r/17cfmv Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Insights on the Global Aircraft Maintenance, Repair and Overhauling Services Industry to 2030 - Benchmark Performance Against Key Competitors", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PORT ST. LUCIE, Fla., March 15, 2021 /PRNewswire/ --Altitude International Holdings, Inc. (OTCQB: \"ALTD\") has announced the signing of an Agreement with Miami sports talk icon Jeff DeForrest making Altitude International the Name Sponsor on his ever-popular radio program. The \"Defo Show\" has been renamed the\"A-L-T-Defo Show brought to you by Altitude International\" and will regularly feature in-depth interviews with the wide array of sports and entertainment talent working with ALTD, as well as numerous live reads and mentions throughout the program. The A-L-T-Defo Show is broadcast live Monday through Friday from 6-10am on Miami's 940 WINZ and 1230 \"The Zone\" in Palm Beach, and can also be heard worldwide on the iheart Radio App and on www.940WINZ.iheart.com Jeff DeForrest has been the premier sports and gaming voice on South Florida morning radio for the past 33 years. His unique and often hilarious takes on sporting events and the wagering that surrounds them have garnered him a fiercely loyal audience both inside and outside the athletic circles. \"Altitude International is the first Name Sponsor I've ever taken on and is just a perfect fit for our program,\" said DeForrest. \"I discovered and talked about ALTD's game-changing capability 2 football seasons back when our local NFL franchise achieved maybe the greatest in-season turnaround in NFL history while training in a simulated altitude chamber custom built by ALTD. Watching the team's remarkable improvement continue right through this NFL season and seeing other professional teams and learning institutions hopping onboard, it seems like it's only a matter of time before ALTD's altitude training becomes an integral part of every elite athlete's conditioning program. And now with the coming mergers and all the new businesses and stars lining up with ALTD, I guarantee you I will have no shortage of topics to discuss or big names to interview associated with this rapidly rising company.\" ABOUT ALTITUDE INTERNATIONAL HOLDINGS ALTD provides custom-built simulated altitude chambers and position-specific protocols to its clients, which include an NFL franchise, an NBA franchise, Tulane University, and Woodway, a leading high- performance treadmill manufacturer. ALTD's team of acclaimed sports scientists represent some of the world's most accomplished in the formulation and execution of cutting-edge training techniques. ALTD chambers have contributed to documented performance improvements for its clients, including the shattering of a world cycling record at Woodway. ALTD recently signed an LOI to acquire Breunich Ho;dings, Inc. Greg Breunichcurrently serves as CEO for both Breunich Holdings and ALTD. For more information about ALTD, please visit altdint.com SAFE HARBOR STATEMENT This press release contains certain \"forward-looking statements,\" as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. The economic, competitive, governmental, technological and other factors identified in the Company's previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements whether as a result of new information future events or otherwise. Media contact: Justin Baronoff 561-750-9800; [emailprotected]. SOURCE Altitude International Holdings, Inc.", "role": "user" }, { "content": "Altitude International Secures Name Sponsorship with iheart Radio's Jeff DeForrest (\"Defo\") Show", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LAKE MARY, Fla., April 28, 2021 /PRNewswire/ --FARO (Nasdaq: FARO), a global leader of 3D measurement, imaging, and realization solutions for the 3D Metrology, AEC (Architecture, Engineering & Construction), and Public Safety Analytics markets, today announced its financial results for the first quarter ended March 31, 2021. \"First quarter demand reflected historical seasonality combined with an ongoing but improving pandemic demand impact that we believe will continue to improve throughout 2021,\" stated Michael Burger, President and Chief Executive Officer. \"Once demand returns to normalized pre-pandemic levels, we believe our new cost structure will enable the sustained achievement of our success model of 20% EBITDA margins.\" Mr. Burger continued, \"While demand recovers, we remain focused on executing our strategic initiatives including the alignment of our hardware and software development activities to add value to our customer's workflows and create long-term product differentiation in our target markets.\" First Quarter 2021 Financial Summary2021 first quarter sales of $76.3 million compare with $79.5 million for the first quarter of 2020. However, new order bookings in the first quarter at $80.6 million were up 3% over the preceding year. The slight decline in sales for the quarter is the result of the economic effect of Covid pandemic which is still in the recovery stage. Sequentially, sales and bookings compared with the fourth quarter 2020 were lower by 18% and 15%, respectively, reflecting normal seasonality in our business. Gross margin was 52.9% for the first quarter 2021, as compared to 55.2% for the same prior year period. Non-GAAP gross margin was 53.0% for the first quarter 2021 compared to 55.5% for the first quarter 2020. The annual decrease in gross margin was primarily a result of changes in product mix and lower sales resulting from the COVID-19 pandemic. Operating expense, was $46.8 million for the first quarter 2021, compared to $60.4 million for the same prior year period. Non-GAAP operating expense was $42.8 million for the first quarter 2021 compared to $44.3 million for the first quarter 2020. Net loss was $3.2 million, or $0.18 per share, for the first quarter 2021, as compared to a net loss of $14.8 million, or $0.84 per share, for the first quarter 2020. Non-GAAP net loss was $0.6 million, or $0.03 per share, for the first quarter 2021 compared to Non-GAAP net loss of $0.4 million, or $0.02 per share, for the first quarter 2020. Adjusted EBITDA was $0.4 million, or 0.5% of total sales, for the first quarter of 2021 compared to Adjusted EBITDA of $3.1 million, or 3.9% of total sales, for the first quarter of 2020. The Company's cash and short-term investments decreased $15.7 million to $170.0 million as of the end of the first quarter of 2021, and the Company remained debt-free. * A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release. An additional explanation of these measures is included below under the heading \"Non-GAAP Financial Measures\". Conference CallThe Company will host a conference call to discuss these results on Thursday, April 29, 2021 at 8:00 a.m. ET. Interested parties can access the conference call by dialing (877) 876-9176 (U.S.) or +1 (785) 424-1670 (International) and using the passcode FARO. A live webcast will be available in the Investor Relations section of FARO's website at: https://www.faro.com/about-faro/investor-relations/events A replay webcast will be available in the Investor Relations section of the company's web site approximately two hours after the conclusion of the call and will remain available for approximately 30 calendar days. About FAROFor 40 years, FARO has provided industry-leading technology solutions that enable customers to quickly and easily measure their world, and then use that data to make smarter decisions faster. FARO continues to be a pioneer in bridging the digital and physical worlds through data-driven reliable accuracy, precision and immediacy. For more information, visithttp://www.faro.com Non-GAAP Financial MeasuresThis press release contains information about our financial results that are not presented in accordance with U.S. generally accepted accounting principles (\"GAAP\"). These non-GAAP financial measures, including non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP loss from operations, non-GAAP other expense, net, non-GAAP net loss and non-GAAP net loss per share, exclude the impact of purchase accounting intangible amortization expense, stock-based compensation, imputed interest expense recorded related to the GSA Matter, restructuring charges, and other tax adjustments, and are provided to enhance investors' overall understanding of our historical operations and financial performance. In addition, we present Adjusted EBITDA, which is calculated as net loss before interest expense, net, income tax benefit and depreciation and amortization, excluding other (income) expense, net, stock-based compensation, and restructuring charges, as measures of our operating profitability. The most directly comparable GAAP measure to Adjusted EBITDA is net loss. We also present Adjusted EBITDA margin, which is calculated as Adjusted EBITDA as a percent of Non-GAAP total sales. Management believes that these non-GAAP financial measures provide investors with relevant period-to-period comparisons of our core operations using the same methodology that management employs in its review of the Company's operating results. These financial measures are not recognized terms under GAAP and should not be considered in isolation or as a substitute for a measure of financial performance prepared in accordance with GAAP. These non-GAAP financial measures have limitations that should be considered before using these measures to evaluate a company's financial performance. These non-GAAP financial measures, as presented, may not be comparable to similarly titled measures of other companies due to varying methods of calculation. The financial statement tables that accompany this press release include a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, such as statements about demand for and customer acceptance of FARO's products, FARO's product development and product launches, FARO's growth, strategic and restructuring plans and initiatives, including but not limited to the additional restructuring charges expected to be incurred in connection with our restructuring plan and the timing and amount of cost savings and other benefits expected to be realized from the restructuring plan and other strategic initiatives, and FARO's growth potential and profitability. Statements that are not historical facts or that describe the Company's plans, objectives, projections, expectations, assumptions, strategies, or goals are forward-looking statements. In addition, words such as \"is,\" \"will\" and similar expressions or discussions of FARO's plans or other intentions identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to various known and unknown risks, uncertainties, and other factors that may cause actual results, performances, or achievements to differ materially from future results, performances, or achievements expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements. Factors that could cause actual results to differ materially from what is expressed or forecasted in such forward- looking statements include, but are not limited to: the Company's ability to realize the intended benefits of its undertaking to transition to a company that is reorganized around functions to improve the efficiency of its sales organization and to improve operational effectiveness; the Company's inability to successfully execute its new strategic plan and restructuring plan, including but not limited to additional impairment charges and/or higher than expected severance costs and exit costs, and its inability to realize the expected benefits of such plans; the Company's potential loss of future government sales and potential impacts on customer and supplier relationships and on the Company's reputation that may result from the GSA matter; development by others of new or improved products, processes or technologies that make the Company's products less competitive or obsolete; the Company's inability to maintain its technological advantage by developing new products and enhancing its existing products; declines or other adverse changes, or lack of improvement, in industries that the Company serves or the domestic and international economies in the regions of the world where the Company operates and other general economic, business, and financial conditions; the effect of the COVID-19 pandemic, including on our business operations, as well as its impact on general economic and financial market conditions; the impact of fluctuations in foreign exchange rates; and other risks detailed in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 that was filed on February 17, 2021. Forward-looking statements in this release represent the Company's judgment as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law. FARO TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Three Months Ended (in thousands, except share and per share data) March 31, 2021 March 31, 2020 Sales Product $ 54,635 $ 56,525 Service 21,696 22,990 Total sales 76,331 79,515 Cost of Sales Product 24,804 23,066 Service 11,120 12,576 Total cost of sales 35,924 35,642 Gross Profit 40,407 43,873 Operating Expenses Selling, general and administrative 33,348 36,324 Research and development 11,973 10,415 Restructuring costs 1,524 13,688 Total operating expenses 46,845 60,427 Loss from operations (6,438) (16,554) Other (income) expense Interest expense, net 10 34 Other (income) expense, net (1,615) 473 Loss before income tax benefit (4,833) (17,061) Income tax benefit (1,612) (2,238) Net loss $ (3,221) $ (14,823) Net loss per share - Basic $ (0.18) $ (0.84) Net loss per share - Diluted $ (0.18) $ (0.84) Weighted average shares - Basic 18,076,410 17,616,964 Weighted average shares - Diluted 18,076,410 17,616,964 FARO TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) March 31, 2020 (unaudited) December 31, 2020 ASSETS Current assets: Cash and cash equivalents $ 169,957 $ 185,633 Accounts receivable, net 59,821 64,616 Inventories, net 47,058 47,391 Prepaid expenses and other current assets 27,231 26,295 Total current assets 304,067 323,935 Non-current assets: Property, plant and equipment, net 21,921 23,091 Operating lease right-of-use asset 24,616 26,107 Goodwill 56,269 57,541 Intangible assets, net 13,254 13,301 Service and sales demonstration inventory, net 31,323 31,831 Deferred income tax assets, net 46,208 47,450 Other long-term assets 2,300 2,336 Total assets $ 499,958 $ 525,592 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 15,969 $ 14,121 Accrued liabilities 29,775 42,593 Income taxes payable 567 3,442 Current portion of unearned service revenues 37,842 39,149 Customer deposits 3,650 2,807 Lease liability 5,596 5,835 Total current liabilities 93,399 107,947 Unearned service revenues - less current portion 21,476 21,757 Lease liability - less current portion 20,965 22,131 Deferred income tax liabilities 642 787 Income taxes payable - less current portion 11,583 11,583 Other long-term liabilities 1,110 1,084 Total liabilities 149,175 165,289 Shareholders' equity: Common stock - par value $.001, 50,000,000 shares authorized; 19,536,531 and 19,384,350 issued, respectively; 18,154,164 and 17,990,707 outstanding, respectively 19 19 Additional paid-in capital 291,603 287,979 Retained earnings 110,287 113,508 Accumulated other comprehensive loss (20,334) (10,160) Common stock in treasury, at cost; 1,382,367 and 1,393,643 shares, respectively (30,792) (31,043) Total shareholders' equity 350,783 360,303 Total liabilities and shareholders' equity $ 499,958 $ 525,592 FARO TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Three Months Ended (in thousands) March 31, 2021 March 31, 2020 Cash flows from: Operating activities: Net loss $ (3,221) $ (14,823) Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Depreciation and amortization 3,190 3,759 Stock-based compensation 2,094 2,178 Provisions for bad debts, net of recoveries (89) (15) Loss on disposal of assets 20 10 Provision for excess and obsolete inventory 1,404 204 Deferred income tax benefit (1,612) (2,326) Change in operating assets and liabilities: Decrease (Increase) in: Accounts receivable 3,676 16,084 Inventories (3,999) 1,795 Prepaid expenses and other current assets (1,346) 7,408 (Decrease) Increase in: Accounts payable and accrued liabilities (9,823) 4,756 Income taxes payable (1,153) (1,389) Customer deposits 896 (961) Unearned service revenues (323) (365) Net cash (used in) provided by operating activities (10,286) 16,315 Investing activities: Purchases of property and equipment (1,547) (757) Proceeds from sale of investments 9,000 Payments for intangible assets (890) (435) Net cash (used in) provided by investing activities (2,437) 7,808 Financing activities: Payments on finance leases (86) (82) Payments for taxes related to net share settlement of equity awards (3,336) (1,581) Proceeds from issuance of stock related to stock option exercises 5,118 2,802 Net cash provided by financing activities 1,696 1,139 Effect of exchange rate changes on cash and cash equivalents (4,649) (1,656) Increase in cash and cash equivalents (15,676) 23,606 Cash and cash equivalents, beginning of period 185,633 133,634 Cash and cash equivalents, end of period $ 169,957 $ 157,240 FARO TECHNOLOGIES, INC. AND SUBSIDIARIES RECONCILIATION OF GAAP TO NON-GAAP (UNAUDITED) Three Months Ended March 31, (dollars in thousands, except per share data) 2021 2020 Gross profit, as reported $ 40,407 $ 43,873 Stock-based compensation (2) 66 271 Non-GAAP adjustments to gross profit 66 271 Non-GAAP gross profit $ 40,473 $ 44,144 Gross margin, as reported 52.9 % 55.2 % Non-GAAP gross margin 53.0 % 55.5 % Selling, general and administrative, as reported $ 33,348 $ 36,324 Stock-based compensation (2) (1,682) (1,523) Purchase accounting intangible amortization (185) (124) Non-GAAP selling, general and administrative $ 31,481 $ 34,677 Research and development, as reported $ 11,973 $ 10,415 Stock-based compensation (2) (346) (382) Purchase accounting intangible amortization (328) (401) Non-GAAP research and development $ 11,299 $ 9,632 Operating expenses, as reported $ 46,845 $ 60,427 Stock-based compensation (2) (2,028) (1,905) Restructuring costs (3) (1,524) (13,688) Purchase accounting intangible amortization (513) (525) Non-GAAP adjustments to operating expenses (4,065) (16,118) Non-GAAP operating expenses $ 42,780 $ 44,309 Loss from operations, as reported $ (6,438) $ (16,554) Non-GAAP adjustments to gross profit 66 271 Non-GAAP adjustments to operating expenses 4,065 16,118 Non-GAAP loss from operations $ (2,307) $ (165) Other (income) expense, net, as reported $ (1,605) $ 507 Interest expense increase due to GSA sales adjustment (1) (149) Non-GAAP adjustments to other (income) expense, net (149) Non-GAAP other (income) expense, net $ (1,605) $ 358 Net loss, as reported $ (3,221) $ (14,823) Non-GAAP adjustments to gross profit 66 271 Non-GAAP adjustments to operating expenses 4,065 16,118 Non-GAAP adjustments to other (income) expense, net 149 Income tax effect of non-GAAP adjustments (1,478) (2,133) Non-GAAP net loss $ (568) $ (418) Net loss per share - Diluted, as reported $ (0.18) $ (0.84) Stock-based compensation (2) 0.12 0.12 Restructuring costs (3) 0.08 0.78 Purchase accounting intangible amortization 0.03 0.03 Interest expense increase due to GSA sales adjustment (1) 0.01 Income tax effect of non-GAAP adjustments (0.08) (0.12) Non-GAAP net loss per share - Diluted $ (0.03) $ (0.02) (1) Late in the fourth quarter of 2018, during an internal review we preliminarily determined that certain of our pricing practices may have resulted in the U.S. Government being overcharged under our General Services Administration (\"GSA\") Federal Supply Schedule contracts (the \"Contracts\") (the \"GSA Matter\"). In the first quarter 2020 we recorded imputed interest expense of $0.1 million related to the GSA Matter. Effective as of February 25, 2021, as a result of the review, we entered into a settlement agreement with the GSA and have paid in full and final satisfaction of any and all claims, causes of actions, appeals and the like, including damages, costs, attorney's fees and interest arising under or related to the GSA Matter. (2) We exclude stock-based compensation, which is non-cash, from the non-GAAP financial measures because the Company believes that such exclusion provides a better comparison of results of ongoing operations for current and future periods with such results from past periods. (3) On February 14, 2020, our Board of Directors approved a global restructuring plan (the \"Restructuring Plan\"), which is intended to support our strategic plan in an effort to improve operating performance and ensure that we are appropriately structured and resourced to deliver increased and sustainable value to our shareholders and customers. In connection with the Restructuring Plan, during the first quarters 2020 and 2021 we recorded a pre-tax charge of approximately $13.7million and $1.5 million, respectively, primarily consisting of severance and related benefits. FARO TECHNOLOGIES, INC. AND SUBSIDIARIES RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA (UNAUDITED) Three Months Ended March 31, (in thousands) 2021 2020 Net loss $ (3,221) $ (14,823) Interest expense, net 10 34 Income tax benefit (1,612) (2,238) Depreciation and amortization 3,190 3,759 EBITDA (1,633) (13,268) Other (income) expense, net (1,615) 473 Stock-based compensation 2,094 2,176 Restructuring costs (1) 1,524 13,688 Adjusted EBITDA $ 370 $ 3,069 Adjusted EBITDA margin (2) 0.5 % 3.9 % (1) On February 14, 2020, our Board of Directors approved a global restructuring plan (the \"Restructuring Plan\"), which is intended to support our strategic plan in an effort to improve operating performance and ensure that we are appropriately structured and resourced to deliver increased and sustainable value to our shareholders and customers. In connection with the Restructuring Plan, during the first quarters 2020 and 2021 we recorded a pre-tax charge of approximately $13.7million and $1.5 million, respectively, primarily consisting of severance and related benefits. (2)Calculated as Adjusted EBITDA as a percentage of Non-GAAP total sales, which adjusts for the GSA sales adjustment. FARO TECHNOLOGIES, INC. AND SUBSIDIARIES SALES DISAGGREGATED BY GEOGRAPHY (UNAUDITED) For the Three Months Ended March 31, (in thousands) 2021 2020 Total sales to external customers Americas (1) $ 32,549 $ 35,590 EMEA (1) 25,454 23,690 APAC (1) 18,328 20,235 $ 76,331 $ 79,515 (1) Regions represent North America and South America (Americas); Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific (APAC). SOURCE FARO Related Links http://www.faro.com", "role": "user" }, { "content": "FARO Announces First Quarter 2021 Financial Results", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SANTA MONICA, Calif., July 8, 2020 /PRNewswire/ --TigerConnect, healthcare's most advanced, reliable, and widely adopted care team collaboration solution, has been named a top vendor in the latestClinical Communication Platforms 2020 Advanced User Insights report from KLAS, a research and insights firm that gathers data and delivers reports on healthcare technology. (PRNewsfoto/TigerConnect) KLAS also highlighted TigerConnect as the only platform with over 50% adoption of those surveyed regarding advanced workflows in nine out of ten categories, including the top vendor for patient-centered care team communications, clinical support staff workflows, pre-admission workflows, and discharge & post-discharge workflows. \"The KLAS report highlights one of TigerConnect's biggest strengths our ability to help healthcare organizations across the full continuum of care meaningfully connect and enhance outcomes,\" says Brad Brooks, TigerConnect CEO. \"More than 6,000 healthcare organizations rely on our platform to enable seamless collaboration in a scalable, fully integrated, easy-to-use solution. With so many challenges facing our industry during the COVID-19 pandemic, now is the time for innovation that enhances care and strengthens the bottom line.\" Standout capabilities include the ability to communicate during EMR downtime, messages linking to patient records to pull in all pertinent information for patient care, and care coordinators' ability to use the platform to coordinate patient care with referred caregivers.For the report, KLAS collected information from multiple case studies and conducted in-depth, on-site interviews with organizational leaders, including CIOs, clinicians and IT personnel. The organizations profiled are at the cutting edge of clinical communication and have often made significant contributions in partnership with vendors like TigerConnect to develop solution capabilities and drive outcomes.About KLASKLAS is a data-driven company on a mission to improve the world's healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights it provides, visitklasresearch.comAbout TigerConnect, Inc.TigerConnect is healthcare's most widely adopted communication platform uniquely modernizing care collaboration among doctors, nurses, care teams, and patients. TigerConnect is the only solution that combines a consumer-like user experience for both clinical and patient communication with serious security, privacy, and clinical workflow requirements that today's healthcare organizations demand. TigerConnect accelerates productivity, reduces costs, and improves patient outcomes.Trusted by more than 6,000 healthcare organizations, TigerConnect maintains 99.99% verifiable uptime and processes more than 10 million messages each day. To learn more about TigerConnect, visittigerconnect.com.SOURCE TigerConnect", "role": "user" }, { "content": "KLAS Rates TigerConnect Among Top Advanced Clinical Communication Platforms KLAS recognizes TigerConnect for its highly customer-centric, very large customer base across inpatient and non-inpatient care settings, delivering nimble development and \"most extensive breadth of workflows for advanced users\"", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: IRVINE, Calif.--(BUSINESS WIRE)--Resources Global Professionals (RGP), the operating subsidiary of Resources Connection, Inc. (Nasdaq: RECN), announced today that the Board of Directors of its parent company has approved a cash dividend of $0.14 per share, payable on March 18, 2021 to all shareholders of record on February 18, 2021. ABOUT RGP RGP is a global consulting firm that enables rapid business outcomes by bringing together the right people to create transformative change. As a human capital partner to our global client base, we support our clients needs through both professional staffing and project execution in the areas of transactions, regulations, and transformations. Our pioneering approach to workforce strategy and our agile human capital model quickly align the right resources for the work at hand with speed and efficiency. Our engagements are designed to leverage human connection and collaboration to deliver practical solutions and more impactful results that power our clients, consultants and partners success. Our mission as an employer is to connect our team members to meaningful opportunities that further their career ambitions within the context of a supportive talent community of dedicated professionals. With approximately 3,300 professionals, we annually engage with over 2,400 clients around the world from more than 60 physical practice offices and multiple virtual offices. We are their partner in delivering on the future of work. Headquartered in Irvine, California, RGP is proud to have served 88 of the Fortune 100. The Company is listed on the Nasdaq Global Select Market, the exchanges highest tier by listing standards. To learn more about RGP, visit: http://www.rgp.com. (RGP-F)", "role": "user" }, { "content": "Resources Global Professionals Announces Quarterly Dividend and Dividend Payment Date", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, April 20, 2020 /PRNewswire/ --High Throughput Screening (HTS) market worldwide is projected to grow by US$8.8 Billion, driven by a compounded growth of 7.5%. Consumables/Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$13.2 Billion by the year 2025, Consumables/Reagents will bring in healthy gains adding significant momentum to global growth. Read the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN - Representing the developed world, the United States will maintain a 6.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$306.6 Million to the region's size and clout in the next 5 to 6 years. Over US$260.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables/Reagents will reach a market size of US$658.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.1% over the next couple of years and add approximately US$2.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include, among others, Agilent Technologies Inc. Aurora Biomed Inc. Axxam SpA BD Biosciences Beckman Coulter Inc. Bio-Rad Laboratories Inc. BioTek Instruments Inc. BMG LABTECH GmbH Charles River Laboratories International Inc. Corning Inc. Danaher Corporation DiscoveRx Corporation Evotec AG F. Hoffmann-La Roche Ltd. Genedata AG IntelliCyt Corporation Luminex Corporation Molecular Devices Inc. Pall ForteBio LLC PerkinElmer Inc. Sigma-Aldrich Corp. Tecan Group Ltd. Thermo Fisher Scientific Inc. Read the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEWHigh Throughput Screening (HTS): A PreludeRecent Market ActivityHTS: The Mainstream Technology for Drug Discovery ProgramsUnparalleled Advantages in Compound Screening Drives WiderAdoptionKey Benefits of HTS - An OverviewSoaring R&D Spending Creates Conducive Environment for HTSShift towards High Throughput Research Builds Momentum for HTSUpward Trajectory in Med Tech Sector Generates ParallelOpportunitiesStable Economic Outlook to Keep Market Sentiment Intact in theNear TermDeveloped Regions: Key Revenue ContributorsHTS Adoption Continues to Expand in Developing RegionsKey Factors Driving Demand for HTS in the Developing RegionsCompetitive ScenarioLeading Players in the World HTS MarketM&A ActivityGlobal Competitor Market SharesHigh Throughput Screening (HTS) Competitor Market ShareScenario Worldwide (in %): 2020 & 20292. FOCUS ON SELECT PLAYERSAgilent Technologies, Inc. (USA)Aurora Biomed, Inc. (Canada)Axxam SpA (Italy)BD Biosciences (USA)Danaher Corporation (USA)Beckman Coulter, Inc. (USA)Molecular Devices Inc. (USA)Pall ForteBio LLC (USA)Bio-Rad Laboratories, Inc. (USA)BioTek Instruments Inc. (USA)BMG LABTECH GmbH (Germany)Charles River Laboratories International, Inc. (USA)Corning Inc. (USA)DiscoveRx Corporation (USA)Evotec AG (Germany)F. Hoffmann-La Roche Ltd. (Switzerland)Genedata AG (Switzerland)IntelliCyt Corporation (USA)Luminex Corporation (USA)PerkinElmer, Inc. (USA)Sigma-Aldrich Corp. (USA)Tecan Group Ltd. (Switzerland)Thermo Fisher Scientific Inc. (USA)3. MARKET TRENDS & DRIVERSCell-based Assay: The Widely Used HTS TechnologyResolving Technical Limitations: Cornerstone for Future Successof Cell-based HTSHTS Aims to Expand Use Case in Biochemical ApplicationsLabel-Free HTS Demonstrates Fastest GrowthLab-on-a-Chip HTS Seeks to Proliferate the MarketBioinformatics HTS Enhanced with Computational AlgorithmsPositive Prognosis across End-Use Markets to Underpin RevenueGrowthPharmaceutical Industry Leads the WayHTS Deployments Soar in AcademiaProgressive Advancements in HTS Instruments Accelerate MarketGrowthMicroplate Handling Systems: An Important HTS Instrument TypeLiquid Handling Devices: A Necessity in HTS ProcessesMicroscopic Systems Facilitate Seamless Quantitative AnalysisAdvanced Software Platforms Augment HTS ProficiencyServices: An Important Revenue Generating SegmentExpansion in Compound Libraries Widens Functional Scope of HTSCompound Libraries Facilitate Simultaneous Functional Genomics& Small Molecule AnalysisLaboratory Automation & Miniaturization Spell Opportunities forHTSMiniaturization of Compound Screening Processes Drives Demandfor HTSHTS Miniaturization - Technology DevelopmentsHTS Robotics Support MiniaturizationIVC - A Miniaturized, Powerful HTS TechnologyHTS Assumes Critical Importance in Target Identification &ValidationHTS Gathers Steam in Primary Screening ApplicationsHTS Perceives Bright Future in Stem Cell ResearchHTS in Kinase Inhibitors IdentificationHTS in Alzheimer's Disease Drug DiscoveryHTS for Less Simplified PCR SystemsHTFC Eases Metabolic Activity Analysis for Pharmaceutical DrugsOpen Access Platforms Widen HTS Audience BaseNeed for Stringent QA System to Keep Failures at BayHigh Throughput Screening (HTS) Vs. High Content Screening (HCS)Rise in Adoption of HCS Technology in HTS Laboratories4. GLOBAL MARKET PERSPECTIVETable 1: High Throughput Screening (HTS) Global MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 2: High Throughput Screening (HTS) Global RetrospectiveMarket Scenario in US$ Million by Region/Country: 2009-2017Table 3: High Throughput Screening (HTS) Market Share Shiftacross Key Geographies Worldwide: 2009 VS 2019 VS 2025Table 4: Consumables/Reagents (Product Type) World Market byRegion/Country in US$ Million: 2018 to 2025Table 5: Consumables/Reagents (Product Type) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 6: Consumables/Reagents (Product Type) Market ShareBreakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS2025Table 7: Instruments (Product Type) Potential Growth MarketsWorldwide in US$ Million: 2018 to 2025Table 8: Instruments (Product Type) Historic Market Perspectiveby Region/Country in US$ Million: 2009 to 2017Table 9: Instruments (Product Type) Market Sales Breakdown byRegion/Country in Percentage: 2009 VS 2019 VS 2025Table 10: Software & Services (Product Type) Geographic MarketSpread Worldwide in US$ Million: 2018 to 2025Table 11: Software & Services (Product Type) Region WiseBreakdown of Global Historic Demand in US$ Million: 2009 to2017Table 12: Software & Services (Product Type) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 13: Cell-based Assay (Technology) World Market Estimatesand Forecasts by Region/Country in US$ Million: 2018 to 2025Table 14: Cell-based Assay (Technology) Market Historic Reviewby Region/Country in US$ Million: 2009 to 2017Table 15: Cell-based Assay (Technology) Market Share Breakdownby Region/Country: 2009 VS 2019 VS 2025Table 16: Label-Free Technology (Technology) World Market byRegion/Country in US$ Million: 2018 to 2025Table 17: Label-Free Technology (Technology) Historic MarketAnalysis by Region/Country in US$ Million: 2009 to 2017Table 18: Label-Free Technology (Technology) Market ShareDistribution in Percentage by Region/Country: 2009 VS 2019 VS2025Table 19: Other Technologies (Technology) World MarketEstimates and Forecasts in US$ Million by Region/Country: 2018to 2025Table 20: Other Technologies (Technology) Market WorldwideHistoric Review by Region/Country in US$ Million: 2009 to 2017Table 21: Other Technologies (Technology) Market PercentageShare Distribution by Region/Country: 2009 VS 2019 VS 2025Table 22: Target Identification & Validation (Application)Global Opportunity Assessment in US$ Million by Region/Country:2018-2025Table 23: Target Identification & Validation (Application)Historic Sales Analysis in US$ Million by Region/Country:2009-2017Table 24: Target Identification & Validation (Application)Percentage Share Breakdown of Global Sales by Region/Country:2009 VS 2019 VS 2025Table 25: Primary & Secondary Screening (Application) WorldwideSales in US$ Million by Region/Country: 2018-2025Table 26: Primary & Secondary Screening (Application) HistoricDemand Patterns in US$ Million by Region/Country: 2009-2017Table 27: Primary & Secondary Screening (Application) MarketShare Shift across Key Geographies: 2009 VS 2019 VS 2025Table 28: Toxicology Assessment (Application) Global MarketEstimates & Forecasts in US$ Million by Region/Country:2018-2025Table 29: Toxicology Assessment (Application) RetrospectiveDemand Analysis in US$ Million by Region/Country: 2009-2017Table 30: Toxicology Assessment (Application) Market ShareBreakdown by Region/Country: 2009 VS 2019 VS 2025Table 31: Other Applications (Application) Demand PotentialWorldwide in US$ Million by Region/Country: 2018-2025Table 32: Other Applications (Application) Historic SalesAnalysis in US$ Million by Region/Country: 2009-2017Table 33: Other Applications (Application) Share BreakdownReview by Region/Country: 2009 VS 2019 VS 2025Table 34: Pharmaceutical & Biotechnology Companies (End-Use)Worldwide Latent Demand Forecasts in US$ Million byRegion/Country: 2018-2025Table 35: Pharmaceutical & Biotechnology Companies (End-Use)Global Historic Analysis in US$ Million by Region/Country:2009-2017Table 36: Pharmaceutical & Biotechnology Companies (End-Use)Distribution of Global Sales by Region/Country: 2009 VS 2019 VS2025Table 37: Academic & Government Institutes (End-Use) SalesEstimates and Forecasts in US$ Million by Region/Country forthe Years 2018 through 2025Table 38: Academic & Government Institutes (End-Use) Analysisof Historic Sales in US$ Million by Region/Country for theYears 2009 to 2017Table 39: Academic & Government Institutes (End-Use) GlobalMarket Share Distribution by Region/Country for 2009, 2019, and2025Table 40: Contract Research Organizations (CRO) (End-Use)Global Opportunity Assessment in US$ Million by Region/Country:2018-2025Table 41: Contract Research Organizations (CRO) (End-Use)Historic Sales Analysis in US$ Million by Region/Country:2009-2017Table 42: Contract Research Organizations (CRO) (End-Use)Percentage Share Breakdown of Global Sales by Region/Country:2009 VS 2019 VS 2025Table 43: Other End-Uses (End-Use) Worldwide Sales in US$Million by Region/Country: 2018-2025Table 44: Other End-Uses (End-Use) Historic Demand Patterns inUS$ Million by Region/Country: 2009-2017Table 45: Other End-Uses (End-Use) Market Share Shift acrossKey Geographies: 2009 VS 2019 VS 2025III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSISUNITED STATESMarket Facts & FiguresUS High Throughput Screening (HTS) Market Share (in %) byCompany: 2020 & 2025Market AnalyticsTable 46: United States High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Product Type: 2018to 2025Table 47: High Throughput Screening (HTS) Market in the UnitedStates by Product Type: A Historic Review in US$ Million for2009-2017Table 48: United States High Throughput Screening (HTS) MarketShare Breakdown by Product Type: 2009 VS 2019 VS 2025Table 49: High Throughput Screening (HTS) Market in US$ Millionin the United States by Technology: 2018-2025Table 50: United States High Throughput Screening (HTS) MarketRetrospective Analysis in US$ Million by Technology: 2009-2017Table 51: United States High Throughput Screening (HTS) MarketShare Breakdown by Technology: 2009 VS 2019 VS 2025Table 52: United States High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Application: 2018 to 2025Table 53: High Throughput Screening (HTS) Historic DemandPatterns in the United States by Application in US$ Million for2009-2017Table 54: High Throughput Screening (HTS) Market ShareBreakdown in the United States by Application: 2009 VS 2019 VS2025Table 55: United States High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by End-Use: 2018 to 2025Table 56: High Throughput Screening (HTS) Historic DemandPatterns in the United States by End-Use in US$ Million for2009-2017Table 57: High Throughput Screening (HTS) Market ShareBreakdown in the United States by End-Use: 2009 VS 2019 VS 2025CANADATable 58: Canadian High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 59: Canadian High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 60: High Throughput Screening (HTS) Market in Canada:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 61: High Throughput Screening (HTS) Market Analysis inCanada in US$ Million by Technology: 2018-2025Table 62: High Throughput Screening (HTS) Market in Canada:Historic Review in US$ Million by Technology for the Period2009-2017Table 63: Canadian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 64: Canadian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 65: High Throughput Screening (HTS) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 66: Canadian High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 67: Canadian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 68: High Throughput Screening (HTS) Market in Canada:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 69: Canadian High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025JAPANTable 70: Japanese Market for High Throughput Screening (HTS):Annual Sales Estimates and Projections in US$ Million byProduct Type for the Period 2018-2025Table 71: High Throughput Screening (HTS) Market in Japan:Historic Sales Analysis in US$ Million by Product Type for thePeriod 2009-2017Table 72: Japanese High Throughput Screening (HTS) Market ShareAnalysis by Product Type: 2009 VS 2019 VS 2025Table 73: Japanese Medium & Long-Term Outlook for HighThroughput Screening (HTS) Market in US$ Million by Technology:2018-2025Table 74: High Throughput Screening (HTS) Market in Japan inUS$ Million by Technology: 2009-2017Table 75: Japanese High Throughput Screening (HTS) MarketPercentage Share Distribution by Technology: 2009 VS 2019 VS2025Table 76: Japanese Demand Estimates and Forecasts for HighThroughput Screening (HTS) in US$ Million by Application: 2018to 2025Table 77: Japanese High Throughput Screening (HTS) Market inUS$ Million by Application: 2009-2017Table 78: High Throughput Screening (HTS) Market Share Shift inJapan by Application: 2009 VS 2019 VS 2025Table 79: Japanese Demand Estimates and Forecasts for HighThroughput Screening (HTS) in US$ Million by End-Use: 2018 to2025Table 80: Japanese High Throughput Screening (HTS) Market inUS$ Million by End-Use: 2009-2017Table 81: High Throughput Screening (HTS) Market Share Shift inJapan by End-Use: 2009 VS 2019 VS 2025CHINATable 82: Chinese High Throughput Screening (HTS) Market GrowthProspects in US$ Million by Product Type for the Period2018-2025Table 83: High Throughput Screening (HTS) Historic MarketAnalysis in China in US$ Million by Product Type: 2009-2017Table 84: Chinese High Throughput Screening (HTS) Market byProduct Type: Percentage Breakdown of Sales for 2009, 2019, and2025Table 85: High Throughput Screening (HTS) Market Estimates andForecasts in China in US$ Million by Technology: 2018-2025Table 86: Chinese High Throughput Screening (HTS) RetrospectiveMarket Scenario in US$ Million by Technology: 2009-2017Table 87: High Throughput Screening (HTS) Market in China:Percentage Share Analysis by Technology for 2009, 2019, and2025Table 88: Chinese Demand for High Throughput Screening (HTS) inUS$ Million by Application: 2018 to 2025Table 89: High Throughput Screening (HTS) Market Review inChina in US$ Million by Application: 2009-2017Table 90: Chinese High Throughput Screening (HTS) Market ShareBreakdown by Application: 2009 VS 2019 VS 2025Table 91: Chinese Demand for High Throughput Screening (HTS) inUS$ Million by End-Use: 2018 to 2025Table 92: High Throughput Screening (HTS) Market Review inChina in US$ Million by End-Use: 2009-2017Table 93: Chinese High Throughput Screening (HTS) Market ShareBreakdown by End-Use: 2009 VS 2019 VS 2025EUROPESMarket Facts & FiguresEuropean High Throughput Screening (HTS) Market: CompetitorMarket Share Scenario (in %) for 2020 & 2025Market AnalyticsTable 94: European High Throughput Screening (HTS) MarketDemand Scenario in US$ Million by Region/Country: 2018-2025Table 95: High Throughput Screening (HTS) Market in Europe:A Historic Market Perspective in US$ Million by Region/Countryfor the Period 2009-2017Table 96: European High Throughput Screening (HTS) Market ShareShift by Region/Country: 2009 VS 2019 VS 2025Table 97: European High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type:2018-2025Table 98: High Throughput Screening (HTS) Market in Europe inUS$ Million by Product Type: A Historic Review for the Period2009-2017Table 99: European High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 100: European High Throughput Screening (HTS) MarketAssessment in US$ Million by Technology: 2018-2025Table 101: European High Throughput Screening (HTS) HistoricMarket Review in US$ Million by Technology: 2009-2017Table 102: High Throughput Screening (HTS) Market in Europe:Percentage Breakdown of Sales by Technology for 2009, 2019, and2025Table 103: European High Throughput Screening (HTS) AddressableMarket Opportunity in US$ Million by Application: 2018-2025Table 104: High Throughput Screening (HTS) Market in Europe:Summarization of Historic Demand in US$ Million by Applicationfor the Period 2009-2017Table 105: European High Throughput Screening (HTS) MarketShare Analysis by Application: 2009 VS 2019 VS 2025Table 106: European High Throughput Screening (HTS) AddressableMarket Opportunity in US$ Million by End-Use: 2018-2025Table 107: High Throughput Screening (HTS) Market in Europe:Summarization of Historic Demand in US$ Million by End-Use forthe Period 2009-2017Table 108: European High Throughput Screening (HTS) MarketShare Analysis by End-Use: 2009 VS 2019 VS 2025FRANCETable 109: High Throughput Screening (HTS) Market in France byProduct Type: Estimates and Projections in US$ Million for thePeriod 2018-2025Table 110: French High Throughput Screening (HTS) HistoricMarket Scenario in US$ Million by Product Type: 2009-2017Table 111: French High Throughput Screening (HTS) Market ShareAnalysis by Product Type: 2009 VS 2019 VS 2025Table 112: French High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Technology:2018-2025Table 113: French High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Technology: 2009-2017Table 114: French High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 115: High Throughput Screening (HTS) Quantitative DemandAnalysis in France in US$ Million by Application: 2018-2025Table 116: French High Throughput Screening (HTS) HistoricMarket Review in US$ Million by Application: 2009-2017Table 117: French High Throughput Screening (HTS) Market ShareAnalysis: A 17-Year Perspective by Application for 2009, 2019,and 2025Table 118: High Throughput Screening (HTS) Quantitative DemandAnalysis in France in US$ Million by End-Use: 2018-2025Table 119: French High Throughput Screening (HTS) HistoricMarket Review in US$ Million by End-Use: 2009-2017Table 120: French High Throughput Screening (HTS) Market ShareAnalysis: A 17-Year Perspective by End-Use for 2009, 2019, and2025GERMANYTable 121: High Throughput Screening (HTS) Market in Germany:Recent Past, Current and Future Analysis in US$ Million byProduct Type for the Period 2018-2025Table 122: German High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Product Type: 2009-2017Table 123: German High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 124: German High Throughput Screening (HTS) Latent DemandForecasts in US$ Million by Technology: 2018-2025Table 125: High Throughput Screening (HTS) Market in Germany:A Historic Perspective by Technology in US$ Million for thePeriod 2009-2017Table 126: German High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 127: High Throughput Screening (HTS) Market in Germany:Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 128: German High Throughput Screening (HTS) Market inRetrospect in US$ Million by Application: 2009-2017Table 129: High Throughput Screening (HTS) Market ShareDistribution in Germany by Application: 2009 VS 2019 VS 2025Table 130: High Throughput Screening (HTS) Market in Germany:Annual Sales Estimates and Forecasts in US$ Million by End-Usefor the Period 2018-2025Table 131: German High Throughput Screening (HTS) Market inRetrospect in US$ Million by End-Use: 2009-2017Table 132: High Throughput Screening (HTS) Market ShareDistribution in Germany by End-Use: 2009 VS 2019 VS 2025ITALYTable 133: Italian High Throughput Screening (HTS) MarketGrowth Prospects in US$ Million by Product Type for the Period2018-2025Table 134: High Throughput Screening (HTS) Historic MarketAnalysis in Italy in US$ Million by Product Type: 2009-2017Table 135: Italian High Throughput Screening (HTS) Market byProduct Type: Percentage Breakdown of Sales for 2009, 2019, and2025Table 136: High Throughput Screening (HTS) Market Estimates andForecasts in Italy in US$ Million by Technology: 2018-2025Table 137: Italian High Throughput Screening (HTS)Retrospective Market Scenario in US$ Million by Technology:2009-2017Table 138: High Throughput Screening (HTS) Market in Italy:Percentage Share Analysis by Technology for 2009, 2019, and2025Table 139: Italian Demand for High Throughput Screening (HTS)in US$ Million by Application: 2018 to 2025Table 140: High Throughput Screening (HTS) Market Review inItaly in US$ Million by Application: 2009-2017Table 141: Italian High Throughput Screening (HTS) Market ShareBreakdown by Application: 2009 VS 2019 VS 2025Table 142: Italian Demand for High Throughput Screening (HTS)in US$ Million by End-Use: 2018 to 2025Table 143: High Throughput Screening (HTS) Market Review inItaly in US$ Million by End-Use: 2009-2017Table 144: Italian High Throughput Screening (HTS) Market ShareBreakdown by End-Use: 2009 VS 2019 VS 2025UNITED KINGDOMTable 145: United Kingdom Market for High Throughput Screening(HTS): Annual Sales Estimates and Projections in US$ Million byProduct Type for the Period 2018-2025Table 146: High Throughput Screening (HTS) Market in the UnitedKingdom: Historic Sales Analysis in US$ Million by Product Typefor the Period 2009-2017Table 147: United Kingdom High Throughput Screening (HTS)Market Share Analysis by Product Type: 2009 VS 2019 VS 2025Table 148: United Kingdom Medium & Long-Term Outlook for HighThroughput Screening (HTS) Market in US$ Million by Technology:2018-2025Table 149: High Throughput Screening (HTS) Market in the UnitedKingdom in US$ Million by Technology: 2009-2017Table 150: United Kingdom High Throughput Screening (HTS)Market Percentage Share Distribution by Technology: 2009 VS2019 VS 2025Table 151: United Kingdom Demand Estimates and Forecasts forHigh Throughput Screening (HTS) in US$ Million by Application:2018 to 2025Table 152: United Kingdom High Throughput Screening (HTS)Market in US$ Million by Application: 2009-2017Table 153: High Throughput Screening (HTS) Market Share Shiftin the United Kingdom by Application: 2009 VS 2019 VS 2025Table 154: United Kingdom Demand Estimates and Forecasts forHigh Throughput Screening (HTS) in US$ Million by End-Use: 2018to 2025Table 155: United Kingdom High Throughput Screening (HTS)Market in US$ Million by End-Use: 2009-2017Table 156: High Throughput Screening (HTS) Market Share Shiftin the United Kingdom by End-Use: 2009 VS 2019 VS 2025SPAINTable 157: Spanish High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 158: Spanish High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 159: High Throughput Screening (HTS) Market in Spain:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 160: High Throughput Screening (HTS) Market Analysis inSpain in US$ Million by Technology: 2018-2025Table 161: High Throughput Screening (HTS) Market in Spain:Historic Review in US$ Million by Technology for the Period2009-2017Table 162: Spanish High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 163: Spanish High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 164: High Throughput Screening (HTS) Market in Spain:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 165: Spanish High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 166: Spanish High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 167: High Throughput Screening (HTS) Market in Spain:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 168: Spanish High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025RUSSIATable 169: Russian High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Product Type: 2018to 2025Table 170: High Throughput Screening (HTS) Market in Russia byProduct Type: A Historic Review in US$ Million for 2009-2017Table 171: Russian High Throughput Screening (HTS) Market ShareBreakdown by Product Type: 2009 VS 2019 VS 2025Table 172: High Throughput Screening (HTS) Market in US$Million in Russia by Technology: 2018-2025Table 173: Russian High Throughput Screening (HTS) MarketRetrospective Analysis in US$ Million by Technology: 2009-2017Table 174: Russian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 175: Russian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Application: 2018 to 2025Table 176: High Throughput Screening (HTS) Historic DemandPatterns in Russia by Application in US$ Million for 2009-2017Table 177: High Throughput Screening (HTS) Market ShareBreakdown in Russia by Application: 2009 VS 2019 VS 2025Table 178: Russian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by End-Use: 2018 to 2025Table 179: High Throughput Screening (HTS) Historic DemandPatterns in Russia by End-Use in US$ Million for 2009-2017Table 180: High Throughput Screening (HTS) Market ShareBreakdown in Russia by End-Use: 2009 VS 2019 VS 2025REST OF EUROPETable 181: Rest of Europe High Throughput Screening (HTS)Market Estimates and Forecasts in US$ Million by Product Type:2018-2025Table 182: High Throughput Screening (HTS) Market in Rest ofEurope in US$ Million by Product Type: A Historic Review forthe Period 2009-2017Table 183: Rest of Europe High Throughput Screening (HTS)Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025Table 184: Rest of Europe High Throughput Screening (HTS)Market Assessment in US$ Million by Technology: 2018-2025Table 185: Rest of Europe High Throughput Screening (HTS)Historic Market Review in US$ Million by Technology: 2009-2017Table 186: High Throughput Screening (HTS) Market in Rest ofEurope: Percentage Breakdown of Sales by Technology for 2009,2019, and 2025Table 187: Rest of Europe High Throughput Screening (HTS)Addressable Market Opportunity in US$ Million by Application:2018-2025Table 188: High Throughput Screening (HTS) Market in Rest ofEurope: Summarization of Historic Demand in US$ Million byApplication for the Period 2009-2017Table 189: Rest of Europe High Throughput Screening (HTS)Market Share Analysis by Application: 2009 VS 2019 VS 2025Table 190: Rest of Europe High Throughput Screening (HTS)Addressable Market Opportunity in US$ Million by End-Use:2018-2025Table 191: High Throughput Screening (HTS) Market in Rest ofEurope: Summarization of Historic Demand in US$ Million byEnd-Use for the Period 2009-2017Table 192: Rest of Europe High Throughput Screening (HTS)Market Share Analysis by End-Use: 2009 VS 2019 VS 2025ASIA-PACIFICTable 193: Asia-Pacific High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Region/Country:2018-2025Table 194: High Throughput Screening (HTS) Market inAsia-Pacific: Historic Market Analysis in US$ Million byRegion/Country for the Period 2009-2017Table 195: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis by Region/Country: 2009 VS 2019 VS 2025Table 196: High Throughput Screening (HTS) Market inAsia-Pacific by Product Type: Estimates and Projections in US$Million for the Period 2018-2025Table 197: Asia-Pacific High Throughput Screening (HTS)Historic Market Scenario in US$ Million by Product Type:2009-2017Table 198: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis by Product Type: 2009 VS 2019 VS 2025Table 199: Asia-Pacific High Throughput Screening (HTS) MarketEstimates and Projections in US$ Million by Technology:2018-2025Table 200: Asia-Pacific High Throughput Screening (HTS)Historic Market Analysis in US$ Million by Technology:2009-2017Table 201: Asia-Pacific High Throughput Screening (HTS)Historic Market Analysis in US$ Million by Technology: 2009 VS2019 VS 2025Table 202: High Throughput Screening (HTS) Quantitative DemandAnalysis in Asia-Pacific in US$ Million by Application:2018-2025Table 203: Asia-Pacific High Throughput Screening (HTS)Historic Market Review in US$ Million by Application: 2009-2017Table 204: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis: A 17-Year Perspective by Application for 2009,2019, and 2025Table 205: High Throughput Screening (HTS) Quantitative DemandAnalysis in Asia-Pacific in US$ Million by End-Use: 2018-2025Table 206: Asia-Pacific High Throughput Screening (HTS)Historic Market Review in US$ Million by End-Use: 2009-2017Table 207: Asia-Pacific High Throughput Screening (HTS) MarketShare Analysis: A 17-Year Perspective by End-Use for 2009,2019, and 2025AUSTRALIATable 208: High Throughput Screening (HTS) Market in Australia:Recent Past, Current and Future Analysis in US$ Million byProduct Type for the Period 2018-2025Table 209: Australian High Throughput Screening (HTS) HistoricMarket Analysis in US$ Million by Product Type: 2009-2017Table 210: Australian High Throughput Screening (HTS) MarketShare Breakdown by Product Type: 2009 VS 2019 VS 2025Table 211: Australian High Throughput Screening (HTS) LatentDemand Forecasts in US$ Million by Technology: 2018-2025Table 212: High Throughput Screening (HTS) Market in Australia:A Historic Perspective by Technology in US$ Million for thePeriod 2009-2017Table 213: Australian High Throughput Screening (HTS) MarketShare Breakdown by Technology: 2009 VS 2019 VS 2025Table 214: High Throughput Screening (HTS) Market in Australia:Annual Sales Estimates and Forecasts in US$ Million byApplication for the Period 2018-2025Table 215: Australian High Throughput Screening (HTS) Market inRetrospect in US$ Million by Application: 2009-2017Table 216: High Throughput Screening (HTS) Market ShareDistribution in Australia by Application: 2009 VS 2019 VS 2025Table 217: High Throughput Screening (HTS) Market in Australia:Annual Sales Estimates and Forecasts in US$ Million by End-Usefor the Period 2018-2025Table 218: Australian High Throughput Screening (HTS) Market inRetrospect in US$ Million by End-Use: 2009-2017Table 219: High Throughput Screening (HTS) Market ShareDistribution in Australia by End-Use: 2009 VS 2019 VS 2025INDIATable 220: Indian High Throughput Screening (HTS) MarketEstimates and Forecasts in US$ Million by Product Type: 2018 to2025Table 221: Indian High Throughput Screening (HTS) HistoricMarket Review by Product Type in US$ Million: 2009-2017Table 222: High Throughput Screening (HTS) Market in India:Percentage Share Breakdown of Sales by Product Type for 2009,2019, and 2025Table 223: High Throughput Screening (HTS) Market Analysis inIndia in US$ Million by Technology: 2018-2025Table 224: High Throughput Screening (HTS) Market in India:Historic Review in US$ Million by Technology for the Period2009-2017Table 225: Indian High Throughput Screening (HTS) Market ShareBreakdown by Technology: 2009 VS 2019 VS 2025Table 226: Indian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by Application:2018 to 2025Table 227: High Throughput Screening (HTS) Market in India:Summarization of Historic Demand Patterns in US$ Million byApplication for 2009-2017Table 228: Indian High Throughput Screening (HTS) Market ShareAnalysis by Application: 2009 VS 2019 VS 2025Table 229: Indian High Throughput Screening (HTS) MarketQuantitative Demand Analysis in US$ Million by End-Use: 2018 to2025Table 230: High Throughput Screening (HTS) Market in India:Summarization of Historic Demand Patterns in US$ Million byEnd-Use for 2009-2017Table 231: Indian High Throughput Screening (HTS) Market ShareAnalysis by End-Use: 2009 VS 2019 VS 2025SOUTH KOREATable 232: High Throughput Screening (HTS) Market in SouthKorea: Recent Past, Current and Future Analysis in US$ Millionby Product Type for the Period 2018-2025Table 233: South Korean High Throughput Screening (HTS)Please contact our Customer Support Center to get the complete TabRead the full report: https://www.reportlinker.com/p04368329/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "Global High Throughput Screening (HTS) Industry", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) today announced the winners of its CX Excellence Awards 2020. Winning organizations were honored for leveraging innovation to drive exceptional customer and employee experiences and improve the bottom line. The 16 award winners across five categories will be recognized at Interactions Live, NICE's first-ever virtual conference highlighting the path to uncompromising customer service via best practices for agility, flexibility and adaptability in today's changing reality. The winners were also featured in a commemorative digital magazine which highlights how they used innovation to provide brand-differentiating customer service. The CX Excellence Award winners span a variety of industries including financial services, healthcare, insurance, retail, telecommunications, utilities and more. Winners demonstrated remarkable results in one of five categories: Barak Eilam, CEO, NICE said, \"We believe innovation is the critical path to success both in dynamic times as well as in measured ones. These organizations define what it means to be CX Agile in ensuring exceptional experiences even as market conditions evolve, and we're proud to celebrate them. We remain committed to developing novel technologies that allow our customers to make a meaningful impact on the lives of their consumers in any business environment. I'd like to take this opportunity to thank the award applicants and winners for sharing their successes with us this year.\" Click here to access the commemorative digital magazine showcasing how the winners used innovation to drive service excellence. About NICE NICE (Nasdaq: NICE) is the worlds leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com. Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICEs marks, please see: www.nice.com/nice-trademarks. Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Eilam, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the Company). In some cases, such forward-looking statements can be identified by terms such as believe, expect, seek, may, will, intend, should, project, anticipate, plan, estimate, or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Companys growth strategy; success and growth of the Companys cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company's products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Companys dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the SEC). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company's reports filed from time to time with the SEC, including the Companys Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.", "role": "user" }, { "content": "NICE Honors CX Excellence Award Winners at Interactions Live, Celebrating the Delivery of Exceptional Experiences and CX Agility Through Innovation Winners powered unmatched customer experiences, motivated employees to boost engagement, flawlessly rolled out cloud and improved their bottom line by leveraging innovation", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: INDIANAPOLIS, Feb. 8, 2021 /PRNewswire/ --eCoronaPasshas announced a partnership with East Alabama Medical Center (EAMC) in providing a vaccination management software solution. The software features the ability for self-scheduling of vaccines, real-time reporting, inventory management, and much more. eCoronaPass is partnering with East Alabama Medical Center (EAMC) for vaccination tracking and management software. eCoronaPass' scalable and functional software meets EAMC's demands, capable of handling over 1 million people at once. Tweet this eCoronaPass was able to meet the deadline of less than 2 weeks to have the software set up, allowing for Alabama residents to sign up and schedule their COVID vaccine. The software is fully scalable and functional to meet the demands of EAMC, capable of handling over 1 million people simultaneously. Through this partnership, eCoronaPass will facilitate and expand its ease-of-use software into other counties in the state of Alabama. The software features compliance with the state, as well as offering real-time reporting. \"We are excited for this new partnership with EAMC,\" says Happy Dhani, CEO of Softbir, the leader of medical software solutions which includes eCoronaPass. \"Our eCoronaPass software has been an effective platform for healthcare providers. We knew that optimizing our software to be able to incorporate effective modules for the vaccination rollout was necessary for successful implementation. It is more critical than ever to rapidly deploy these vaccines with ease of use to healthcare providers and suppliers.\"The United States has overall struggled with the vaccine rollout regarding organization, inventory tracking, scheduling, and more. eCoronaPass is helping EAMC overcome these obstacles to efficiently distribute vaccines to Alabama residents, saving lives and creating a healthier atmosphere for the state. The inventory management feature of the software will allow for EAMC to keep tracking of vaccines being administered to patients, as well as being able to track the total vaccines stored in order to prevent waste since that has become a major problem in the country's rollout. The eCoronaPass software will give EAMC and its patients a peace-of-mind. Patients can take control of their health by scheduling appointments with available EAMC sites that fit their availability and needs. eCoronaPass is built on Amazon Web Services (AWS), compliant with HIPAA/HITECH/NIST standards, and follows all FDA/CDC regulations, allowing for a safe and secure portal for patients and providers.Learn more about eCoronaPass in this video. Media Contact Jim Ray Rodriguez317-561-9125 [emailprotected]https://ecoronapass.com/vaccine-management/ SOURCE Softbir Related Links https://www.softbir.com", "role": "user" }, { "content": "eCoronaPass Partners with East Alabama Medical Center for Vaccination Management and Tracking Software eCoronaPass is offering vaccination management, self-scheduling, inventory tracking, and automated reporting in their partnership with East Alabama Medical Center (EAMC).", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PHILADELPHIA, Feb. 9, 2021 /PRNewswire/ -- In its Fourth Quarter report to shareholders, Hyperion Bank noted that 2020 was a record year for the bank.\"Thanks to the efforts of our dedicated employees, 2020 was a record year for Hyperion,\" says veteran community banker Charles B. (Charlie) Crawford, Jr., Hyperion's Chairman and CEO. \"Loans increased 41%, deposits were up 29% and assets grew to over $250 million.\" Continue Reading Hyperion Bank's Charlie Crawford Hyperion Bank's Lou DeCesare He notes that, in particular, \"Our team members adapted quickly and continually as COVID changed how we go about providing the high level of service our customers expect. That includes being diligent about understanding how the pandemic affected life and business for customers and ensuring their banking was as seamless as possible.\" Louis J. DeCesare, Jr., Hyperion's President & COO, adds other highlights of 2020 for Hyperion: In SBA PPP Round One, Hyperion tackled as much or more of the market than many larger financial institutions, helping more than 300 businesses access funds. May 2020 saw the launch of Hyperion Mortgage, a joint venture based in Atlanta, originating residential mortgage loans in Georgia and Alabama. September marked the first anniversary of Hyperion's expansion to Atlanta, and the bank marked its 14th anniversary in November. Hyperion's growth was recognized in September when the Philadelphia Business Journal included it on its \"Soaring 76\" list of fastest-growing businesses, with 39 percent revenue growth over the last three years. In October 2020 Hyperion shareholders approved the formation of a holding company, Hyperion Bancshares; Hyperion Bank will become a wholly owned subsidiary of the new holding company. At the time, Crawford said the holding company offers greater flexibility and positions the organization to take advantage of future opportunities, including the ways in which it can raise capital. Looking forward, Crawford says that having a great year is actually a challenge of sorts, \"with Team Hyperion focusing on even better ways to leverage technology and engaged, experienced bankers to bring ever-improving service to the communities we serve.\"Hyperion Bankis a full-service community bank, which connects with customers via technology and highly accessible, experienced, enthusiastic bankers who have local decision-making authority. Member FDIC. Equal Housing Lender. Offer of credit is subject to approval. #communitybanking #HyperionBank #HyperionMortgage #GeorgiaBank #PennsylvaniaBank #PhiladelphiaBank #AtlantaBank #communitybank #communitybankerMedia inquiries: B. Andrew (Drew) Plant [emailprotected] 678-637-5532SOURCE Hyperion Bank", "role": "user" }, { "content": "Hyperion Bank Notes 2020 as a Record Year The year that was challenging in so many ways also was the community bank's best year yet", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DENVER, Feb. 25, 2021 /PRNewswire/ --Voyager Space Holdings, Inc. (Voyager), a global leader in space exploration, today announced a major milestone for its subsidiary, Pioneer Astronautics: the successful launch of its new balloon flight technology, the Gas Replacement System (GRS). This month, GRS technology powered the launch of a high-altitude balloon, which travelled to 107,000 feet. GRS flight image Today, most scientific balloons are powered by costly helium, with fuel leakage limiting flight duration. Pioneer's GRS provides a solution to this problem, catalytically dissociating ammonia into a 25 percent nitrogen and 75 percent hydrogen gas mixture, which provides lighter-than-air float gas for balloons. The GRS can generate float gas for large scientific balloons in flight at altitudes above 100,000 feet, doubling or tripling the duration and scientific return of flights by replacing leakage. It can also be used to launch balloons from remote locations without the need to transport heavy helium compressed air cylinders. \"This technology could be of extraordinary value for high altitude science. Ammonia stores as a liquid at 40 psi pressure at 10 times the density of compressed helium at 4000 psi. So a balloon carrying ammonia to make float gas can carry hundreds of times as much replacement gas in tanks of a given weight as it could using helium. This means flights will be able to stay up much longer, getting a lot more science done for the same money,\" said Dr. Robert Zubrin, President, Pioneer Astronautics. \"Earth is not the only planet where we could use this - I can't wait to try out GRS units on Mars, Venus, and Titan too. Congratulations to principal investigator Mark Berggren, Larsson Johnson, Vincent Workman, and the rest of the GRS team for their brilliant success. Let's fly!\" In the test, the GRS was used to launch a high altitude balloon from the ground. Ascending from Lakewood, Colorado, the craft caught the polar vortex at 95,000 feet and accelerated to a velocity to 128 mph, after which it continued its ascent to burst at 107,000 feet. The gondola then descended by parachute, and was recovered on a ranch in Kit Carson County, Colorado, near the Kansas border.The GRS was developed by Pioneer Astronautics with SBIR Phase 1 program support from NASA Goddard Spaceflight Center. \"Pioneer is dedicated to inventing and proving new technologies to advance humanity's reach into space, and the GRS is an innovative example of achieving this goal,\" said Matthew Kuta, president and COO of Voyager. \"This momentous launch marks the achievement of a major milestone for the company, and I'm eager to see how GRS technology extends the life of science flight missions, on Earth and beyond.\" Technical information and photos taken during the test flight can be found at http://www.pioneerastro.com/gas-replacement-system-grs-successful-flight/For more information on Voyager please visit: https://voyagerspaceholdings.com/ About Voyager Space Holdings, Inc.Voyager Space Holdings, Inc. is a global leader in space exploration. Voyager's long-term mission is to create a vertically integrated publicly traded NewSpace company capable of delivering any mission humans can conceive. By centralizing shared services functions at the parent company level, Voyager enables engineer founded and led subsidiaries to focus more on development of innovative products and services. The firm's first in industry model is uniquely tailored to support the growth needs of commercial space companies by offering an alternative solution to traditional private capital models and replaces them with a longer-term approach as a provider of permanent capital. Voyager is led by founders and space industry veterans Dylan Taylor and Matthew Kuta, with a Board of Directors that includes National Security Expert and four-star Air Force General William Shelton, leading investor Gabe Finke, world leading planetary Scientist, Dr. Alan Stern, noted public company director and former undersecretary of technology Dr. Cheryl Shaversand experienced technology executive, board director, and financial leader, Marian Joh. To learn more about Voyager Space Holdings, Inc., please visit: http://voyagerspaceholdings.com/About Pioneer AstronauticsFounded in 1996 by Dr. Robert Zubrin, Pioneer Astronautics is an aerospace research and development company focused on creating new technologies to help open the space frontier. Over the course of its 24 year history, the company has executed over 70 highly-successful R&D programs for NASA, the Department of Defense, the Department of Energy, and private corporations. While its programs have covered a wide range of applications ranging from rocket propulsion to life support systems to high altitude balloon technology, Pioneer's central focus has been in the area that NASA calls \"In Situ Resource Utilization\" (ISRU) but which Zubrin prefers to call \"Local Resource Creation.\" \"There are no such things as natural resources,\" says Zubrin. \"There are only natural raw materials. It is technology that turns materials into resources. The Moon and Mars have no resources now. But they will have plenty once there are resourceful people there with the right tools for the job. That's where we come in.\"Cautionary Statement Concerning Forward-Looking StatementsThis press release contains \"forward-looking statements.\" All statements, other than statements of historical fact, including those with respect to Voyager Space Holdings, Inc.'s (the \"Company's\") mission statement and growth strategy, are \"forward-looking statements.\" Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated.Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Readers should not place any undue reliance on forward-looking statements since they involve these known and unknown uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.SOURCE Voyager Space Holdings, Inc. Related Links http://voyagerspaceholdings.com/", "role": "user" }, { "content": "Voyager Subsidiary, Pioneer Astronautics, Announces Successful Demonstration of First of its Kind Balloon Flight System Gas Replacement System technology provides float gas to enable longer scientific flights", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CLEVELAND, April 23, 2021 /PRNewswire/ -- On April 7, 2021 Solmax the Canada-based leading global supplier of geosynthetics announced that it had agreed to acquire Tencate Geosynthetics, a unit of Koninklijke Ten Cate (the Netherlands) and a top-five global supplier of geosynthetics. The transaction is expected to be completed in the second quarter of 2021, pending regulatory and other approvals. According to The Freedonia Group Analyst Nick Cunningham, \"The motivation behind Solmax's big purchase is easy to understand, as it allows the company to significantly expand its production capacity, sales presence, research operations, and more by taking over such a big player in geosynthetics. This move will significantly expand the variety of geosynthetics products provided by Solmax, which in the past has focused primarily on geomembranes.\" Prior to its acquisition, Tencate Geosynthetics was primarily a supplier of geotextiles, though the company also manufactured geocomposites and geogrids. The company's products were used in a variety of applications, including highways, roads, bridges, and landfills. Tencate Geosynthetics had sales subsidiaries all over the world, and major manufacturing operations in places such as the US, China, Malaysia, and parts of Western Europe that will now be under Solmax's control. Cunningham noted, \"While the merger of two giants of geosynthetics is big news, the global geosynthetics industry will remain fairly fragmented, with the vast majority of companies being small to medium sized firms with limited product lines and limited product reach. This is because barriers to geosynthetics production are fairly limited, as manufacturing requirements are generally low, requiring neither huge factories nor substantial workforces.\" Global knowledge about the benefits of using geosynthetics remains relatively low. However, Solmax is working to change this, including by sponsoring educational organizations like the International Geosynthetics Society, which holds conferences and publishes information on the benefits of incorporating geosynthetics into infrastructure projects. Cunningham further noted, \"Should these informational efforts be successful, this acquisition leaves no doubt that Solmax will be best positioned to take advantage.\" For more information and analysis of opportunities, see The Freedonia Group's report Global Geosynthetics. Freedonia Custom Research is also available for questions requiring tailored market intelligence. About the Freedonia Group The Freedonia Group, a division of MarketResearch.com, is the premier international industrial research division, providing our clients with product analyses, market forecasts, industry trends, and market share information. From one-person consulting firms to global conglomerates, our analysts provide companies with unbiased, reliable industry market research and analysis to help them make important business decisions. With over 100 studies published annually, we support over 90% of the industrial Fortune 500 companies. Find off-the-shelf studies athttps://www.freedoniagroup.com/or contact us for custom research: +1 440.842.2400. Press Contact:Corinne Gangloff+1 440.842.2400[emailprotected] SOURCE The Freedonia Group Related Links https://www.freedoniagroup.com", "role": "user" }, { "content": "Freedonia Analyst Comments on Solmax's Pending Acquisition of Tencate Geosynthetics, Combining Two Leaders in the Global Geosynthetics Industry", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ORLANDO, Fla., June 25, 2020 /PRNewswire/ -- Community Legal Services of Mid-Florida Inc. (CLSMF), a civil legal aid firm servicing 12 counties in Central Florida, is proud to announce that Attorney Martha Pardo is the newly installed Chair of the Public Interest Law Section of the Florida Bar.The Public Interest Law Section of the Florida Bar's missionis to provide an organization open to all who have a common interest in advocacy and enhancement of constitutional, statutory or other rights that protect the dignity, security, justice, liberty, or freedom of the individual or public, and a forum for discussion and exchange of ideas leading to increased knowledge and understanding of the areas of public interest law. Attorney Martha Pardo (PRNewsfoto/CLSMF) As Chair, Martha is responsible for all things related to the public interest law section of the Florida Bar. She will run all Executive Council meetings and is the direct liaison to the Florida Bar, handling all related media requests from other groups outside of Florida. The most recent Chair of Public Interest Law Section of the Florida Bar, Ericka Garcia, Esq., had this to say about the appointment, \"As Immediate Past Chair, I've worked closely with Martha this past year and while we've endured challenges we didn't expect, as all Florida Bar Sections have, I have no doubt that Martha is ready to lead us through the next Bar Year and look forward to her ideas and how we can continue to respond to our membership's programming requests.\" About MarthaMartha Pardo, Esq. is a bilingual, public interest attorney with over a decade of experience handling diverse civil cases. Martha has served vulnerable communities for most of her legal career. She worked in Legal Aid organizations in both North and South Florida advocating primarily for tenant rights. Martha has collaborated with national and local counsel and organizations on impact litigation and advocacy. With her diverse experience, we are confident she will excel in this new position.This is an important time in history for legal aid, and the exact time for legal aid to be taking a leadership role in the state of Florida.About CLSMFCLSMF is on a mission to increase access to justice in Central Florida. Since 1966, dedicated staff attorneys, paralegals, legal assistants, and advocates have worked diligently to solve civil legal problems that impact the day to day lives of residents who cannot afford private attorney fees. By offering free legal assistance and advocacy, CLSMF can assist the area's low-to moderate-income residents obtain and maintain the necessities of life: food, shelter, healthcare, safety, and education.Contact: Michelle Wargo 407-841-7777 [emailprotected] SOURCE Community Legal Services of Mid-Florida Inc.", "role": "user" }, { "content": "Attorney Martha Pardo of Community Legal Services of Mid-Florida Inc., Leading Public Interest Lawyers in Florida", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NASHVILLE, Tenn., April 8, 2021 /PRNewswire/ --Beam Mobile today announces new iPhone SE and XR cases with data-passthrough ports. Beam cases are designed for hospitals using mobile applications and provide battery backup and advanced drop protection.Dean Shortland, CTO of Beam Mobile, says, \"The key new advantage is a micro-USB data port for mobile provisioning and device management in charging cabinets. This helps with large-scale deployment.\" Beam works with JAMF and Imprivata provisioning, and Datamation storage cabinets. Continue Reading Beam iPhone healthcare cases Beam charger options Beam Mobile cases also provide swappable batteries, which allow for seamless exchange without workflow interruption. Beam is used with Epic, Cerner, Allscripts, and Meditech for EMR, and with secure communication apps such as Patientsafe, Vocera, TigerConnect, and Mobile Heartbeat. Beam's impact-resistant polycarbonate shell is designed to protect smartphones from drops in fast-paced environments. Beam is also wipeable with hospital-grade cleaners and is designed for IP54 dust and water resistance.There are several charging options, including a 5-bay sled dock, a 10-bay battery charger, and a single-user dock. Beam is compatible with the iPhone SE, 8, and XR/11.Beam Mobile products are used by Christ Hospital, WVU Medicine, Mount Sinai Health, UNC Medical, Alberta Health, and many others. An Informatics RN at The Valley Hospital, NJ, wrote, \"In all of the craziness, one of our runners dropped an iPhone that was in a Beam case down the elevator shaft. The device was retrieved this morning, and both the case and iPhone were in perfect working conditionnow that's durable!\"Shortland added, \"Beam is essential for hospitals and clinics wanting to protect their mobile investment.We put our products through the paces in testing to ensure we are providingthe most durable case on the market.\" Based in Nashville, Tennessee, Beam Mobile has led the effort to provide smartphone protection in demanding environments. The Beam team is the legacy of Griffin Technology, which made its mark in consumer smartphone cases. Beam Mobile is available from healthcare integrators nationwide, such as CDW Healthcare. For information, contact [emailprotected]We make the casetmPR contact: Jeff Pack[emailprotected]615-473-6149SOURCE Beam Mobile", "role": "user" }, { "content": "Beam Mobile Announces Upgraded Healthcare Cases for iPhone SE/XR", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, June 10, 2020 /PRNewswire/ -- The \"GAS Pharyngitis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027\" report has been added to ResearchAndMarkets.com's offering. This report on the global GAS pharyngitis diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global GAS pharyngitis diagnostics market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global GAS pharyngitis diagnostics market for the forecast period. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. The report sheds light on changing competitive dynamics in the global GAS pharyngitis diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global GAS pharyngitis diagnostics market.The report delves into the competitive landscape of the global GAS pharyngitis diagnostics market. Key players operating in the global GAS pharyngitis diagnostics market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global GAS pharyngitis diagnostics market that have been profiled in this report.Key Questions Answered in GAS Pharyngitis Diagnostics Market Report What is the sales/revenue generated by each product type across all regions during the forecast period? What are the opportunities in the global GAS pharyngitis diagnostics market? What are the major drivers, restraints, opportunities, and threats in the market? Which region is likely to expand at the fastest CAGR during the forecast period? Which test kit types are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period? What was the market share or position of different companies operating in the global market in 2018? The report analyzes the global GAS pharyngitis diagnostics market in terms of product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global GAS pharyngitis diagnostics market. Key Topics Covered: 1. Preface2. Assumptions and Research Methodology3. Executive Summary 4. Market Overview4.1. Introduction4.2. Overview4.3. Market Dynamics4.4. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-20275. Market Outlook5.1. Strategies of Top 3 Players Operating in the Market5.2. Key Industrial Events6. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Product, 2017-2027 6.1. Introduction & Definition6.2. Key Findings / Developments6.3. Market Value Forecast, by Product, 2017-20276.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Product 7. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by End-user, 2017-2027 7.1. Introduction & Definition7.2. Key Findings / Developments7.3. Global GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017-20277.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by End-user8. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Region, 2017-20278.1. Key Findings8.2. Market Value Forecast, by Region8.3. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Region9. North America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-202710. Europe GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-202711. Asia Pacific GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-202712. Latin America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-202713. Middle East & Africa GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-202714. Competition Landscape14.1. Market Player - Competition Matrix (By Tier and Size of companies)14.2. Comparative Ranking Analysis by Company (2018)14.3. Company ProfilesCompanies Mentioned Quidel Corporation BD Abbott Laboratories bioMrieux SA F. Hoffmann-La Roche Ltd Beckman Coulter, Inc. (Danaher) Meridian Bioscience, Inc. DiaSorin S.p.A. Sekisui Diagnostics For more information about this report visit https://www.researchandmarkets.com/r/x9jf6j About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global GAS Pharyngitis Diagnostics Market Analysis to 2027, Featuring Key Players Quidel Corporation, BD, bioMrieux SA and Meridian Bioscience, Inc.", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, July 6, 2020 /PRNewswire/ -- Amid the COVID-19 crisis and the looming economic recession, the Eddy Current NDT Equipment market worldwide will grow by a projected US$161.5 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.5%. Inline Testing Equipment, one of the segments analyzed and sized in this study, is forecast to grow at over 5.2% and reach a market size of US$19.8 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Inline Testing Equipment market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions. Read the full report: https://www.reportlinker.com/p05899396/?utm_source=PRN As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.4% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$4.9 Million to the region's size over the next 7 to 8 years. In addition, over US$4.8 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Inline Testing Equipment segment will reach a market size of US$1.2 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Eddy Current NDT Equipment market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 9.3% over the next couple of years and add approximately US$43.5 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Eddy Current NDT Equipment market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. Competitors identified in this market include, among others, Ashtead Technology Ltd.; Criterion NDT, Inc.; Eddyfi NDT Inc.; Ether NDE Ltd; Fischer Technology Inc.; Foerster Holding GmbH; General Electric Company; ibg NDT Systems Corporation; IMG ULTRASUONI Srl; Magnetic Analysis Corporation Inc.; Olympus Corporation; Rohmann GmbH; Thermo Fisher Scientific, Inc.; UniWest Corporation; Zetec Inc.Read the full report: https://www.reportlinker.com/p05899396/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Eddy Current NDT Equipment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Eddy Current NDT Equipment Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Eddy Current NDT Equipment Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Eddy Current NDT Equipment Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Inline Testing Equipment (Equipment) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 5: Inline Testing Equipment (Equipment) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 6: Inline Testing Equipment (Equipment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Offline Testing Equipment (Equipment) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 Table 8: Offline Testing Equipment (Equipment) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 Table 9: Offline Testing Equipment (Equipment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Rotational Testing Equipment (Equipment) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 Table 11: Rotational Testing Equipment (Equipment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 Table 12: Rotational Testing Equipment (Equipment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 Table 13: Full-Body Inspection/ Leakage Testing Equipment (Equipment) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 Table 14: Full-Body Inspection/ Leakage Testing Equipment (Equipment) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019 Table 15: Full-Body Inspection/ Leakage Testing Equipment (Equipment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 16: Measurement (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 17: Measurement (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019 Table 18: Measurement (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 19: Detection (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027 Table 20: Detection (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019 Table 21: Detection (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Testing & Inspection (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 Table 23: Testing & Inspection (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 24: Testing & Inspection (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 25: Transportation (End-Use Industry) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 Table 26: Transportation (End-Use Industry) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019 Table 27: Transportation (End-Use Industry) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 Table 28: Power Generation (End-Use Industry) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 29: Power Generation (End-Use Industry) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019 Table 30: Power Generation (End-Use Industry) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 31: Oil & Gas (End-Use Industry) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 Table 32: Oil & Gas (End-Use Industry) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 Table 33: Oil & Gas (End-Use Industry) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 Table 34: Heavy Engineering Equipment (End-Use Industry) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 35: Heavy Engineering Equipment (End-Use Industry) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019 Table 36: Heavy Engineering Equipment (End-Use Industry) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Eddy Current NDT Equipment Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 37: United States Eddy Current NDT Equipment Market Estimates and Projections in US$ Thousand by Equipment: 2020 to 2027 Table 38: Eddy Current NDT Equipment Market in the United States by Equipment: A Historic Review in US$ Thousand for 2012-2019 Table 39: United States Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 40: United States Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 41: Eddy Current NDT Equipment Historic Demand Patterns in the United States by Application in US$ Thousand for 2012-2019 Table 42: Eddy Current NDT Equipment Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 Table 43: United States Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by End-Use Industry: 2020 to 2027 Table 44: Eddy Current NDT Equipment Historic Demand Patterns in the United States by End-Use Industry in US$ Thousand for 2012-2019 Table 45: Eddy Current NDT Equipment Market Share Breakdown in the United States by End-Use Industry: 2012 VS 2020 VS 2027 CANADA Table 46: Canadian Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020 to 2027 Table 47: Canadian Eddy Current NDT Equipment Historic Market Review by Equipment in US$ Thousand: 2012-2019 Table 48: Eddy Current NDT Equipment Market in Canada: Percentage Share Breakdown of Sales by Equipment for 2012, 2020, and 2027 Table 49: Canadian Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 50: Eddy Current NDT Equipment Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 51: Canadian Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 52: Canadian Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by End-Use Industry: 2020 to 2027 Table 53: Eddy Current NDT Equipment Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use Industry for 2012-2019 Table 54: Canadian Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 JAPAN Table 55: Japanese Market for Eddy Current NDT Equipment: Annual Sales Estimates and Projections in US$ Thousand by Equipment for the Period 2020-2027 Table 56: Eddy Current NDT Equipment Market in Japan: Historic Sales Analysis in US$ Thousand by Equipment for the Period 2012-2019 Table 57: Japanese Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 58: Japanese Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 59: Japanese Eddy Current NDT Equipment Market in US$ Thousand by Application: 2012-2019 Table 60: Eddy Current NDT Equipment Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 Table 61: Japanese Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 62: Japanese Eddy Current NDT Equipment Market in US$ Thousand by End-Use Industry: 2012-2019 Table 63: Eddy Current NDT Equipment Market Share Shift in Japan by End-Use Industry: 2012 VS 2020 VS 2027 CHINA Table 64: Chinese Eddy Current NDT Equipment Market Growth Prospects in US$ Thousand by Equipment for the Period 2020-2027 Table 65: Eddy Current NDT Equipment Historic Market Analysis in China in US$ Thousand by Equipment: 2012-2019 Table 66: Chinese Eddy Current NDT Equipment Market by Equipment: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 67: Chinese Demand for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 68: Eddy Current NDT Equipment Market Review in China in US$ Thousand by Application: 2012-2019 Table 69: Chinese Eddy Current NDT Equipment Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 70: Chinese Demand for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 71: Eddy Current NDT Equipment Market Review in China in US$ Thousand by End-Use Industry: 2012-2019 Table 72: Chinese Eddy Current NDT Equipment Market Share Breakdown by End-Use Industry: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Eddy Current NDT Equipment Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 73: European Eddy Current NDT Equipment Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 74: Eddy Current NDT Equipment Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 75: European Eddy Current NDT Equipment Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 76: European Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020-2027 Table 77: Eddy Current NDT Equipment Market in Europe in US$ Thousand by Equipment: A Historic Review for the Period 2012-2019 Table 78: European Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 79: European Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 80: Eddy Current NDT Equipment Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 81: European Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 82: European Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by End-Use Industry: 2020-2027 Table 83: Eddy Current NDT Equipment Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use Industry for the Period 2012-2019 Table 84: European Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 FRANCE Table 85: Eddy Current NDT Equipment Market in France by Equipment: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 86: French Eddy Current NDT Equipment Historic Market Scenario in US$ Thousand by Equipment: 2012-2019 Table 87: French Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 88: Eddy Current NDT Equipment Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027 Table 89: French Eddy Current NDT Equipment Historic Market Review in US$ Thousand by Application: 2012-2019 Table 90: French Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 91: Eddy Current NDT Equipment Quantitative Demand Analysis in France in US$ Thousand by End-Use Industry: 2020-2027 Table 92: French Eddy Current NDT Equipment Historic Market Review in US$ Thousand by End-Use Industry: 2012-2019 Table 93: French Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by End-Use Industry for 2012, 2020, and 2027 GERMANY Table 94: Eddy Current NDT Equipment Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Equipment for the Period 2020-2027 Table 95: German Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by Equipment: 2012-2019 Table 96: German Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 97: Eddy Current NDT Equipment Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 98: German Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 99: Eddy Current NDT Equipment Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 Table 100: Eddy Current NDT Equipment Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use Industry for the Period 2020-2027 Table 101: German Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by End-Use Industry: 2012-2019 Table 102: Eddy Current NDT Equipment Market Share Distribution in Germany by End-Use Industry: 2012 VS 2020 VS 2027 ITALY Table 103: Italian Eddy Current NDT Equipment Market Growth Prospects in US$ Thousand by Equipment for the Period 2020-2027 Table 104: Eddy Current NDT Equipment Historic Market Analysis in Italy in US$ Thousand by Equipment: 2012-2019 Table 105: Italian Eddy Current NDT Equipment Market by Equipment: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 106: Italian Demand for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 107: Eddy Current NDT Equipment Market Review in Italy in US$ Thousand by Application: 2012-2019 Table 108: Italian Eddy Current NDT Equipment Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 109: Italian Demand for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 110: Eddy Current NDT Equipment Market Review in Italy in US$ Thousand by End-Use Industry: 2012-2019 Table 111: Italian Eddy Current NDT Equipment Market Share Breakdown by End-Use Industry: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 112: United Kingdom Market for Eddy Current NDT Equipment: Annual Sales Estimates and Projections in US$ Thousand by Equipment for the Period 2020-2027 Table 113: Eddy Current NDT Equipment Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Equipment for the Period 2012-2019 Table 114: United Kingdom Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 115: United Kingdom Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 116: United Kingdom Eddy Current NDT Equipment Market in US$ Thousand by Application: 2012-2019 Table 117: Eddy Current NDT Equipment Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 Table 118: United Kingdom Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 119: United Kingdom Eddy Current NDT Equipment Market in US$ Thousand by End-Use Industry: 2012-2019 Table 120: Eddy Current NDT Equipment Market Share Shift in the United Kingdom by End-Use Industry: 2012 VS 2020 VS 2027 SPAIN Table 121: Spanish Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020 to 2027 Table 122: Spanish Eddy Current NDT Equipment Historic Market Review by Equipment in US$ Thousand: 2012-2019 Table 123: Eddy Current NDT Equipment Market in Spain: Percentage Share Breakdown of Sales by Equipment for 2012, 2020, and 2027 Table 124: Spanish Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 125: Eddy Current NDT Equipment Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 126: Spanish Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 127: Spanish Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by End-Use Industry: 2020 to 2027 Table 128: Eddy Current NDT Equipment Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use Industry for 2012-2019 Table 129: Spanish Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 RUSSIA Table 130: Russian Eddy Current NDT Equipment Market Estimates and Projections in US$ Thousand by Equipment: 2020 to 2027 Table 131: Eddy Current NDT Equipment Market in Russia by Equipment: A Historic Review in US$ Thousand for 2012-2019 Table 132: Russian Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 133: Russian Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 134: Eddy Current NDT Equipment Historic Demand Patterns in Russia by Application in US$ Thousand for 2012-2019 Table 135: Eddy Current NDT Equipment Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 Table 136: Russian Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by End-Use Industry: 2020 to 2027 Table 137: Eddy Current NDT Equipment Historic Demand Patterns in Russia by End-Use Industry in US$ Thousand for 2012-2019 Table 138: Eddy Current NDT Equipment Market Share Breakdown in Russia by End-Use Industry: 2012 VS 2020 VS 2027 REST OF EUROPE Table 139: Rest of Europe Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020-2027 Table 140: Eddy Current NDT Equipment Market in Rest of Europe in US$ Thousand by Equipment: A Historic Review for the Period 2012-2019 Table 141: Rest of Europe Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 142: Rest of Europe Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 143: Eddy Current NDT Equipment Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 144: Rest of Europe Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 145: Rest of Europe Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by End-Use Industry: 2020-2027 Table 146: Eddy Current NDT Equipment Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use Industry for the Period 2012-2019 Table 147: Rest of Europe Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 148: Asia-Pacific Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 149: Eddy Current NDT Equipment Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 150: Asia-Pacific Eddy Current NDT Equipment Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 151: Eddy Current NDT Equipment Market in Asia-Pacific by Equipment: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 152: Asia-Pacific Eddy Current NDT Equipment Historic Market Scenario in US$ Thousand by Equipment: 2012-2019 Table 153: Asia-Pacific Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 154: Eddy Current NDT Equipment Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027 Table 155: Asia-Pacific Eddy Current NDT Equipment Historic Market Review in US$ Thousand by Application: 2012-2019 Table 156: Asia-Pacific Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 157: Eddy Current NDT Equipment Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use Industry: 2020-2027 Table 158: Asia-Pacific Eddy Current NDT Equipment Historic Market Review in US$ Thousand by End-Use Industry: 2012-2019 Table 159: Asia-Pacific Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by End-Use Industry for 2012, 2020, and 2027 AUSTRALIA Table 160: Eddy Current NDT Equipment Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Equipment for the Period 2020-2027 Table 161: Australian Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by Equipment: 2012-2019 Table 162: Australian Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 163: Eddy Current NDT Equipment Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 164: Australian Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 165: Eddy Current NDT Equipment Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 Table 166: Eddy Current NDT Equipment Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use Industry for the Period 2020-2027 Table 167: Australian Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by End-Use Industry: 2012-2019 Table 168: Eddy Current NDT Equipment Market Share Distribution in Australia by End-Use Industry: 2012 VS 2020 VS 2027 INDIA Table 169: Indian Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020 to 2027 Table 170: Indian Eddy Current NDT Equipment Historic Market Review by Equipment in US$ Thousand: 2012-2019 Table 171: Eddy Current NDT Equipment Market in India: Percentage Share Breakdown of Sales by Equipment for 2012, 2020, and 2027 Table 172: Indian Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 Table 173: Eddy Current NDT Equipment Market in India: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019 Table 174: Indian Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 175: Indian Eddy Current NDT Equipment Market Quantitative Demand Analysis in US$ Thousand by End-Use Industry: 2020 to 2027 Table 176: Eddy Current NDT Equipment Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use Industry for 2012-2019 Table 177: Indian Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 SOUTH KOREA Table 178: Eddy Current NDT Equipment Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Equipment for the Period 2020-2027 Table 179: South Korean Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by Equipment: 2012-2019 Table 180: Eddy Current NDT Equipment Market Share Distribution in South Korea by Equipment: 2012 VS 2020 VS 2027 Table 181: Eddy Current NDT Equipment Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2020-2027 Table 182: South Korean Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by Application: 2012-2019 Table 183: Eddy Current NDT Equipment Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 Table 184: Eddy Current NDT Equipment Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use Industry for the Period 2020-2027 Table 185: South Korean Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by End-Use Industry: 2012-2019 Table 186: Eddy Current NDT Equipment Market Share Distribution in South Korea by End-Use Industry: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 187: Rest of Asia-Pacific Market for Eddy Current NDT Equipment: Annual Sales Estimates and Projections in US$ Thousand by Equipment for the Period 2020-2027 Table 188: Eddy Current NDT Equipment Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Equipment for the Period 2012-2019 Table 189: Rest of Asia-Pacific Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 190: Rest of Asia-Pacific Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 191: Rest of Asia-Pacific Eddy Current NDT Equipment Market in US$ Thousand by Application: 2012-2019 Table 192: Eddy Current NDT Equipment Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 Table 193: Rest of Asia-Pacific Demand Estimates and Forecasts for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 194: Rest of Asia-Pacific Eddy Current NDT Equipment Market in US$ Thousand by End-Use Industry: 2012-2019 Table 195: Eddy Current NDT Equipment Market Share Shift in Rest of Asia-Pacific by End-Use Industry: 2012 VS 2020 VS 2027 LATIN AMERICA Table 196: Latin American Eddy Current NDT Equipment Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 197: Eddy Current NDT Equipment Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 198: Latin American Eddy Current NDT Equipment Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 199: Latin American Eddy Current NDT Equipment Market Growth Prospects in US$ Thousand by Equipment for the Period 2020-2027 Table 200: Eddy Current NDT Equipment Historic Market Analysis in Latin America in US$ Thousand by Equipment: 2012-2019 Table 201: Latin American Eddy Current NDT Equipment Market by Equipment: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 202: Latin American Demand for Eddy Current NDT Equipment in US$ Thousand by Application: 2020 to 2027 Table 203: Eddy Current NDT Equipment Market Review in Latin America in US$ Thousand by Application: 2012-2019 Table 204: Latin American Eddy Current NDT Equipment Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 205: Latin American Demand for Eddy Current NDT Equipment in US$ Thousand by End-Use Industry: 2020 to 2027 Table 206: Eddy Current NDT Equipment Market Review in Latin America in US$ Thousand by End-Use Industry: 2012-2019 Table 207: Latin American Eddy Current NDT Equipment Market Share Breakdown by End-Use Industry: 2012 VS 2020 VS 2027 ARGENTINA Table 208: Argentinean Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Equipment: 2020-2027 Table 209: Eddy Current NDT Equipment Market in Argentina in US$ Thousand by Equipment: A Historic Review for the Period 2012-2019 Table 210: Argentinean Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 211: Argentinean Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 Table 212: Eddy Current NDT Equipment Market in Argentina: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019 Table 213: Argentinean Eddy Current NDT Equipment Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 214: Argentinean Eddy Current NDT Equipment Addressable Market Opportunity in US$ Thousand by End-Use Industry: 2020-2027 Table 215: Eddy Current NDT Equipment Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use Industry for the Period 2012-2019 Table 216: Argentinean Eddy Current NDT Equipment Market Share Analysis by End-Use Industry: 2012 VS 2020 VS 2027 BRAZIL Table 217: Eddy Current NDT Equipment Market in Brazil by Equipment: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 218: Brazilian Eddy Current NDT Equipment Historic Market Scenario in US$ Thousand by Equipment: 2012-2019 Table 219: Brazilian Eddy Current NDT Equipment Market Share Analysis by Equipment: 2012 VS 2020 VS 2027 Table 220: Eddy Current NDT Equipment Quantitative Demand Analysis in Brazil in US$ Thousand by Application: 2020-2027 Table 221: Brazilian Eddy Current NDT Equipment Historic Market Review in US$ Thousand by Application: 2012-2019 Table 222: Brazilian Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 223: Eddy Current NDT Equipment Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use Industry: 2020-2027 Table 224: Brazilian Eddy Current NDT Equipment Historic Market Review in US$ Thousand by End-Use Industry: 2012-2019 Table 225: Brazilian Eddy Current NDT Equipment Market Share Analysis: A 17-Year Perspective by End-Use Industry for 2012, 2020, and 2027 MEXICO Table 226: Eddy Current NDT Equipment Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Equipment for the Period 2020-2027 Table 227: Mexican Eddy Current NDT Equipment Historic Market Analysis in US$ Thousand by Equipment: 2012-2019 Table 228: Mexican Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 229: Eddy Current NDT Equipment Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 Table 230: Mexican Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by Application: 2012-2019 Table 231: Eddy Current NDT Equipment Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 Table 232: Eddy Current NDT Equipment Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use Industry for the Period 2020-2027 Table 233: Mexican Eddy Current NDT Equipment Market in Retrospect in US$ Thousand by End-Use Industry: 2012-2019 Table 234: Eddy Current NDT Equipment Market Share Distribution in Mexico by End-Use Industry: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 235: Rest of Latin America Eddy Current NDT Equipment Market Estimates and Projections in US$ Thousand by Equipment: 2020 to 2027 Table 236: Eddy Current NDT Equipment Market in Rest of Latin America by Equipment: A Historic Review in US$ Thousand for 2012-2019 Table 237: Rest of Latin America Eddy Current NDT Equipment Market Share Breakdown by Equipment: 2012 VS 2020 VS 2027 Table 238: Rest of Latin America Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 Table 239: Eddy Current NDT Equipment Historic Demand Patterns in Rest of Latin America by Application in US$ Thousand for 2012-2019 Table 240: Eddy Current NDT Equipment Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 Table 241: Rest of Latin America Eddy Current NDT Equipment Latent Demand Forecasts in US$ Thousand by End-Use Industry: 2020 to 2027 Table 242: Eddy Current NDT Equipment Historic Demand Patterns in Rest of Latin America by End-Use Industry in US$ Thousand for 2012-2019 Table 243: Eddy Current NDT Equipment Market Share Breakdown in Rest of Latin America by End-Use Industry: 2012 VS 2020 VS 2027 MIDDLE EAST Table 244: The Middle East Eddy Current NDT Equipment Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 245: Eddy Current NDT Equipment Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 246: The Middle East Eddy Current NDT Equipment Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p05899396/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "Amid the COVID-19 crisis and the looming economic recession, the Eddy Current NDT Equipment market worldwide will grow by a projected US$161.5 Million, during the analysis period", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Dec. 1, 2020 /PRNewswire/ -- Euclid Transactional, LLC (\"Euclid Transactional\"), a global managing general agent focused on transactional insurance, announced today that Zurich North America will participate in its program. Zurich joins Swiss Re Corporate Solutions, SCOR and Aspen in supporting Euclid Transactional's team, which specializes in representations and warranties insurance underwriting and claims handling services and other deal-related lines of business. Jay Rittberg, Managing Principal of Euclid Transactional, commented, \"We are excited that Zurich, a global leader with a sophisticated understanding of transactional insurance, has joined our panel of large, creditworthy carriers. Their support for our approach shows the value of our enduring focus on strong execution and best-in-class solutions across all types of transactions.\" \"The Euclid team is a proven leader in the transactional insurance space,\" stated Brian Benjamin, Head of Financial Lines for U.S. Commercial Insurance at Zurich North America. \"I am excited to deepen our commitment to the transactional insurance market by joining the Euclid panel. Zurich looks forward to leveraging our strong balance sheet in support of Jay and his seasoned team as they facilitate M&A deals for so many clients that will be putting their trust in us.\" John N. Colis, President and CEO of Euclid Insurance Services and Chairman of Euclid Transactional, noted, \"This expansion of our collaboration with A.M. Best rated A or better carriers adds Zurich's exceptional balance sheet to support M&A transactions.\" Euclid Transactional has increased in scale significantly since its inception in 2016 and today features more than 50 team members. In July 2020, it opened its fifth global office in Frankfurt, Germany. This follows the opening of the firm's Toronto, Canada office and the expansion of its tax insurance practice in 2019. Since its founding, Euclid Transactional has underwrittenover $45 billion of transactional risk limits, insuring deals with a combined valueof over $1.6 trillion across over 2,100 policies. About Euclid TransactionalEuclid Transactional, LLC is a managing general agency specializing in the underwriting of representations & warranties, tax liability, contingent liability and other transactional insurance coverages. Operated by one of the industry's largest teams of experienced underwriters and claims executives, Euclid Transactional provides the size and security of a large insurer with the customer service of a boutique. The firm has offices inNew York,London,Chicago, FrankfurtandToronto, and offers full-service underwriting for deals across the Americas,Europe,Middle EastandAfrica. Euclid Transactional is a subsidiary ofEuclid Insurance Services,a family of program administrators that provides its subsidiaries with advisory, accounting, information technology and human resource services. Euclid Transactional's insurance capacity is provided by premier insurers, all of which are rated AM Best A (Excellent) or better. For more information, visit: www.euclidtransactional.com. About ZurichZurichNorth Americais one of the largest providers of insurance solutions and services to businesses and individuals. Our customers represent industries ranging from agriculture to construction and include more than 90 percent of the Fortune 500. We've backed the building of some of the most recognizable structures inNorth America. Our North American, LEED Platinum headquarters is located in theChicagoarea. We employ approximately 9,000 people inNorth Americaand have offices throughout the U.S. andCanada. Further information is available atwww.zurichna.com. Media Contact:Davis MacMillanRF\|Binder[emailprotected]212-994-7509 SOURCE Euclid Transactional, LLC Related Links http://www.euclidtransactional.com", "role": "user" }, { "content": "Euclid Transactional Adds Zurich to its M&A Insurance Program", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HANOI, Vietnam--(BUSINESS WIRE)--Vietnams leading IT services provider FPT Software has announced its partnership with conglomerate Mitsui & Co., (Mitsui), looking to tap into growing demands for cybersecurity in the Japanese market. The two companies signed a memorandum of understanding to provide cybersecurity services for Japans businesses on February 26, 2021. FPT Software is very excited to work with Mitsui to address the growing demand for cybersecurity solutions in Japan. Here we have assembled a young and experienced team that can cater to various customers needs. FPT Software also looks forward to collaborating with Mitsui to expand our business globally. I believe we could achieve great things in the future, said FPT Software Chairman Chu Thanh Ha. According to a recent report by IBM Security, Japan reported the highest number of cyber-attacks in the Asia Pacific region in 2020. Local enterprises, therefore, have been urged to step up prevention measures. In recent years, FPT Software has actively ramped up research and innovation efforts to strengthen its cybersecurity capabilities. In 2020, the company launched akaSafe, a cloud security compliance product, helping customers in various domains including healthcare, automotive manage risks and build cyber resilience. It also formed a new business unit dedicated to providing cyber security assurance services earlier this month. About FPT Software FPT Software is a global technology and IT services provider headquartered in Vietnam, with more than USD 500 million in revenue and 16,000 employees in 25 countries. As a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Cloud, AR/VR, BPO, and more. It has served 700+ customers worldwide, a hundred of which are Fortune Global 500 companies in the industries of Automotive, Banking and Finance, Logistics & Transportation, Utilities, and more. For more information, please visit www.fpt-software.com. About Mitsui & Co. Ltd. Mitsui & Co. Ltd. is one of the most diversified and comprehensive trading, investment and service enterprises in the world with presence in 64 countries/regions as of April 1, 2021. Utilizing global operating locations, network and information resources, Mitsui is multilaterally pursuing business that ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects in the following fields: Iron & Steel Products, Mineral & Metal Resources, Energy, Infrastructure Projects, Mobility, Chemicals, Food, Food & Retail Management, Wellness, IT & Communication Business, Corporate Development Business. For more information, please visit http://www.mitsui.com.", "role": "user" }, { "content": "FPT Software Joins Hands with Mitsui to Boost Cybersecurity in Japan", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LAS VEGAS, March 1, 2021 /PRNewswire/ --MGM Resorts International (NYSE: MGM) and Entain plc (LSE: ENT), together with their venture in the U.S. BetMGM LLC (\"BetMGM\"), will host a business update event for analysts and investors on Wednesday, April 21, 2021. The event will provide deeper insights into the rapidly growing U.S. sports betting and iGaming business of BetMGM. The virtual event is expected to begin at 11:00 a.m. EDT (4:00 p.m. BST / 8:00 a.m. PDT). Further details, including registration, will be released in due course. ABOUT BETMGMBetMGM is a market leading sports betting and gaming entertainment company, pioneering the online gaming industry. Born out of a partnership between MGM Resorts International (NYSE: MGM) and Entain Plc (LSE: ENT), BetMGM has exclusive access to all of MGM's U.S. land-based and online sports betting, major tournament poker, and online gaming businesses. Utilizing Entain's US-licensed, state of the art technology, BetMGM offers sports betting and online gaming via market leading brands including BetMGM, Borgata Casino, Party Casino and Party Poker. Founded in 2018, BetMGM is headquartered in New Jersey. For more information, visit www.betmgminc.com. ABOUT MGM RESORTS INTERNATIONALMGM Resorts International (NYSE: MGM) is an S&P 500 global entertainment company with national and international locations featuring best-in-class hotels and casinos, state-of-the-art meetings and conference spaces, incredible live and theatrical entertainment experiences, and an extensive array of restaurant, nightlife and retail offerings. MGM Resorts creates immersive, iconic experiences through its suite of Las Vegas-inspired brands. The MGM Resorts portfolio encompasses 29 unique hotel and destination gaming offerings in the United States and Macau, including some of the most recognizable resort brands in the industry such as Bellagio, MGM Grand, ARIA and Park MGM. The Company's 50/50 venture, BetMGM, LLC, offers U.S. sports betting and online gaming through market-leading brands, including BetMGM and partypoker. The Company is currently pursuing targeted expansion in Asia through the integrated resort opportunity in Japan. Through its \"Focused on What Matters: Embracing Humanity and Protecting the Planet\" initiative, MGM Resorts commits to creating a more sustainable future, while striving to make a bigger difference in the lives of its employees, guests, and in the communities where it operates. The global employees of MGM Resorts are proud of their company for being recognized as one of FORTUNE Magazine's World's Most Admired Companies. For more information, please visit us at www.mgmresorts.com. Please also connect with us @MGMResortsIntl on Twitter as well as Facebook and Instagram. ABOUT ENTAIN PLCEntain plc (LSE:ENT) is a FTSE100 company and is one of the world's largest sports-betting and gaming groups, operating both online and in the retail sector. The Group owns a comprehensive portfolio of established brands; Sports Brands include bwin, Coral, Crystalbet, Eurobet, Ladbrokes, Neds and Sportingbet; Gaming Brands include CasinoClub, Foxy Bingo, Gala, Gioco Digitale, partypoker and PartyCasino. The Group owns proprietary technology across all of its core product verticals and in addition to its B2C operations provides services to a number of third-party customers on a B2B basis. The Group has also entered into a joint-venture with MGM Resorts to capitalise on the sports-betting and gaming opportunity in the US. The Group is tax resident in the UK with licenses in more than 20 countries, across five continents. For more information see the Group's website: www.entaingroup.com MGM RESORTS INTERNATIONAL CONTACTS Investment Community News Media CATHERINE PARK BRIAN AHERN Executive Director, Investor Relations Director of Media Relations [emailprotected] [emailprotected] ENTAIN PLC CONTACT David Lloyd-Seed Director of Investor Relations & External Communications [emailprotected] BETMGM CONTACT Elisa Richardson Head of Communications [emailprotected] SOURCE MGM Resorts International Related Links mgmresorts.com", "role": "user" }, { "content": "MGM Resorts International And Entain plc Announce BetMGM Business Update Event", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MILPITAS, Calif.--(BUSINESS WIRE)--ABBYY and Bizagi have formed a strategic alliance stemming from challenges organizations face to maintain business continuity and meet customers needs as they pivot operations in a new socially distant and virtual environment. The companies have already transformed several organizations disrupted manual businesses processes including onboarding, processing of loans, and accounts payable. Efficiency is crucial right now. Its more important than ever for organizations to shift from manual and untraceable processes to agile digital applications, commented Rachel Brennan, Senior Director of Product Marketing at Bizagi. Theres so much that companies can transform using the combination of Bizagis low-code application platform and ABBYYs intelligent document processing capabilities. We look forward to many more successful projects in 2021. Industries where ABBYY and Bizagi have seen the most traction include financial services, manufacturing and the public sector. This is expected to broaden into other industries during 2021. Joint customers include DHL, First Home Bank and others. The speed in which companies are transforming their businesses, often within weeks, is truly unprecedented, and the only way they can accomplish this is by using industry leading digital platforms, commented Bruce Orcutt, SVP of Product Marketing at ABBYY. Along with Bizagi, we are focused on meeting the needs of organizations that are accelerating their digital transformation initiatives by offering them solutions that enable them to clearly understand their data, know their processes, and achieve hyperautomation. Bizagi is the only low-code process platform on the market that provides native integration for all three leading robotic process automation vendors: Automation Anywhere, Blue Prism, and UiPath. ABBYYs Digital Intelligence platform delivers access to real-time data about how organizations processes are currently working and the content that fuels them. Bizagi added a connector for ABBYY solutions to its platform to enable customers to turn unstructured data within documents into structured data ready for automation. Additional resources available include the ABBYY Bizagi partner page, Add Content Intelligence to Bizagi to download the connector, an on-demand webinar, ABBYY: Intelligent Document Processing Integration Made Easy, and the upcoming Finance Process Automation 2020 online event on Dec. 10 at 11:00 a.m. EST Top 3 Technologies To Leverage For Accounts Payable & Finance Automation & How To Deploy Them. Contact [email protected] for information about Bizagis platform, and for information about ABBYY Digital Intelligence solutions contact [email protected]. About Bizagi Bizagis industry leading platform for intelligent process automation connects people, applications, robots and information. As the most business friendly and flexible solution on the market, Bizagi enables true collaboration between business and IT, delivering faster adoption and success. Fueled by a community of over 1 million users, Bizagi powers enterprises worldwide including adidas, BAE Systems and Old Mutual. For more information visit www.bizagi.com About ABBYY ABBYY empowers organizations to gain a complete understanding of their business processes and the content that fuels them with its Digital Intelligence platform. ABBYY technologies are used by more than 5,000 companies, including many of the Fortune 500, and is recognized for its leadership in Intelligent Document Processing (IDP) and Process Discovery & Mining for driving significant impact where it matters most: customer experience, effectiveness, profitability and competitive advantage. ABBYY is a global company with offices in 14 countries. For more information, visit www.abbyy.com or visit us on social on LinkedIn, Twitter and Facebook. ABBYY and the ABBYY Logo are either registered trademarks or trademarks of ABBYY Software Ltd. Other product names mentioned herein may be trademarks and/or registered trademarks of their respective owners and are hereby recognized.", "role": "user" }, { "content": "ABBYY and Bizagi Join Forces to Deliver Intelligent Automation Solutions to Enterprises Striving to Accelerate Digital Transformation Joint customers worldwide in financial services, transportation and logistics, and public sector benefit from leveraging Digital Intelligence with Process Automation", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN FRANCISCO, Jan. 4, 2021 /PRNewswire/ --On December 28, the Ministry of Digital Transformation of Ukraine and the Stellar Development Foundation (SDF) signed a Memorandum of Understanding and Cooperation, within which they will work on the development of a strategy for virtual assets in Ukraine. Under the Memorandum, the Ministry of Digital Transformation and SDFwill work to develop a modern virtual asset marketinfrastructure and enhance Ukraine's status as an innovative digital country in the financial market in Eastern Europe. \"The Ministry of Digital Transformation is working on creating the legal environment for the development of virtual assets in Ukraine. We believe our cooperation with the Stellar Development Foundation will contribute to development of the virtual asset industry and its integration into the global financial ecosystem,\" said Oleksandr Bornyakov, Deputy Minister of Digital Transformation for IT Development. \"Another important aspect of this cooperation is contributing to the development of the infrastructure for a Ukrainian national digital currency. Most of the world's leading countries are developing their own national digital currencies. The National Bank of Ukraine has been researching the possibility of CBDC implementation since 2017. It demonstrates Ukraine's movement towards one of major financial trends. At the Ministry, we aspire to ensure our country's adaptation to technological innovations and competitiveness in the financial market in Eastern Europe.\" The memorandum outlines the core focus of the partnership as follows: cooperation on the development of the virtual assets market in Ukraine; provision of support to projects related to virtual assets; implementation and regulation of stablecoin circulation in Ukraine; and, facilitation of the development of the digital currency of the Central Bank in Ukraine. \"We believe digital assets and national digital currencies are one of the most important innovations of our lifetimes and we are excited to play a role in the creation of Ukraine's digital asset infrastructure,\" said Denelle Dixon, CEO and Executive Director, Stellar Development Foundation. \"Through the leadership of the Ministry, Ukraine has demonstrated its commitment to fostering an environment of innovation for the digital economy. We look forward to working with the Ministry and other stakeholders to digitize the hryvnia, to bring Stellar-based tools and services to the people and businesses of Ukraine, and to introduce new partnership opportunities in Ukraine to businesses in the Stellar ecosystem.\" Stellar Development Foundation will officially launch its activity withUkraine in January 2021. About StellarStellar is a decentralized, fast, scalable, and uniquely sustainable network for financial products and services. It is both a cross-currency transaction system and a platform for digital asset issuance, designed to connect the world's financial infrastructure. Dozens of financial institutions worldwide issue assets and settle payments on the Stellar network, which has grown to over 4.7 million accounts. About the Stellar Development FoundationThe Stellar Development Foundation (SDF) is a non-profit organization that supports the development and growth of Stellar, an open-source network that connects the world's financial infrastructure. Founded in 2014, the Foundation helps maintain Stellar's codebase, supports the technical and business communities building on the network, and serves as a voice to regulators and institutions. The Foundation seeks to create equitable access to the global financial system, using the Stellar network to unlock the world's economic potential through blockchain technology. SOURCE The Stellar Development Foundation Related Links https://www.stellar.org/", "role": "user" }, { "content": "Ukrainian Ministry of Digital Transformation to develop virtual assets and to facilitate CBDC infrastructure with the Stellar Development Foundation USA - English esko - etina Espaa - espaol Polska - Polski - P Deutschland - Deutsch France - Franais Slovensko - slovenina Deputy Minister Oleksandr Bornyakov announces partnership with the Stellar Development Foundation to facilitate development of the virtual assets ecosystem and national digital currency of Ukraine", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOSTON, Nov. 25, 2020 /PRNewswire/ -- Commercial vehicles go battery-electric assisted by battery life of one million miles (fit-and-forget) and ranges of up to 600 miles being imminent. Shenzhen alone has 70,000 electric logistics vehicles. Next come robot buses, robotrucks and robotaxis with driver elimination reducing cost by intensive use. IDTechEx has a report on the topic, \"Electric, Hybrid & Fuel Cell Light Commercial Vehicles 2021-2041\". Continue Reading Number of robot shuttles trialing by country by type. Source: IDTechEx report \"Robot Shuttles and Autonomous Buses 2020-2040\", www.IDTechEx.com/Shuttles (PRNewsfoto/IDTechEx) Radically different robot shuttles will do these tasks and much more. See the IDTechEx report, \"Robot Shuttles and Autonomous Buses 2020-2040\". Specifically for cities, they replace ten or more types of vehicle and they will be allowed to go where none of these are allowed, such as down paths, across plazas, into shopping malls, symmetrical so no U-turns, with some even moving sideways when needed. Superb technology roadmap Expect multiple paybacks such as windows on all sides carrying moving color advertising paying the cost of the school bus mode twice a day. The IDTechEx report, \"Micro-LED Displays 2020-2030: Technology, Commercialization, Opportunity, Market and Players\" describes that new technology. Solar-on-supercapacitor bodies replacing batteries, with wireless top-up? Toyota Woven City plans robot shuttles as the only vehicles allowed centrally, so no congestion or accidents. Its e-Palette robot shuttles reconfigure from fast food to utility vehicles, taxis, buses, hire cars, parcel post and mobile libraries. The poor and disabled are empowered. No sidewalks needed.However, all robot vehicles need to wait to 2030 or so to go big time with trusted, safe, insurable, legal, affordable Level 5 autonomy with no driver capability. Then exponential growth to $18 billion in 2040 awaits. Let us look at the latest situation with robot shuttles followed by an appraisal of new robot versions of what we have already. Very widely trialingThere are 36 projects in 15 countries with trials in 20 countries. Ignore those using golf cars or small buses. They are unable to test even the shuttle essentials such as no U-turns, travel and impact strength in two directions, smallest footprint per passenger, rapid reconfiguration. The best types emerging are upright, boxy, 8-20 person symmetrical vehicles with small footprint, all-round vision, large sliding doors, quiet, zero-emission and able perform many different tasks even in one day, surviving intensive use, gated to never exceed 50-60 kph. They are backed by giants like Toyota and Baidu to startups, one having raised $1 billion. Trials mainly explore new people applications, often free-of-charge, from empowering the poor and disabled, inner circulators or viably filling in gaps in the transportation network and replacing very underutilised vehicles such as school buses and private cars.Local MotorsLocal Motors has recently received $15 million from Future Creation Fund II in Japan for its 80% 3D-printed Olli robot shuttle project trialing worldwide. Its new partner, Florida's Mobility-as-a-Service (MaaS) provider BEEP, plans to deploy hundreds. Olli 2.0 has 160 km range, speed of up to 40 km/h. Its Protean in-wheel motors improve safety, performance and space. Perhaps it will fit Protean 360 degree motor-wheels next like castors on a trolley. See the IDTechEx report, \"Electric Motors for Electric Vehicles: Land, Water, Air 2020-2030\".Einride and Streat are subsetsSwedish \"Einride Pods\" are remotely-controlled electric trucks with no driver's cab. Lee Sungwook has recently drawn a concept food truck \"Streat\" like a windowless robot shuttle. This autonomous, pre-fab food-truck would be customized based on the restaurant running within it and rented out at low cost, he suggests.Pollution drives fewer, not just cleaner vehicles Air pollution is now the world's fourth killer (State of Global Air Report late 2020) - 4.5 million deaths from outdoor air pollution in 2019. Over 90% of the global population lives in areas where fine particulate matter levels do not meet the World Health Organization guidelines. Since even \"zero-emission\" vehicles emit these particles from their tires, the message is now fewer, not just cleaner vehicles. Multipurposing robot shuttles come to the rescue.For the full portfolio ofElectric Vehicle and Roboticsresearch available from IDTechEx please visitwww.IDTechEx.com/Research. IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact[emailprotected]or visitwww.IDTechEx.com.Images download: https://www.dropbox.com/sh/d382lqucgqnnxb3/AADzj1T6JeD9_rX3zl9HzcYra?dl=0Media Contact: Natalie Moreton Digital Marketing Manager [emailprotected]+44(0)1223 812300 Social Media Links:Twitter: https://www.twitter.com/IDTechExLinkedIn: https://www.linkedin.com/company/idtechex/Facebook: https://www.facebook.com/IDTechExResearchSOURCE IDTechEx", "role": "user" }, { "content": "Robot Shuttle $18 Billion Market Attracts Diversity, IDTechEx Reports", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Dec. 11, 2020 /PRNewswire/ -- The \"Chicory Market by Product Type (Extracts, Roasted, Instant Powder, Flour), Form (Powder, Cubes, Liquid), Plant Part, Application (Food & Beverage, Dietary Supplement, Feed & Pet food, Cosmetics & Personal Care), and Region - Global Forecast to 2025\" report has been added to ResearchAndMarkets.com's offering. The chicory market is projected to grow at a CAGR of 5.7% from 2020 to reach USD 905.3 million by 2025. Factors such as the rising costs of coffee beans, increasing consumption of organic foods and beverages, and the growing number of applications of chicory are projected to drive the growth of the chicory industry during the forecast period. However, the growth of the chicory market is inhibited by factors, such as health risks associated with heavy consumption of chicory. In addition, higher technical expertise required for producing certain chicory-based products along with limited consumer awareness inhibits the growth of this market.By type, the instant powder segment is projected to grow at the highest CAGR during the forecast period. Owing to the functional benefits and availability of instant powder have led to an increase in demand for it. Also, it's largely consumed across B2B as well as B2C segments as well. Moreover, demand for caffeine-free ready-to-drink beverages to boost the demand for instant powder. In its instant form, chicory is ideal for all types of drinks and a wide range of desserts. Its slightly caramelized taste gives them deep flavors with a hint of bitterness. The majority of the players prevailing in the chicory market offer the instant powder type of chicory, and hence, it is expected to grow at a substantial rate, in the coming years. By form, the powder form is estimated to account for the fastest growth rate. The powdered form of chicory is the most widely known chicory product in the market. In powder form, roasted chicory can be consumed by itself or easily mixed with coffee, enhancing various flavors, adding a touch of sweetness, and reducing the caffeine content of an array of beverages. Most chicory manufacturing and processing companies across the world mainly produce and market roasted chicory powder. The demand for powder chicory is high because most coffee manufacturing companies mix chicory powder with coffee so as to enhance its taste and aroma. This is also an effective way for coffee manufacturers to protect margins. Hence, all of this results in exhibiting high growth potential for the powder form of chicory, during the forecast period. By plant-part, the root segment is projected to grow at the highest CAGR during the forecast period. Chicory roots are also being used widely in pet foods and feed, as chicory is highly digestible for ruminants and has a low fiber concentration. Chicory roots are a substitute for oats for horses due to their protein and fat content. Apart from these applications, the chicory roots are widely demanded by the food & beverage manufacturing companies. All these reasons are causing the demand for chicory roots to rise, and hence, in many countries, the cultivation of chicory roots is witnessing an increase. Thus, the market is projected to witness a positive outlook in the coming years. By application, the food & beverage segment is expected to record the highest CAGR during the forecast period. Chicory finds its most important and wide application in the food & beverage industry. Furthermore, chicory is generally considered to be healthy because of its high inulin content, and thereby is demanded by most of the food & beverage companies. The flowers and leaves may be used in salads and flavored vinegar. Apart from that, chicory flour extracted at the very initial stage of processing, is used as filler and flavor enhancer in many bakery products, such as breads, cookies, and cakes. Thus, the food & beverage application of chicory are witnessing an increase, in turn driving the growth. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period The market for chicory is still in the nascent stage in the region, particularly in countries, such as India, Japan, and other developing countries, in the region. This is attributed to the countries in the region with a dense population, of which a majority of the population is either unaware of such health benefitting ingredients or have limited spending power for premium organic and all-natural food products. However, people are becoming aware of the association of high risks of chronic diseases with unhealthy dietary lifestyles and the lack of essential nutrients in the body. A number of key players are also expanding and investing in the region. Thus, all these factors are projected to drive the major market growth in the coming few years. Key Topics Covered: 1 Introduction 2 Research Methodology3 Executive Summary4 Premium Insights4.1 Brief Overview of the Chicory Market4.2 Chicory Market, by Region4.3 Chicory Market, by Type4.4 Chicory Market, by Form4.5 Chicory Market, by Plant Part4.6 Chicory Market, by Application4.7 Europe: Chicory Market, by Type & Country4.8 Chicory Market, by Key Countries5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Rise in Concern Regarding Negative Effects due to High Intake of Caffeine5.2.1.2 Preference for Chicory as a Cheaper Substitute for Coffee5.2.1.3 High Medicinal Values and Health Benefits Associated with the Consumption of Chicory5.2.1.4 Easy Cultivation Process of the Chicory Crop5.2.1.5 Recent Government Regulations Upholding the Dietary Fiber Status for Chicory Roots5.2.2 Restraints5.2.2.1 High Dependency on Mainstream Products Such as Coffee5.2.2.2 Health Risks Associated with Heavy Consumption of Chicory5.2.3 Opportunities5.2.3.1 Rise in Demand for Chicory and Chicory-Based Products Across Several Emerging Markets5.2.3.2 Growth in Applications of Chicory Across Various Industries5.2.4 Challenges5.2.4.1 Higher Technical Expertise Required for Producing Certain Chicory-Based Products5.2.4.2 Limited Consumer Awareness About Chicory Products5.2.5 Impact of COVID-19 on Chicory5.3 Patent Analysis5.4 Pricing Analysis5.5 Trade Analysis5.6 Ecosystem5.7 Yc-Ycc Shift6 Regulations6.1 Food Safety Authority of Ireland6.2 Food Safety and Standards Authority of India (Fssai)6.3 European Commission6.4 Chicory as Soluble Dietary Fiber and Its Regulations6.5 Prosky Method6.6 Mccleary Method6.7 Rapid Integrated Total Dietary Fiber7 Case Study Analysis7.1 Case Studies on Top Industry Innovations and Best Practices7.1.1 Innovations and Developments in Chicory Applications and Products to Cater to the Dynamic Consumer Needs: a Positive Outlook7.1.2 Higher Demand for Chicory as a Cheaper and Healthier Substitute to Various Ingredients Drives Investments and Expansions by Key Players7.1.3 Chicory Ingredients Play an Essential Role in Skincare8 Chicory Market, by Type8.1 Introduction8.2 COVID-19 Impact Analysis8.3 Extracts8.3.1 Multiple Application Areas for Extracts Including Food & Beverages and Dietary Supplements8.4 Roasted Chicory8.4.1 Growing Demand for Coffee Expands the Growth Potential for Roasted Chicory8.5 Instant Powder8.5.1 Demand for Caffeine-Free Ready-To-Drink Beverages to Boost the Demand for Instant Powder8.6 Chicory Flour8.6.1 Increase in Number of Applications Areas and Rise in Demand from Bakery Industry8.7 Other Types8.7.1 Availability of Other Types at a Cheaper Price Points for Food & Beverage Product Manufactures9 Chicory Market, by Form9.1 Introduction9.2 COVID-19 Impact Analysis9.3 Powder9.3.1 Widespread Availability and Acceptability of the Powder Form of Chicory9.4 Cubes9.4.1 Growth Awareness Regarding the Usability of Chicory Cubes Across an Array of Industries9.5 Liquid9.5.1 Rise in Innovations and Developments in Application of Liquid Form of Chicory9.6 Other Forms9.6.1 Diverse Usage of These Forms of Chicory Across an Array of Industries10 Chicory Market, by Plant Part10.1 Introduction10.2 COVID-19 Impact Analysis10.3 Leaf10.3.1 Rise in Number of Consumers Preferring Healthier Food Options Such as Salads10.4 Roots10.4.1 Growth in Areas of Applications of Chicory Roots Across Various Industry Applications10.5 Other Plant Parts10.5.1 Increase in Number of Innovations and Developments Introduced with the Use of Other Plant Parts of Chicory11 Chicory Market, by Application11.1 Introduction11.2 COVID-19 Impact Analysis11.3 Food & Beverages11.3.1 Widespread Acceptability and Usage Across Regions by Several Players in an Array of Food Applications11.4 Dietary Supplements11.4.1 Rise in Demand and Awareness for Natural and Organically Sourced Health Supplements11.5 Feed & Pet Food11.5.1 Increase in Developments and Innovations in the Feed & Pet Food Industry11.6 Cosmetics & Personal Care11.6.1 Developing Applications of Chicory in the Skincare Industry with Consumers Shifting Toward All-Natural Products12 Chicory Market, by Region12.1 Introduction12.2 COVID-19 Impact Analysis12.3 North America12.4 Europe12.5 Asia-Pacific12.6 South America12.7 Rest of World13 Competitive Landscape13.1 Overview13.2 Key Developments of the Leading Players in the Chicory Market, 2018-202013.3 Market Share Analysis, 202013.4 Competitive Scenario14 Company Evaluation Matrix and Company Profiles14.1 Competitive Leadership Mapping14.2 Cosucra Groupe Warcoing14.3 Delecto Foods Pvt Ltd14.4 Beneo Ghmb14.5 Sensus14.6 Leroux14.7 Cargill Incorporated14.8 Reily Foods Company14.9 Pioneer Chicory14.10 Pmv Nutrient Products Pvt Ltd14.11 Farmvilla Food Industries Pvt Ltd14.12 Murlikrishna Foods Pvt Ltd14.13 Starwest Botanicals14.14 Stokros Company Ltd14.15 Nature's Gold Production14.16 Organic Herb Trading Co14.17 Narasu's Coffee Company14.18 Np Nutra14.19 Shaanxi Sciphar Natural Product Co Ltd14.20 Jamnagar Chicory Industries14.21 Herbs & Crops Overseas15 Appendix For more information about this report visit https://www.researchandmarkets.com/r/fjjxcz Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Chicory Market by Product Type, Form, Plant Part, Application, and Region - Global Forecast to 2025", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HONG KONG, April 7, 2021 /PRNewswire/ --iClick Interactive Asia Group Limited(\"iClick\" or the \"Company\") (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, is proud to launch its new Enterprise Solutions flagship standard product \"iSmartGo\", a SaaS-based cross-border smart retail solution that enables international brands to access the enormous purchasing power in China through efficiently building and operating their own private domain traffic marketplacesin WeChat ecosystem. iSmartGoexpands iClick's standard product offerings and potential client base to brands which have not yet established a presence in China. The ongoing rollout of standard products is a reflection of the company's determination to further ramp up its Enterprise Solutions business and gain more mid-tier clients in 2021. iSmartGohelps international clients address the challenges of cross-border e-commerce when they first step into the China market. This new standard SaaS product reduces the cost of consumer acquisition and increases consumer retention through five key functions: iSmartGo'spowerful SaaS-based WeChat mini-program development platform offers diverse and ready-to-use store templates to fit clients' business needs. The platform also provides various smart tools for marketing activities to increase consumer conversion and purchase rate. iSmartGo integrates with reliable logistics companies to provide one-stop cross-border logistic services, creating an end-to-end e-commerce supply chain including overseas shipping, customs declaration and real-time delivery status tracking. iSmartGo features an all-in-one payment solution that supports cross-border payments in several regions. Leveraging iClick's advanced marketing technology, iSmartGo powers comprehensive advertising promotions to drive quality traffic and conversions covering all ad marketplaces in the Tencent ecosystem as well as open ad marketplaces. iSmartGo's cross-channel private domain traffic data analytics, generates intelligent insights into clients' sales performance and consumer behavior, helping clients make smart business decisions. \"One of iClick's missions is to develop standard products that help large and medium-size local and international brands to achieve success in the China market,\" said Jian \"T.J.\" Tang, Chief Executive Officer and Co-Founder of iClick. \"Our latest SaaS-based enterprise solution, iSmartGo, leverages the WeChat mini-program platform to help international brands who are new to the market to break through pain points and supercharge sales growth. We will continue to focus on developing and upgrading our technologies and solutions as our SaaS-based offerings accelerate the growth of our Enterprise Solutions business.\" Formore information on how iSmartGo can help your business, please contact [emailprotected]. About iClick Interactive Asia Group Limited iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences inChina. Built on cutting-edge technologies, our proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences inChina. Headquartered inHong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide includingAsiaandEurope. For more information, please visitir.i-click.com. Safe Harbor Statement This announcement contains forward-looking statements, including those related to the Company's business strategies, operations and financial performance. These statements constitute \"forward-looking\" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \"will,\" \"expects,\" \"anticipates,\" \"future,\" \"intends,\" \"plans,\" \"believes,\" \"estimates,\" \"confident\" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's fluctuations in growth; its success in implementing its mobile and new retail strategies, including extending its solutions beyond its core online marketing business; its success in structuring a CRM & Marketing Cloud platform; relative percentage of its gross billing recognized as revenue under the gross and net models; its ability to retain existing clients or attract new ones; its ability to retain content distribution channels and negotiate favorable contractual terms; market competition, including from independent online marketing technology platforms as well as large and well-established internet companies; market acceptance of online marketing technology solutions and enterprise solutions; effectiveness of its algorithms and data engines; its ability to collect and use data from various sources; ability to integrate and realize synergies from acquisitions, investments or strategic partnership; fluctuations in foreign exchange rates; and general economic conditions in China and other jurisdictions where the Company operates; and the regulatory landscape in China and other jurisdictions where the Company operates. Further information regarding these and other risks is included in the Company's annual report on Form 20-F and other filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law. For investor and media inquiries, please contact: In China: In the United States: iClick Interactive Asia Group Limited Core IR Lisa Li Tom Caden Phone: +86-21-3230-3931 #892 Tel: +1-516-222-2560 E-mail: [emailprotected] E-mail: [emailprotected] SOURCE iClick Interactive Asia Group Limited Related Links www.optaim.com", "role": "user" }, { "content": "iClick Interactive Helps International Brands Access the Power of Private Domain Traffic in China with New SaaS-based Standard Solution, iSmartGo", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA, April 8, 2020 /PRNewswire/ --Brightlinkis scaling up its network capacity to help businesses ensure critical voice and messaging connections as well as enable unprecedented volumes of emergency notifications. The company is also working closely with organizations that need extra capacity right now such as education technology giant Blackboard, which is focused on bringing remote learning, professional development and community notification solutions to global customers in the K12, higher education, government and business sectors. As a leading education technology company for teaching, learning and student engagement, Blackboard is helping K12 districts and higher education institutions provide families and the broader education community with critical updates via email, voice messages, and SMS texting through its suite of community engagement solutions. In March alone, Blackboard experienced a 3.5x increase in voice calls through its Mass Notification & Connect solutions. This surge in activity is in direct response to the widespread shift to remote teaching and learning. \"Network capacity - which is always important - is critical right now, and the whole industry is coming together to help address this,\" said Joe White, Brightlink Chief Technology Officer. \"We're seeing the largest communications volumes in history and are committed to helping customers - whether businesses providing important services or loved ones trying to stay in touch with friends and family.\" Brightlink, which does a lot of work in the education sector as well as in retail, financial services and the UCaaS and collaboration industries, is focused on both expanded capacity for voice calls and SMS messages as well as emergency notifications. The company owns and operates a nationwide IP voice and messaging network that easily scales for companies in need. Brightlink is also adding different communications solutions such as business messaging, which allows businesses to connect with customers more efficiently via text using their existing phone numbers. \"Nearly half of the nation's school districts rely on Blackboard's Community Engagement solutions to relay vital information to families, educators, and students across critical communications channels,\" said Christina Fleming, Vice President of K12 at Blackboard. \"We've worked hand-in-hand with Brightlink over the past several weeks to facilitate an unprecedented number of communications to support K12 and higher education institutions as they transition to remote teaching and learning environments.\" Blackboard is working closely with K12 districts and higher institutions to support their education continuity efforts and make the implementation of Blackboards virtual conferencing tool, Blackboard Collaborate, and Blackboard Learn, its flagship Learning Management System, feasible.The Company is also offering a library of learning and communications resources to help K12 educators and higher education instructors cope with the COVID-19 outbreak. These resources can be found here. For businesses looking for extra network capacity and/or help with customer notifications or emergency notifications, email[emailprotected]. About Brightlink Brightlink is a leading communications platform and technology company that delivers voice, messaging, analytics and cloud-based solutions. Our industry-leading CPaaS platform, technology solutions, and network services are used by companies ranging from small to mid-sized businesses to the largest enterprises and communication service providers around the globe. We power more than 35 billion communication interactions each year with industry-leading quality of service, 24x7 support, and a next-generation IP network that has the highest levels of performance, reliability, scalability and security. Brightlink is based in Atlanta, GA. Visit www.brightlink.com and follow us on Twitter, LinkedIn and Facebook. For Brightlink media inquiries, please contact: Rebecca Harbin Allison+Partners 404-832-0698 [emailprotected] SOURCE Brightlink Related Links http://www.brightlink.com", "role": "user" }, { "content": "Brightlink Scaling Up Capacity to Help Businesses Ensure Uninterrupted Customer Communications E-Learning Company Blackboard Scaling 3X Normal Volume to Meet Demand", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Pain Therapeutics - Drugs, Markets and Companies\" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report describes the latest concepts of pathomechanisms of pain as a basis for the management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brain imaging. Most of the currently used analgesic drugs fall into the categories of opioids and nonsteroidal anti-inflammatory drugs such as COX-2 inhibitors. Non-opioid analgesics include ketamine, an N-methyl-D-aspartate receptor antagonist. Adjuvant analgesics include antidepressants and antiepileptic drugs used for the treatment of neuropathic pain. Management of pain is multidisciplinary and includes both pharmacological and non-pharmacological methods such as acupuncture, transcutaneous electrical nerve stimulation and surgery. Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan. Drug delivery is an important consideration in pain treatment. Controlled release preparations provide a steady delivery of analgesics. Well-known non-injection methods such as transdermal, pulmonary, and intranasal applications have been used. Topical analgesics and local anesthetics are also available. Devices such as implanted pumps are used for the delivery of drugs such as opioids intrathecally (introduction into spinal subarachnoid space by lumbar puncture) in patients with cancer pain. The wide variety of drugs in development includes opioid receptor ligands, bradykinin antagonists, mPGES-1 inhibitors, glutamate receptor antagonists, substance P and neurokinin receptor antagonists, norepinephrine transporter inhibitors, P2X2 neuron receptor antagonists and nitric oxide-based analgesics. A number of cannabinoids are also in development for pain. Fish-derived tetrodotoxin was initially focused on an indication of opiate addiction withdrawal but is found to have an analgesic action as well. Cone shells contain therapeutically useful peptides including the conotoxins, and one such peptide, ziconotide, has been approved. Various cell and gene therapies are also being developed for the management of pain. Advances in molecular and biological techniques are markedly advancing our understanding of pain. Understanding the pathophysiology of pain is an important factor in the discovery of rational therapies for pain. Advances in pharmacogenomics and pharmacogenetics are enabling the development of personalized approaches to the management of pain. Over 500 companies have been identified to be involved in developing or marketing pain therapeutics and 173 of these are profiled in the report along with 156 collaborations. These are a mix of pharmaceutical companies and biotechnology companies. The worldwide analgesic markets were analyzed for the year 2020 and projected to 2030. Calculations are based on the epidemiology of various painful conditions and the development of analgesic drugs and devices. Unfulfilled needs for analgesics are identified and strategies are outlined to develop markets for analgesic drugs. The report is supplemented with 77 tables, 25 figures, and 600 selected references to the literature. The report contains information on the following: Key Topics Covered: Executive Summary 1. Basic Aspects of Pain 2. Assessment of Pain and Analgesics 3. Pharmacotherapy of Pain 4. Management of Pain 5. Drug Delivery for Pain 6. Drug Development for Pain 7. Safety, Regulatory and Legal issues of pain management 8. Pain Markets 9. Future of Pain Therapeutics 10. Companies Involved in Pain Therapeutics 11. References For more information about this report visit https://www.researchandmarkets.com/r/ajbhix", "role": "user" }, { "content": "Global Pain Therapeutics Market Report 2021 - Profiling 173 Companies Along with 156 Collaborators - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MILWAUKEE, July 13, 2020 /PRNewswire/ --A. O. Smith Corporation (NYSE:AOS), one of the world's leading manufacturers of residential and commercial water heating equipment and boilers, as well as a manufacturer of water treatment and air purification products, today announced the upcoming retirement of Peter Martineau as chief information officer/senior vice president and the hiring of S. Melissa Scheppele as Martineau's successor. Martineau, who is retiring in late August, and Scheppele, who is joining A. O. Smith on July 13, will work together in the coming weeks to ensure a smooth and seamless transition. Peter Martineau, A. O. Smith Corporation S. Melissa Scheppele, A. O. Smith Corporation \"I want to thank Peter for his many years of service and dedication to A. O. Smith,\" said Kevin Wheeler, chairman and chief executive officer of A. O. Smith Corporation. \"Peter has been a key leader for our Company for over 25 years. He has held progressively responsible roles in finance and customer service before taking on the leadership responsibility for the SAP Implementation. Shortly thereafter, he was named CIO. Under Peter's leadership, we have successfully implemented SAP and SuccessFactors at all locations in North America. We wish him all the best in his retirement.\" \"We're pleased to welcome Melissa Scheppele to the A. O. Smith organization,\" continued Wheeler. \"She is a strong IT leader with a wealth of experience in establishing global IT strategies and building and directing complex global information technology teams. She is sure to be an asset to our Company, given her extensive background in developing processes and leveraging technology solutions to help advance organizations.\" As Chief Information Officer, Scheppele will be responsible for the continued growth and transformation of the Company's information technology platforms, as well as the creation of the Company's technology strategies to assist the Company in meeting its goals and objectives. Additionally, Scheppele will serve as a member of the Company's Executive Leadership Team, which is responsible for shaping the Company's overall corporate strategy and direction.Previously, Scheppele served as chief information officer and vice president at Triumph Group, a global aerospace and defense business, where she drove the creation of IT shared services to create efficiencies within the organization. Prior to that, Scheppele served as chief information officer and vice president at Ascend Performance Materials, a global specialty chemical manufacturer, where she led an initiative to upgrade the company's IT infrastructure and leveraged technology platforms to help advance operations. Scheppele has also held management positions at: CIO By Request, Cooper Industries, Tyson Foods and Nestle USA. She holds a Bachelor of Arts in public administration and political science from California State University, Fullerton. About A. O. SmithA. O. Smith Corporation, with headquarters in Milwaukee, Wis., is a global leader applying innovative technology and energy-efficient solutions to products manufactured and marketed worldwide. Listed on the New York Stock Exchange (NYSE), the company is one of the world's leading manufacturers of residential and commercial water heating equipment and boilers, as well as a manufacturer of water treatment and air purification products. For more information, visit www.aosmith.com. SOURCE A. O. Smith Corporation Related Links http://www.aosmith.com", "role": "user" }, { "content": "A. O. Smith Announces Retirement of Peter Martineau and Hiring of S. Melissa Scheppele as Chief Information Officer", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Global Neobanking Market By Account Type (Business Account and Savings Account), By Application (Enterprises, Personal and Others), By Region, Industry Analysis and Forecast, 2020 - 2026\" report has been added to ResearchAndMarkets.com's offering. The Global Neobanking Market size is expected to reach $333.4 billion by 2026, rising at a market growth of 47.1% CAGR during the forecast period. Neobanks provide a broad range of banking solutions with no physical branches or offices. The rising demand for the comfort of customer in the banking industry is anticipated to boost the market growth. Neobanks are customer-centric and provide customized services to customers, which make them different from conventional banks. Neobank platforms help users to validate their service offerings in real-time with the help of mobile sites and online channels. With the help of these platforms, the need for human interference is eliminated, hence decreasing errors related to the transaction. In addition, neobanking offers numerous advantages like quick servicing, healthy interest rates, and cost-effective banking, which are anticipated to boost the growth of the market during the forecast years. Neobanks have considerable growth potential which is boosted by its low-cost model for end-users with very low or no monthly fees for financial services like deposits, withdrawals, and balance maintenance. The market potential for neobanks is driven by the rising penetration of internet and the smartphones across the globe. Also, the global market competition is boosted by the increasing customer interest, hence pushing neobanks to introduce various features like sign-up incentives and overdraft protection. Various neobanks work under a freemium model, under which they provide their services for free, hence appealing to a broad customer base. Customers are also extensively accepting neobanking services due to advantages like personal finance management features, such as low-interest rates, and enhanced user experience. By Account Type Based on Account Type, the market is segmented into Business Account and Savings Account. The market was dominated by the business account segment in 2019. Several businesses globally are adopting neobanking as the preferred method of payment for bulk payouts. Moreover, neobanking models smoothly incorporate banking into business workflows with developer-friendly banking Application Programming Interface (API) to boost the fast and scalable growth of businesses. By Application Based on Application, the market is segmented into Enterprises, Personal and Others. The personal application segment is expected to observe considerable growth over the forecast period. The massive penetration rate of smartphones has facilitated customers to extensively choose neobanking services due to convenience and ease of use. The services are provided utilizing mobile app interfaces, which further assist money transfers and payments with the help of the app. The comfort of opening and operating accounts efficiently is further expected to boost the adoption of neobanking over the forecast years. By Region Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific is anticipated to emerge as the highest growing market over the forecast period. The increasing adoption of internet services, along with the high utilization of smartphones, is anticipated to push the market growth. In order to accelerate modernization and innovation through competition, regional regulators are slowly creating neobanking systems for wider participation. New entrants are likely to explore avenues to introduce extremely related services in the region with an exceptional level of ease & comfort and low pricing. Companies Profiled Unique Offerings from the Publisher Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 Cardinal Matrix 3.2 Recent Industry Wide Strategic Developments 3.3 Top Winning Strategies 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020) 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May - 2020, Nov) Leading Players Chapter 4. Global Neobanking Market by Account Type 4.1 Global Neobanking Market Business Account Market by Region 4.2 Global Neobanking Market Savings Account Market by Region Chapter 5. Global Neobanking Market by Application 5.1 Global Enterprises Market by Region 5.2 Global Personal Market by Region 5.3 Global Others Market by Region Chapter 6. Global Neobanking Market by Region 6.1 North America Neobanking Market 6.2 Europe Neobanking Market 6.3 Asia Pacific Neobanking Market 6.4 LAMEA Neobanking Market Chapter 7. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/ulislk", "role": "user" }, { "content": "Global Neobanking Market (2020 to 2026) - by Account Type, Application and Region - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CINCINNATI--(BUSINESS WIRE)--Great American Insurance Group announces the retirement of Mark R. Lonneman, Sr., Divisional President of its Property & Casualty Groups Risk Solutions Division, effective April 2021. Mr. Lonneman began his 41-year career with Great American as a casualty underwriter in the Agricultural Excess & Surplus Lines operation. He later joined the Home Office Underwriting Department in 1985 and held positions of increasing responsibility in underwriting management roles. In 2010, Mr. Lonneman was named Divisional President of the Specialty E&S Division. He assumed his current role in 2018, when he successfully led the merger of the Specialty E&S Division and American Empire Surplus Lines Insurance Company to form Great American Risk Solutions. Mr. Lonneman will be succeeded by Brian D. DeSoto, Divisional Senior Vice President of Great American Risk Solutions. Mr. DeSoto joined Great American in 2008. About Great American Insurance Group Great American Insurance Groups roots go back to 1872 with the founding of its flagship company, Great American Insurance Company. Based in Cincinnati, Ohio, the operations of Great American Insurance Group are engaged primarily in property and casualty insurance, focusing on specialty commercial products for businesses, and in the sale of traditional fixed and indexed annuities in the retail, financial institutions, broker-dealer and registered investment advisor markets. Great American Insurance Company has received an A (Excellent) or higher rating from the A.M. Best Company for more than 110 years (most recent rating evaluation of A+ (Superior) affirmed October 20, 2020). The members of Great American Insurance Group are subsidiaries of American Financial Group, Inc. (AFG), also based in Cincinnati, Ohio. AFGs common stock is listed and traded on the New York Stock Exchange under the symbol AFG.", "role": "user" }, { "content": "Great American Insurance Group Announces the Retirement of Mark R. Lonneman, Sr., Divisional President", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PALM BEACH GARDENS, Fla., Oct. 27, 2020 /PRNewswire/ -- Wound Educators has fully revamped their online wound care certification courses. As the first online wound course provider, Wound Educators aims to offer the most current, 100% online wound care education for all healthcare providers. Founder Laurie Swezey stated, \"Achieving wound care certification has never been more important for personal career growth and improved patient care. As rapidly as technology is advancing, we wanted to fully update our wound care course material to keep it relevant and cutting-edge for today's standards.\" Wound Educators has always prioritized having seasoned wound care heroes contribute to their online wound care courses. Former contributors include board-certified wound specialists, past American Board of Wound Management (ABWM) chairmen, past president of the American Academy of Wound Management (AAWM), National Pressure Ulcer Advisory Board, Association for the Advancement of Wound Care (AAWC) board members, and wound research publishers. New 2020 contributors include the author of Wound Management: Principles and Practice and board member of the World Alliance of Wound and Lymphedema Care, the Why Wound Care Campaign, and the Editorial Board for Today's Wound Clinic. \"We want the very best for our students - that includes the best contributors, course material, the best price, an 'Until-You-Pass' guarantee, and the most continuing education hours provided per dollar spent. Our course access is 24/7, so those committed to wound care can fit learning into their busy lifestyles,\" Swezey noted. Courses can be used to prepare for multiple wound certifications, including the CWCN (Certified Wound Care Nurse), CWCA (Certified Wound Care Associate), CWS (Certified Wound Specialist), and CWSP (Certified Wound Specialist Physician) certification, AWCC Advanced Wound Care Certification, and the WCC (Wound Care Certified) Certification. Formerly, students who purchased a course through WoundEducators.com also received a CD and textbooks. In efforts to further keep up with the digital movement and on-the-go healthcare professionals, Wound Educators has modified their course to now offer e-textbooks instead. This additional change allows greater flexibility when studying for the wound care certification exam. Wound Educators' mission is to revolutionize wound care by delivering convenient, affordable wound care education, facilitating wound care certification, and enhancing practitioner expertise and patient care. Wound Educators also offers corporate wound care training programs to ensure staff is properly educated on evidence-based wound management. For more information, visit www.woundeducators.com. Laurie Swezey (800) 637-5526[emailprotected] SOURCE WoundEducators.com Related Links https://woundeducators.com", "role": "user" }, { "content": "Wound Educators Reveals Newly Updated Online Wound Certification Courses", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DETROIT, March 22, 2021 /PRNewswire/ --Freed Kanner London & Millen LLC; Kohn, Swift & Graf, P.C.; Spector Roseman & Kodroff, P.C.; Preti, Flaherty, Beliveau & Pachios LLP; Cera LLP; and Cohen Milstein Sellers & Toll PLLC (\"Settlement Class Counsel\") announce that the United States District Court for the Eastern District of Michigan, Southern Division (\"Court\") has approved the following announcement of a proposed class action settlement with the JTEKT, Nachi, NSK, NTN, and SKF Defendants totaling $37.5 million, and the proposed distribution of the proceeds of the settlement. The lawsuit claims that Defendants conspired to suppress and eliminate competition for Bearings by agreeing to raise, fix, maintain, and/or stabilize prices, rig bids, and/or allocate markets and customers for Bearings sold to distributors in the United States, in violation of federal antitrust laws. The settlement affects those distributors who purchased Bearings in the United States from January 1, 2000 through December 31, 2014 directly from any of the following entities (or their subsidiaries or affiliates): JTEKT Corporation; JTEKT North America Corporation (formerly Koyo Corporation of U.S.A.); Koyo France SA; Koyo Deutschland GmbH; Nachi-Fujikoshi Corp.; Nachi America Inc.; Nachi Technology, Inc.; Nachi Europe GmbH; NSK Ltd.; NSK Americas, Inc.; NSK Europe Ltd.; NSK Corporation; NTN Corporation; NTN USA Corporation; NTN Wlzlager GmbH; NTN-SNR Roulements; Schaeffler Group USA Inc.; Schaeffler Technologies AG & Co. KG (formerly Schaeffler Technologies GmbH & Co. KG); FAG Kugelfischer GmbH; AB SKF; SKF GmbH; and SKF USA Inc. A hearing will be held on June 10, 2021, at 10:30 a.m., before the Honorable Sean F. Cox, United States District Judge, at the Theodore Levin United States Courthouse, 231 West Lafayette Boulevard, Detroit, MI 48226, Courtroom 817 (or such other courtroom as may be assigned for the hearing, or if the Court believes that it is appropriate, remotely by telephone or other electronic means), for the purpose of determining whether to approve: (1) the proposed settlement with the JTEKT, Nachi, NSK, NTN, and SKF Defendants; (2) the proposed plan of distribution of the settlement fund to members of the settlement class; and (3) Settlement Class Counsel's requests for an award of attorneys' fees, and reimbursement of litigation costs and expenses. A Notice of Proposed Settlement (the \"Notice\") was mailed to potential Settlement Class members on or about March 11, 2021. The Notice describes in more detail the litigation and options available to Settlement Class members with respect to the settlement. The Notice and other important documents related to the settlement can be accessed at www.AutoPartsAntitrustLitigation.com/BearingsDistributor, or by calling 1-800-574-1808 or writing to Bearings Direct Purchaser Antitrust Litigation, P.O. Box 2939, Portland, OR 97208-2939. Those who believe they may be a member of the Settlement Class, are urged to obtain a copy of the Notice. URL: www.AutoPartsAntitrustLitigation.com/BearingsDistributor SOURCE United States District Court for the Eastern District of Michigan Southern Division", "role": "user" }, { "content": "Settlement Reached with Bearings Manufacturers in Price Fixing Class Action Lawsuit", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, Oct. 9, 2020 /PRNewswire/ --Today, UMe and Tuff Gong announce three new and exclusive limited-edition collector series coming later this year. UMe and Tuff Gong announce three new and exclusive limited-edition collector series coming later this year. Bob Marley limited-edition LP series, pressed at Tuff Gong International in Jamaica to be released December 11. Vinyl half-speed masters series available November 20. Complete Island Recordings CD box set available December 4. On December 11, twelve limited-edition Bob Marley vinyl LP's, each numbered and pressed exclusively at the legendary Tuff Gong International headquarters in Kingston, Jamaica, will be available, featuring nine original studio albums and two original live albums, plus the world's best-selling reggae album, Legend, all including a highly-desirable Tuff Gong stamp. Additionally, Catch A Fire, originally recorded by The Wailers in Jamaica and eventually released with overdubs and a mix overseen by Island founder Chris Blackwell at the label's London headquarters, will be available in its original Jamaica-recorded version, with two extra tracks from the sessions and some tracks with longer fades. Produced entirely by Bob Marley & the Wailers and mixed by longtime Marley associate Errol Brown, this Jamaican version will be on vinyl for the first time. The limited-edition albums were pressed at Tuff Gong'snewly refurbished vinyl pressing plant, which re-opened in summer 2020 and will have an annual capacity of 250,000 units. Each album was mastered by Dave Cooley at Elysian Masters in Los Angeles. To view the full list of the limited-edition Jamaican LPs, click HERE. To listen or purchase, click HERE. On November 20, the twelve titles will also be available on premium half-speed mastered vinyl. This specialist artisan process results in amore detailed representation of the original sound sourcecuts, with a far superior high-frequency (treble) response, and richer and fuller low to middle frequencies. All tracks were mastered by Miles Showell at Abbey Road Studios in London. To view the full list of the half-speed master LPs, click HERE. To listen or purchase, click HERE.On December 4, the long-awaited CD version of the iconic Complete Island Recordings LP box, which includes all nine Bob Marley & The Wailers studio albums recorded for Island Records, plus two live albums,Live!andBabylon By Bus, will be released.The Complete Island RecordingsCD boxsetwill include the 11 albums packaged in CD wallets, housed in a brushed silver clamshell box that simulates the larger hinged lighter from the LP set. To view the full list of the Complete Island CDs, click HERE. To listen or purchase, click HERE.Released on October 13, in continued celebration of the late musical and cultural icon's 75th birthday Rizzoli published Bob Marley: Portrait of the Legend, a celebration of the life and influence of the forefather of reggae, and the first book authorized by the Bob Marley Foundation.Drawing exclusively on images from the Marley family archives, Bob Marley: Portrait of the Legend showcases over 150 photographs in celebration of the life of one of the greatest musical and socio-political icons of twentieth-century pop culture. Making the most of its oversize pages, the book is designed as a monument to Marley's influence, mixing the iconic and the intimate, bringing together striking images of his on-stage performances, along with glimpses into his creative process in and out of the studio, and family life in Jamaica.About the release, Ziggy Marley said, \"I am blessed to present to you this very special collection of photographs from our archives. There is a cliche term, \"a picture is worth a thousand words.\" From my experience of looking through hundreds and hundreds of photos for this book, I will say, yes, it is true.\" For more details, click HERE:In other literary news, for the first time, Marley's daughter-singer, entrepreneur, philanthropist, and bestselling author,Cedella Marleyshares her father's timeless words on striving for change withRedemption: Reflections on Creating a Better World, released on September 15.Lovingly curating and compiling Marley's sage wisdom, Cedella Marley dives deep into recorded and archived radio interviews, along with song lyrics that speak to Marley's pursuit of redemption, to create a powerful narrative about freeing yourself so you can help free others.Discussing \"Redemption Song,\" Cedella Marley shares that it \"is an anthem for times of conflict and despair and calls out the systematic oppression that continues to plague alllevels of society. But it also offers a way forward. The answer is in the title itself.\" This is why she believes that the song \"resonates today as much as it did when my father originally wrote it\" over forty years ago.As we find ourselves more divided,Redemption: Reflections on Creating a Better Worldoffers Marley's enduring message as a way to heal and change individually and collectively. Redemption: Reflections on Creating a Better World is out everywhere now. To order, click HERE.Also recently announced, in August, Bob Marley was the first \"Artist of the Month\" for Amazon Music's [RE]DISCOVER campaign, a new global brand developed to support artist catalogs across all music genres. The [RE]DISCOVER brand showcases carefully curated artist playlists across various genres, which take listeners on a career-spanning journey of musical discovery, or re-discovery, through the featured artist's entire body of work. The [RE]DISCOVER campaign includes links to stream and download Marley's music; physical music selections; links to related films and books; and a collection of exclusive merchandise including an exclusive 2LP set of Bob Marley & The Wailers' Live At The Rainbow, recorded on June 4, 1977, in London. Live At The Rainbow was previously only available on VHS and DVD, and isnow available for the first time in full, in performance sequence, and on vinyl anywhere. The 2LP also features a newly discovered, unreleased performance. Learn more about [RE]DISCOVER Bob Marley HERE.Also available now, Grammy-nominated DJ and producer Robin Schulz has reworked the Bob Marley classic \"Sun Is Shining\" via Island Records into a high-energy, club-focused version. Originally released on Bob Marley & The Wailers' 1971 album Soul Revolution, \"Sun Is Shining\" is one of Marley's most critically acclaimed tracks. On \"Sun Is Shining,\" Robin Schulzhas transformed a Bob Marley classic into a sunkissed dance track by adding an infectious bassline and feelgood piano chords to the more downtempo original, with serious crossover appeal. Listen to the remix HERE.Lastly, Eagle Records and the Bob Marley Estate recently announced the release of Uprising Live, in celebration of Bob Marley 75. Uprising Live will be available for the first time on vinyl, with black vinyl 3LP and highly-collectible, limited-edition colored vinyl 3LP. Listen or purchase HERE.In this digital era, Bob Marley remains one of the most followed posthumous artists on social media, and MARLEY75 will serve to bring his music and message to the digital foreground, reaching new audiences and perspectives with innovative content and groundbreaking technology. Special live events, exclusive digital content, recordings, exhibitions, plus rare and unearthed treasures will also be revealed throughout the year.Bob Marley's music continues to inspire generation upon generation, as his legacy lives on through his message of love, justice, and unity, a sentiment needed more than ever in 2020. In conjunction with Tuff Gong and UMe, a division of the Universal Music Group, the Marley family will continue to ensure the highest quality, integrity, and care is taken to honor Bob's legacy and to celebrate one of the 20th century's most important and influential figures.Additional information on MARLEY75 events will be revealed soon.SubscribetoBob Marley's Official YouTube Channeland never miss an update.#BobMarley75ABOUT BOB MARLEY:Bob Marley, a Rock and Roll Hall of Fame inductee, is notable not only as the man who put reggae on the global map but, as a statesman in his native Jamaica, he famously brought together the country's warring factions. Today, Bob Marley remains one of the 20th century's most important and influential entertainment icons. Marley's lifestyle and music continue to inspire new generations as his legacy lives on through his music. In the digital era, he has the second-highest social media following of any posthumous celebrity, with the official Bob Marley Facebook page drawing more than 70 million fans, ranking it among the Top 20 of all Facebook pages and Top 10 among celebrity pages. Marley's music catalog has sold millions of albums worldwide. His iconic collection, LEGEND, holds the distinction of being the longest-charting album in the history of Billboard magazine's Catalog Albums chart and remains the world's best-selling reggae album. Marley's accolades include inductions into the Rock and Roll Hall of Fame (1994) and ASCAP Songwriters Hall of Fame (2010), a GRAMMY Lifetime Achievement Award (2001), multiple entries in the GRAMMY Hall Of Fame, and a star on the Hollywood Walk of Fame (2001). For more information, visit bobmarley.com and facebook.com/bobmarley.Photo credit:Peter Murphy / Caption: Press conference in Switzerland before the first date of the Uprising Tour at Hallenstadion in Zurich. Late May, 1980. Fifty-Six Hope Road Music Ltd.SOURCE UMe", "role": "user" }, { "content": "Bob Marley Limited-edition LP Series, Pressed At Tuff Gong International In Jamaica To Be Released December 11", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO, Dec. 10, 2020 /PRNewswire/ -- CME Group Inc., the world's leading and most diverse derivatives marketplace, today declared its annual variable dividend, amounting to $2.50 per share. The dividend is payable January 13, 2021, to shareholders of record on December 28, 2020. The annual variable dividend of $2.50 per share to be paid in January 2021 totals approximately $900 million. Including today's announced variable dividend and the previously announced fourth-quarter 2020 dividend of $0.85 per share to be paid in December, the total dividend yield for dividends announced during 2020 is 3.3% based on the average closing stock price in 2020 to date. The company will have paid a total of more than $15 billion in quarterly and variable dividends since adopting the annual variable dividend structure in the beginning of 2012. When CME Group adopted its annual variable dividend structure in February 2012, the intention was to determine the excess cash available at the end of each year, with the level to increase or decrease from year to year based on operating results, potential investment activity and other forms of capital return. As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based oninterest rates,equity indexes,foreign exchange,energy,agricultural productsandmetals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana. CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-miniare trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec, EBS, TriOptima, and Traiana are trademarks of BrokerTec Europe LTD, EBS Group LTD, TriOptima AB, and Traiana, Inc., respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners. CME-G SOURCE CME Group Related Links http://www.cmegroup.com", "role": "user" }, { "content": "CME Group Declares Annual Variable Dividend", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Jan. 5, 2021 /PRNewswire/ -- The \"Real World Evidence Solutions - Global Market Trajectory & Analytics\" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Real World Evidence Solutions estimated at US$770.8 Million in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 13.7% over the period 2020-2027. Data Sets, one of the segments analyzed in the report, is projected to grow at a 14.3% CAGR to reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 12.4% CAGR for the next 7-year period. This segment currently accounts for a 32% share of the global Real World Evidence Solutions market.The Real World Evidence Solutions market in the U. S. is estimated at US$227.8 Million in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$329.8 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while the Rest of European market (as defined in the study) will reach US$329.8 Million by the year 2027. The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others: Anthem, Inc. Clinigen Group Plc Cognizant Technology Solutions Corporation IBM Corporation ICON PLC IQVIA Optum, Inc. Oracle Corporation Parexel International Corporation PerkinElmer, Inc. Pharmaceutical Product Development LLC SAS Institute, Inc. Syneos Health Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Impact of COVID-19 and a Looming Global Recession Global Competitor Market Shares Real World Evidence Solutions Competitor Market Share Scenario Worldwide (in %): 2018E 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSISIV. COMPETITIONFor more information about this report visit https://www.researchandmarkets.com/r/dhq0qk About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Real World Evidence Solutions Market Trajectory and Analytics 2020-2027 - A US$1.9 Billion Market by 2027", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Jan. 14, 2021 /PRNewswire/ --Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share.If you are an Alexion shareholder, click here to learn more about your rights and options. Change Healthcare Inc. (NASDAQ: CHNG)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to Optum, a company that is part of UnitedHealth Group. Under the merger agreement, Change Healthcare shareholders will receive $25.75 per share in cash.If you are a Change Healthcare shareholder, click here to learn more about your rights and options. RealPage, Inc. (NASDAQ: RP)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravofor $88.75 in cash per share.If you are a RealPage shareholder, click here to learn more about your rights and options. RigNet, Inc. (NASDAQ: RNET)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to Viasat, Inc. for 0.1845 Viasat common shares for each RigNet common share.If you are a RigNet shareholder, click here to learn more about your rights and options. MDC Partners Inc. (NASDAQ: MDCA)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP.Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options. NantKwest, Inc. (NASDAQ: NK)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its merger with ImmunityBio. Under the terms of the agreement, ImmunityBio shareholders will receive a fixed exchange ratio of 0.8190 shares of NantKwest for each share of ImmunityBio owned. If you are an ImmunityBio shareholder, click here to learn more about your rights and options. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [emailprotected]or [emailprotected]. Halper Sadeh LLPrepresents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLPDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060[emailprotected][emailprotected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP Related Links www.halpersadeh.com", "role": "user" }, { "content": "INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CHNG, RP, RNET, MDCA, NK; Shareholders Are Encouraged to Contact the Firm", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DALLAS--(BUSINESS WIRE)--CenterOak Partners LLC (CenterOak), a Dallas-based private equity firm, today announced that its portfolio company Service Champions (the Company) has acquired ProSkill Services (ProSkill) and Jet Plumbing Heating & Drain Services (Jet), two market-leading home services brands serving the Phoenix, Arizona and Reno, Nevada markets. Including these transactions, Service Champions has completed ten acquisitions since CenterOaks initial investment. We are excited to grow in Arizona and Nevada with these two acquisitions, said Leland Smith, CEO of Service Champions. Our team has been diligently searching for the right partners in these markets and are thrilled to welcome these two local market leaders to the Service Champions platform. This transaction represents a natural fit for our long-term growth plan as the largest residential HVAC and plumbing services company in the Western United States. The ProSkill and Jet acquisitions mark an important milestone for Service Champions expansion history, said Lucas Cutler, a Managing Partner with CenterOak. After expanding Service Champions into the largest residential services provider in California, the Company is well-positioned to be the acquiror of choice for market leading residential services businesses across the broader Western United States. About Service Champions Headquartered in Orange County, CA, Service Champions is a premier provider of essential home services specializing in heating, air conditioning and plumbing services. As the largest residential service provider in the Western U.S., Service Champions goes to market via several iconic local trade names including Service Champions, Moore Home Services, Bell Brothers, ASI, and Adeedo! About CenterOak Partners LLC CenterOak Partners LLC is a private equity firm with a focus on making control-oriented investments in middle market companies organized or operating in the United States. The Firm specializes in three key industry sectors: Industrial Growth, Consumer, and Business Services. Based in Dallas, Texas, the investment and portfolio management team has a strong history of creating significant value through operational improvement. CenterOak and its Partners have managed over $2.2 billion of equity capital commitments and have completed over 100 acquisitions, representing over $4.8 billion in transaction value. For additional information, please visit www.centeroakpartners.com", "role": "user" }, { "content": "Service Champions Expands Footprint to Phoenix and Reno", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MILAN--(BUSINESS WIRE)--Regulatory News: Engie EPS (Paris:EPS) (EPS: FP), announces the date of its Technology Revolution Day, in which the 2023 Technology Roadmap will be presented. The event will be held on Thursday 18 February in a full-digital format and will be streamed on the website www.engie-eps.com. After completing the 2020 Technology Roadmap which allowed the company to award tenders in the energy storage sector for over 100 million and develop iconic technologies for electric mobility, such as easyWallbox and the largest Vehicle- to-Grid project in the world , Engie EPS will reveal its future technological positioning, as a result of the newly filed patent innovations. Over the past three years we have developed a unique technological platform, with renewable energy storage systems that proved their competitiveness on a global scale and, in partnership with FCA, with innovative solutions to accelerate the spread of electric mobility. The 2023 Technology Roadmap will mark a new chapter of this evolution, the final meeting point between energy storage and e-mobility, in order to revolutionize the energy transition paradigm\", explained Carlalberto Guglielminotti, CEO and General Manager of Engie EPS. Engie EPS has chosen to disclose the date of the Technology Revolution Day with a video (https://vimeo.com/engieeps/techday2021) set in the Vigezzo Valley in Italy focused on the values which inspired the new 2023 Technological Roadmap: Excellence, Speed and Environmental Sustainability. The video features Roberto Di Stefano, Head of eMobility FCA, Cesare Toniutti, former Olympic Alpine Ski Team Coach, and Gabriel Di Pietro, young talent of the European rally. * * * ENGIE EPS Engie EPS is the technology and industrial player within the ENGIE group, developing technologies to revolutionize the paradigm in the global energy system towards renewable energy sources and electric mobility. Listed on Euronext Paris regulated market (EPS.PA), Engie EPS forms part of the CAC Mid & Small and CAC All-Tradable financial indices. Its registered office is in Paris, with research, development and production located in Italy. For further information, go to www.engie-eps.com follow us on LinkedIn", "role": "user" }, { "content": "Technology Revolution Day: 18 February 2021 Engie EPS will present the 2023 Technology Roadmap with a full-digital event", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HOUSTON, Aug. 26, 2020 /PRNewswire/ -- Riviana Foods Inc. is voluntarily recalling 19,931 cases of certain coded Ronzoni Smart Taste Extra-Wide Noodle cellophane packages that contain an egg noodle product. The affected Ronzoni Smart Taste Extra-Wide Noodle packages do not declare the allergen \"egg\", which is an ingredient in the noodle product. People who have an allergy or severe sensitivity to egg run the risk of serious allergic reaction if they consume this product. The affected product was distributed nationally from March through August of this year. (PRNewsfoto/Riviana Foods Inc.) The product at issue can be identified by the manufacturing code and UPC number listed on the package as listed in the chart below. Product Size Product Name Manufacturing Codes Individual Package UPC 12 oz. each RONZONI Smart Taste Extra-Wide Noodles MAR3022H, MAR3122H, JUN0422H, JUN0522H, JUL2422H, JUL2522H 71300 05008 No other varieties and no other manufacturing codes are included in this recall.At this time, Riviana has received one consumer complaint and no reports of illness or injury associated with this product. The recall was initiated after it was discovered that product containing egg was distributed in packaging that did not reveal the presence of egg. Subsequent investigation indicates the problem was caused by a temporary breakdown in Riviana's packaging review processes.Riviana has instructed distributors and retailers who purchased affected product from Riviana to segregate the recalled products from their inventories so that a Riviana sales representative may assist retailers in the disposition of the product.Consumers should return the affected product to the store where they purchased it for a full refund. Consumers who may have questions or concerns should call Riviana's toll free Consumer Relations number at 1-800-730-5957, Monday through Friday, between 9 am and 5 pm (Eastern).SOURCE Riviana Foods Inc.", "role": "user" }, { "content": "Riviana Foods Inc. Voluntarily Recalls Certain Manufacturing Date and UPC Number Of Ronzoni Smart Taste Extra-Wide Noodles Due To Possible Undeclared Egg Allergen", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Leadership Quadrant of Smart Textiles Suppliers - 2021\" report has been added to ResearchAndMarkets.com's offering. Smart textiles are used for a variety of end-use industries, such as healthcare, military and defense, entertainment, automotive, sports and fitness, and others and is forecast to grow at a CAGR of 33%. The smart textiles manufacture landscape is diverse and continually evolving. Major players in smart textiles market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the smart textiles market extends beyond routine macro-economic elements of supply and demand. It is the relationship between buyer's needs and seller's capabilities as well as the macroeconomic forces at work that affect the market. It is how well and how efficiently the sellers meet the needs of the buyers that determine long-term success. Over the years, the level of demand for smart textiles has increased due to increasing use in health care, military and defense, and entertainment industrial applications. The major growth drivers for this market are growth in the wearable electronics market, miniaturization of electronic component, and growing demand for low-cost smart wireless sensor network. Firms that produce smart textiles are approaching market opportunities with starkly different strategies. The analyst, a leading global management consulting and market research firm, has analyzed the global smart textiles suppliers and has come up with a comprehensive research report, \"Leadership Quadrant and Strategic Positioning of Smart Textiles Suppliers\". This report also offers a full competitive analysis from target markets to product mapping, from selling strategies to production capabilities. The seven profiled manufacturers are grouped in the quadrant. The leadership quadrant analyzes the relative strength among these players. The leadership quadrant addresses the need in the market for manufacturer evaluation based on objective data and metrics. Some of the features of this research study are as follows: Leadership and competitive analysis: This report answers the following key questions: Key Topics Covered: 1. Leadership Analysis 1.1: Market Description 1.2: Scoring Criteria 1.3: Leadership Quadrant Analysis 1.3.1: Leaders (Top Right) 1.3.2: Contenders (Bottom Right) 1.3.3: Visionaries (Top Left) 1.3.4: Specialists (Lower Left) 2. Competitive Benchmarking 2.1: Product Portfolio Analysis 2.2: Financial Strength 2.3: Market Share Analysis 2.3.1: Market Share in Various Segments 2.3.2: Market Share in Various Regions 3. Textronics Profile 3.1: Company Overview 3.1.1: Textronics Company Description and Business Segments 3.1.2: Textronics Company Statistics 3.2: Smart Textiles Business Overview 3.2.1: Smart Textiles Business Segment 3.2.2: Global Smart Textiles Operations 3.2.3: Key Differentiators and Strengths 3.3: Products and Product Positioning 3.3.1: Product Line Overview 3.3.2: Smart Textiles Product Mapping 3.3.3: Product Positioning in Market Segments 3.4: Markets and Market Positioning 3.4.1: Market Position in Global Smart Textiles Business 3.5: Revenue Breakdown by Market Segments 3.6: Revenue Breakdown by Regions 3.7: Production 3.7.1: Global Manufacturing Operations 3.8: Innovation and Market Leadership 3.9: Marketing, Sales, and Organizational Capabilities 3.9.1: Marketing and Sales 3.9.2: Management Commitment and Track Record 3.10: Financial Strength 4. Milliken Profile 5. Ohmatex Profile 6. Outlast Technologies Profile 7. Gentherm Profile 8. Adidas AG Profile 9. Schoeller Profile For more information about this report visit https://www.researchandmarkets.com/r/blwyf0", "role": "user" }, { "content": "Global Smart Textiles Suppliers Leadership and Benchmark Report 2021: Focus on Textronics, Milliken, Ohmatex, Outlast Technologies, Gentherm, Adidas AG, and Schoeller Technologies - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DENVER, Dec. 8, 2020 /PRNewswire/ --Gates (NYSE: GTES), a leading global provider of fluid power and power transmission solutions, today unveiled its all-new PowerGrip GT Extend line of industrial synchronous belts, initially available for the Asia-Pacific (APAC) region. Manufactured in region, for region, and engineered with the latest in advanced technology and materials science expertise, Gates PowerGrip GT Extend delivers a better solution for an expanded range of industrial applications. The new PowerGrip GT Extend lineup is the perfect replacement solution to revitalize existing power transmission drives and is yet another innovative addition to Gates' industry-leading synchronous belt portfolio. The new materials and construction utilized enable higher power-carrying capacity versus previous HTD (High-Torque Drive) generation belts while delivering larger temperature range capabilities. In addition, PowerGrip GT Extend Belts are manufactured without chlorinated compounds, also offering customers an environmentally friendly solution. \"For over a century, Gates has prided itself on delivering the highest-quality belts in all performance segments, and the launch of the all-new PowerGrip GT Extend Belt affirms our commitment to offering the ideal synchronous belt solutions for our industrial customers,\" said Tom Pitstick, CMO and senior vice president of Strategic Planning for Gates. \"It also provides customers the perfect complement to Gates' existing heavy-duty Poly Chain & PowerGrip industrial product lines, enabling further transition away from traditional, high-cost chain drives.\" Utilizing Gates' renowned innovations in materials science, the PowerGrip GT Extend product is constructed with next-generation ethylene elastomer compounds, allowing for extended application in high and low temperature environments. It features advanced materials including nylon tooth fabric and an industry-leading GT tooth profile to improve power capacity, along with increased chemical resistance. When compared to a chain drive, the PowerGrip GT Extend solution provides a lighter weight product with zero lubrication or maintenance requirements, resulting in increased uptime and lower total-cost-of-ownership. The belts are also rust-free and safe for use in food-handling and other sensitive manufacturing areas. With reduced environmental risks and improved chemical resistance against common degraders of rubber like alkalis, acids, UV and ozone, PowerGrip GT Extend is the latest in durable, application-specific and environmentally friendly industrial belt solutions offered by Gates. About GatesGates is a global manufacturer of innovative, highly engineered power transmission and fluid power solutions. Gates offers a broad portfolio of products to diverse replacement channel customers and to original equipment (\"first-fit\") manufacturers as specified components. Gates participates in many sectors of the industrial and consumer markets. Gates products play essential roles in a diverse range of applications across a wide variety of end markets ranging from harsh and hazardous industries such as agriculture, construction, manufacturing and energy, to everyday consumer applications such as printers, power washers, automatic doors and vacuum cleaners, and virtually every form of transportation. Gates products are sold in 128 countries across four commercial regions: the Americas; Europe, Middle East and Africa; Greater China; and East Asia and India. More about Gates can be found at www.gates.com. SOURCE Gates", "role": "user" }, { "content": "All-New PowerGrip GT Extend Line of Synchronous Rubber Belts Reduces Total Cost of Ownership While Providing an Environmentally-Friendly Alternative Innovative approach to synchronous belt construction delivers improved performance for an expanded range of industrial applications", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN DIEGO, Jan. 19, 2021 /PRNewswire/ --2020 was a year of resilience, innovation, and change in the real estate industry. During a year when many homebuyers and sellers evaluated their housing needs due to COVID-19, Pacific Sotheby's International Realty's agents navigated through uncertainty. They led our industry in health and safety, innovation, and virtual solutions, all while delivering unparalleled service. Continue Reading Brian Arrington, Owner and CEO, Pacific Sotheby's International Realty 2020 also marked a major milestone for Pacific Sotheby's International Realty: 10 years of successful business in the Southern California real estate market. Though there was no official celebration held, the company ended the year with a $6.7 billion sales volume, exceeding all previous sales records. Across the firm, the average sale price of real estate transactions increased by 15% to $1,123,671. The Sotheby's International Realty global network's true power was seen through the company's relocation and referral service numbers that reached an all-time high of inbound closed 216 units resulting in $232,068,346 sales volume, in addition to 273 outbound closings. The challenges of 2020 brought opportunity, innovation, and a new direction for Pacific Sotheby's International Realty. With the technology and tools already in place, Pacific Sotheby's International Realty was poised to deliver on virtually marketing properties and worked to ensure agents were well-prepared to adjust to the changing real estate landscape and client needs. The company leveraged existing virtual technology tools to showcase properties and stage homes virtually when many were sheltering in place. In June 2020, Founder and CEO Brian Arrington assumed complete control of Pacific Sotheby's International Realty to return his company to the core beliefs of total unyielding integrity, commitment to uphold the highest ethical standards in the industry, and provide its agents with every opportunity to increase their business in a company that is anchored by the strategic pillars of service, respect, and value. Key organizational changes followed, including expanding its dynamic leadership team, aligning with agents whose integrity, experience, and business ethic match those of the Sotheby's International Realty brand, and updating offices to offer a modern lifestyle experience for clients. \"2020 brought significant changes and allowed us the opportunity to move forward in a new direction,\" says Arrington. \"With the right leadership team now in place, our focus is all about next-level quality. Our priority is to increase our agents' productivity and the innovative services they provide to their clients through cutting-edge tools, resources, and experienced management.\"Pacific Sotheby's International Realty was founded in 2010 and quickly grew into the most dominant real estate firm in San Diego. In 2018, Pacific Sotheby's International Realty expanded its reach by acquiring HOM Sotheby's International Realty allowing for contiguous service territory throughout Southern California, representing over 120 miles of prime coastal real estate. Media ContactColby Arrington619-871-1321[emailprotected]SOURCE Pacific Sotheby's International Realty", "role": "user" }, { "content": "Celebrating a Decade of Success \| Pacific Sotheby's International Realty Achieved Record Sales in 2020 Turning Uncertainty into Opportunity and Setting a New Standard in Real Estate", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WILMINGTON, N.C., July 1, 2020 /PRNewswire/ --You, or someone you know, could be featured in the 2021 Wilmington 60 Strong calendar, an exclusive calendar showcasing inspirational \"60 somethings\" and highlighting Wilmington events and activities. In addition to appearing in the calendar, winners receive \"celebrity treatment\" with a virtual \"kick-off party,\" professional photo shoot and compensation for their modeling time. (PRNewsfoto/Anchor Senior Care Advantage) Anyone age 18 or older can nominate a friend or family member -- age 60 to 69 -- who has achieved remarkable levels of fitness, pursued a new hobby or helps those in need. The candidate might be \"giving back\" to their community, fighting a chronic condition or caring for someone who is. Here's how it works: Log on to www.Wilmington60Strong.comand submit an application form, 200-400-word essay, head shot and full-length photo by Monday, August 17. Instead of the essay, you can upload a smart phone video describing the candidate. Or download an application form at www.Wilmington60Strong.com and mail the completed form, a 200-400-word essay, head-shot and full-length photo to: Wilmington 60 Strong Contest, c/o Anchor Senior Care Advantage, 1202 Medical Center Drive, Wilmington, NC 28401. The entry must be postmarked by Thursday, August 13. Those who nominate winning candidates receive a $50 gift certificate. Wilmington 60 Strong candidates must be between the ages of 60 and 69 on Sept. 1, 2020, and a resident of the following Wilmington, N.C. counties: Bladen, Brunswick, Columbus, Duplin, New Hanover, Onslow and Pender. Celebrity judges will select 12 winners who exemplify how life after sixty can be a vibrant and active time. Contestants are judged on their health/fitness/wellness, community involvement, volunteerism and how they are inspirational to others. Winners must be available Thursday, September 24, through Saturday, September 26, 2020. Questions? Email us at [emailprotected]. All proceeds from the calendar will benefit the YMCA of Southeastern North Carolina to support their mission to improve health and strengthen the community.About Anchor Senior Care AdvantageWilmington Health is proud to announce the Wilmington 60 Strong contest in conjunction with the launch of Anchor Senior Care Advantage, a program designed to provide seamless and greater coordination of care for their senior patients.SOURCE Anchor Senior Care Advantage", "role": "user" }, { "content": "Enter the Virtual Wilmington 60 Strong Calendar Contest: Celebrate Life After 60! Nominate an Inspirational Senior Between ages 60 and 69 To Be Featured on the Wilmington 60 Strong Calendar!", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MIAMI, April 27, 2021 /PRNewswire/ -- Insightec, a global healthcare company focused on creating the next generation of patient care, announced today that Aetna is the first national payor to cover MR-guided Focused Ultrasound for treating medication-refractory Essential Tremor. \"This is a huge step in expanding patient access to non-Medicare patients,\" saidDee Kolanek, Insightec Vice President of Reimbursement. \"We applaud leading insurers like Aetnafor their decisionto cover this outpatient treatment for patients suffering from Essential Tremor.\" Essential Tremor, a movement disorder that causes uncontrollable shaking, affects an estimated ten million Americans. Many patients do not get satisfactory relief from available medications, causing them to withdraw from personal, professional, and social interactions. Focused ultrasound is performed in a single, outpatient procedure with many patients showing immediate improvement of tremor in the treated hand with minimal complications. \"Focused Ultrasound technology has come a long way since the initial Essential Tremor pilot trial,\" said Dr. Jeffrey Elias, the Director of Stereotactic and Functional Neurosurgery at the University of Virginia. \"Today, the clinical community is able to provide strong real-world evidence in support of coverage decisions.\" \"Developing amazing technology is just the beginning patient access is critical,\" commented Maurice R. Ferr MD, INSIGHTEC'S CEO and Chairman of the Board of Directors. \"We continue to focus on helping transform the lives of millions of people by giving them back their ability to live independently, return to work, and improve their mental and physical health.\" There are currently more than 60 Treatment Centers around the worldusing Insightec's ExablateNeuro platform to treat Essential Tremor patients on a regular basis. Focused ultrasound treatment for medication-refractory Essential Tremor is covered under Medicare in all 50 states and is a covered benefit under 30 independent Blue Cross Blue Shield Association plans and nine private payors. About Insightec Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with Essential Tremor and Tremor-dominant Parkinson's Disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai and Tokyo. Follow us onFacebook,LinkedInandTwitteror visitwww.insightec.comfor more information. Forward-looking Statements This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: \"may,\" \"can,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"intend,\" \"plan,\" \"anticipate,\" \"believe,\" \"estimate,\" \"predict,\" \"project,\" \"potential,\" \"promise,\" \"continue,\" \"ongoing,\" or the negative of these terms. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement. All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec's expectations. \"Exablate,\" and \"Exablate Neuro,\" as well as the \"INSIGHTEC\" logo, whether standing alone or in connection with the word \" Insightec\", are protected trademarks of Insightec. Insightec Media Contact G&S Business Communications for InsightecElizabeth Mannheimer+1 917.595.3034[emailprotected] SOURCE INSIGHTEC", "role": "user" }, { "content": "Insightec Announces Positive Coverage Decision By Aetna For MR-guided Focused Ultrasound To Treat Essential Tremor USA - English USA - English First National Payor to Cover Outpatient Procedure Beyond Medicare in all 50 States", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA and PHILADELPHIA, April 1, 2021 /PRNewswire/ -- The Pediatric Brain Tumor Foundation (PBTF, www.curethekids.org) Board of Directors elected its newest member in the battle against the most common and fatal of children's cancersbrain tumors. Ken Murphy, CEO of theComotoFamily of Brands, joins in PBTF's fight for kids with brain cancer, uniting in the nonprofit leader's pledge to transform care, discover a cure, and help impacted families thrive. Since 2019, Murphy has led theComotofamily ofmoto enthusiast retail brands, which includeRevZilla,Cycle Gear,J&P Cycles, and most recently REVER, the world's largest motorcycle GPS app and community, and a multi-year national partner of PBTF's Ride for Kids. \"We're excited to welcome Ken Murphy to our team,\" says Courtney Davies, PBTF's President and CEO. \"Our board is committed to furthering the Pediatric Brain Tumor Foundation's work driving breakthrough childhood brain tumor research through funding and collaboration, while providing support and compassion to families navigating this devastating disease. Ken's extensive retail experience and commitment to the brain tumor community will be valuable assets as we accelerate our strategic plan to continue to lead the charge against the deadliest form of childhood cancer.\" Prior to leadingComoto, Murphy was president and CEO ofEbLens, a footwear, apparel, and accessories lifestyle retailer. His background also includes a successful 20-year career in the home furnishings industry, where he held various leadership roles for the multi-billion-dollarbedding specialty retailer Mattress Firm, including ultimately serving as president and CEO. \"Having lost my mother to brain cancer in the late 90s, and as a proud father of five myself, I am deeply committed to helping other families affected by this disease,\" says Murphy. \"I am grateful for this opportunity to bring my personal and professional experience to PBTF. Learning about the motorcycling community's long history of support for this cause continues to inspire me. I'm excited to get on my bike and participate in this year's inaugural National Ride for Kids Day, and I invite everyone to join me.\" Visitridecomoto.comfor more information aboutComoto'sfamily of brands and learn more about PBTF's partnership with the motorcycling industry and inaugural National Ride for Kids Dayhere. About the Pediatric Brain Tumor FoundationEvery day, 13 children and teens are diagnosed with a brain tumor, the deadliest form of childhood cancer. Every day after, they are in a fight for their life.It'sa fight the Pediatric Brain Tumor Foundation is here to help families win. A leader in the brain tumor and childhood cancer communities, PBTF's mission of Care. Cure. Thrive. reflects its commitment to curing all pediatric brain tumors and transforming how children and their families are cared for. Since 1991, PBTF has provided strategic leadership and funding to accelerate the number of targeted therapies for children battling brain tumors today, while equipping families with the patient family education, financial relief, and emotional support they need to navigate their child's journey. A world without childhood brain tumors is possible when we stand together to effect real, meaningful change. Learn more atwww.curethekids.org. AboutComotoFamily of BrandsComotois America's largest and fastest growing omni-channel platform in the powersports aftermarket-products industry, dedicated to advancing the experience of moto enthusiasts across the globe.Comoto'sbrands,RevZilla, Cycle Gear, J&P Cycles, and REVER deliver premium products, dedicated expertise, engaging media, and passionate customer support of the rider community through best-in-class eCommerce and retail experiences. SOURCE Pediatric Brain Tumor Foundation Related Links www.curethekids.org", "role": "user" }, { "content": "Pediatric Brain Tumor Foundation Welcomes Comoto Family of Brands CEO Ken Murphy to Board of Directors", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Triton Digital, the global technology and services leader to the digital audio and podcast industry, released today its monthly Webcast Metrics Global Ranker as well as its regional US, LATAM, and EMEA Streaming Rankers for December 2020. Tritons rankers provide insight into the top-performing streaming audio stations and networks around the world for the month of December. Tritons Global ranker is inclusive of publishers that subscribe to Tritons enhanced measurement service - Webcast Metrics - which requires publishers to meet a broader set of technical and operational requirements which are subject to a third-party audit. The full results of the Global & Regional Rankers for December 2020 can be found here. Tritons Webcast Metrics and Streaming Metrics services are the industry standard for online audio consumption data. They provide credible, validated data that enable audio publishers around the world to analyze the consumption of their content by daypart, device type, geography, distribution platform, and more. About Triton Digital Triton Digital is the global technology and services leader to the digital audio and podcast industry. Operating in more than 80 countries, Triton provides innovative technology that enables broadcasters, podcasters, and online music services to build their audience, maximize their revenue, and streamline their day-to-day operations. In addition, Triton powers the global online audio industry with Webcast Metrics, the leading online audio measurement service and Podcast Metrics, one of the first IAB certified podcast measurement services in the industry. With unparalleled integrity, excellence, teamwork, and accountability, Triton remains committed to connecting audio, audience, and advertisers to continuously fuel the growth of the global online industry. Triton Digital is a wholly owned subsidiary of The E.W. Scripps Company (NASDAQ: SSP). For more information, visit www.TritonDigital.com.", "role": "user" }, { "content": "Triton Digital Releases Rankings for the Top Digital Audio Properties for December 2020", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Antoinette (Tonie) Leatherberry, an experienced technology strategist and executive, to its Board of Directors. Her appointment increases the size of the Board from 12 to 13 members, and she will serve on the Boards Audit and Corporate Governance Committees. As Zoetis increasingly focuses on implementing a digital and data transformation for our company and the animal health industry, Tonie Leatherberry brings invaluable experience and insights to our Board, said Zoetis CEO Kristin Peck. In her 30 years at Deloitte, Tonie advised the worlds top companies on tech-enabled strategies, and played an instrumental role in Deloittes work to advance women and people of color through internal forums and as president of the Deloitte Foundation. Ms. Leatherberry recently retired from Deloitte, an industry-leading consulting, audit, tax and advisory services company, culminating a distinguished career of working with Fortune 500 companies on complex information technology transformations and operational issues. She has authored numerous articles and publications on information technology and governance, and was named to the National Association of Corporate Directors NACD Directorship 100 in 2019 and 2020. Ms. Leatherberry has been recognized in such publications as Consulting Magazines Top 25 Consultants and Black Enterprises Most Powerful Women in Business. She has also devoted much of her professional life to creating opportunities for women and people of color. At Deloitte, Ms. Leatherberry was the principal architect of The Board Leadership Forum and the NextGen CEO Academy, which helped place more than 70 Black leaders into executive level and board roles. She currently serves as chair of the Executive Leadership Council (ELC), a preeminent association of Black business leaders, which focuses on board and executive leadership development, philanthropy, skills and talent development. Ms. Leatherberry serves on the Board of Directors for the American Family Insurance Mutual Holding Company, the Widener University Board of Trustees, and the Boston University Board of Trustees. She holds a bachelors degree in Mechanical Engineering from Boston University and an MBA in Operations Management and Supervision from Northeastern University, and is pursuing a doctorate in higher education policy at Widener University. About Zoetis Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees. For more information, visit www.zoetis.com. DISCLOSURE NOTICES Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, including in the sections thereof captioned Forward-Looking Statements and Factors That May Affect Future Results and Item 1A. Risk Factors, in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. Such risks and uncertainties may be amplified by the coronavirus (COVID-19) pandemic and its potential impact on the global economy and our business. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis. ZTS-COR ZTS-IR", "role": "user" }, { "content": "Zoetis Appoints Tonie Leatherberry to Its Board of Directors Former Deloitte executive and technology leader brings valuable digital and data experience to Zoetis Board", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: EXETER, N.H., June 9, 2020 /PRNewswire/ --How can we keep students engaged in their education, inspired to learn about the world, and excited about pursuing career-related activities amidst the global pandemic? The Virtual Learning Academy Charter School (VLACS) is doing its part to answer this questions with the announcement of its latest offering, Career Explorations.Career Explorations makes it possible to kickstart the career investigation process by meeting with professionals who work in careers that match with students' interests and talents. Continue Reading VLACS Students who enroll in Career Explorations will meet industry experts through live video conferences to gain insight into the type of work they can expect to do in the career they are exploring. For example, a student interested in forensic science could join a session hosted by a crime scene investigator to view the analysis of evidence. Or, a student with a passion for music might meet a professional musician to learn about the opportunities available in the entertainment industry. Throughout the course, a VLACS instructor will assist students and help them learn about the fantastic opportunities available after high school. The possibilities are endless. Students who want to dig deeper into a career may also enroll in VLACS career-focused courses in areas such as health science, coding, business, or the arts. Moreover, students could pursue a work-based learning opportunity like a job shadow or a micro-internship. Each time a student completes the Career Explorations course they will earn high school credit and a career badge that verifies the skills they have acquired through the experience. VLACS's Director of Instruction Scott Prescott explained that Career Exploration provides students with a unique opportunity to engage with professionals from NH and beyond. \"Students will see what professionals actually do in their work and have the opportunity to ask them questions. By offering these in an online setting, we are reducing the inequity that occurs due to students' location. It allows students in remote areas to have the same opportunities as students in more industry and business-heavy locations. This is a great way for students to identify a career they might want pursue, or it could lead them to interesting job shadows or micro-internships,\" Prescott said.Our mission: The Virtual Learning Academy Charter School is a state-approved charter school, public school, and a 501(c)(3) non-profit organization serving over 13,000 students in New Hampshire and nationwide. VLACS provides elementary school, middle school, high school, and adult learners with rigorous, personalized, flexible learning via a relationship-focused, online experience designed to ensure college, career, and life readiness.For more information about VLACS, visit vlacs.org.Media Contact:Alex Enayat603-778-2500[emailprotected]SOURCE VLACS Related Links http://vlacs.org", "role": "user" }, { "content": "VLACS Launches Innovative Solution to Promote Career Exploration", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: INDIANAPOLIS, April 23, 2020 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2020. $ in millions, except per share data First Quarter % 2020 2019 Change Revenue $ 5,859.8 $ 5,092.2 15% Net Income Reported 1,456.5 4,241.6 (66)% EPS Reported 1.60 4.31 (63)% Net Income Non-GAAP 1,598.8 1,236.7 29% EPS Non-GAAP 1.75 1.33 32% Certain financial information for 2020 and 2019 is presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with U.S. generally accepted accounting principles (GAAP), include all revenue and expenses recognized during the periods, and reflect Elanco Animal Health (Elanco) as discontinued operations during 2019. Non-GAAP measures reflect adjustments for the items described in the reconciliation tables later in the release, and assume that the disposition of Elanco occurred at the beginning of 2019 (including the benefit from the reduction in shares of common stock outstanding). The company's 2020 financial guidance is being provided on both a reported and a non-GAAP basis. The non-GAAP measures are presented to provide additional insights into the underlying trends in the company's business. \"Lilly is rising to meet the challenges of the COVID-19 pandemic, whether it be by supporting our employees, our communities, patients with chronic diseases who are the most vulnerable to the virus, or directly attacking the disease with new and existing therapies,\" said David A. Ricks, Lilly's chairman and CEO. \"Lilly's purpose - to make life better - has never been more important.We're focused on reliably supplying medicines, keepingour employeessafe and pushing scientific efforts at top speed to defeat COVID-19.We're also committed to improving the affordability of and access to our medicines, particularly insulin, during these challenging times.\" \"Lilly exited 2019 with strong revenue growth and margin expansion, driven by the uptake of our newer medicines. That momentum continued in Q1 2020 and was augmented by higher patient and supply chain purchasing due to the COVID-19 pandemic,\" commented Josh Smiley, Lilly's CFO. \"Our revenue and operating margin outlook for 2020 is unchanged, but the economic and healthcare consequences of this pandemic are uncertain and could negatively affect our financial results later in 2020 and beyond, due to reduced non-COVID healthcare activities and global economic challenges. We are therefore widening the range of our 2020 EPS guidance to reflect both our underlying strong performance as well as future uncertainty; however, the long-term fundamentals of our business remain strong, as does our financial outlook for the mid-2020s and beyond.\" Key Events Over the Last Three Months COVID-19 The company entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to study baricitinib as an arm in NIAID's Adaptive COVID-19 Treatment Trial. The Phase 3 study will investigate the efficacy and safety of baricitinib as a potential treatment for hospitalized patients diagnosed with COVID-19. The company announced that it will advance LY3127804, an investigational selective monoclonal antibody against Angiopoietin 2 (Ang2), to Phase 2 testing in pneumonia patients hospitalized with COVID-19 who are at a higher risk of progressing to acute respiratory distress syndrome (ARDS). The company entered into an agreement with AbCellera to co-develop antibody products for the potential treatment and prevention of COVID-19. The collaboration will leverage AbCellera's rapid pandemic response platform, developed under the DARPA Pandemic Prevention Platform (P3) Program, and Lilly's global capabilities for rapid development, manufacturing and distribution of therapeutic antibodies. The company announced an update on its clinical trial activities in light of the COVID-19 pandemic. The company has delayed most new study starts and has paused enrollment in most ongoing studies, but will continue ongoing clinical trials for patients who are already enrolled. Regulatory The U.S. Food and Drug Administration (FDA) approved Trulicity for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. The FDA approved a supplemental Biologics License Application (sBLA) for Taltz for the treatment of pediatric patients (ages 6 to under 18) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The company's newest mealtime insulin received approval in both the European Union and Japan for the treatment of adults with diabetes as part of a multiple daily injection regimen or delivered by an insulin pump. This novel, fast-acting formulation of insulin lispro is for use by adults with type 1 and type 2 diabetes to reduce blood glucose. The FDA issued a complete response letter for the supplemental New Drug Application (sNDA) of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes. The letter indicates that the FDA is unable to approve the application in its current form. Clinical An analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study showed that solanezumab did not meet the primary endpoint of the study. At this time, Lilly does not plan to pursue a submission for solanezumab in people with dominantly inherited Alzheimer's disease (DIAD), also known as autosomal dominant Alzheimer's disease. The company completed a Phase 4 study of Taltz in patients with moderate to severe psoriasis. Taltz demonstrated non-inferiority to guselkumab on the final secondary endpoint at week 24. As previously disclosed, Taltz achieved superiority compared to guselkumab on all primary and key secondary endpoints at week 12. Mirikizumab met the co-primary and key secondary endpoints in a Phase 3, placebo-controlled study, which evaluated the safety and efficacy of mirikizumab for the treatment of moderate to severe plaque psoriasis over 52 weeks. A second Phase 3, placebo- and active- controlled 52-week study is expected to be completed later in 2020. Business Development/Other Developments The company entered into an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. The collaboration will study up to four novel preclinical targets identified by Sitryx that could lead to potential new medicines for autoimmune diseases. The company completed the acquisition of Dermira, Inc. The acquisition expands Lilly's immunology pipeline with the addition of lebrikizumab, which is being evaluated in a Phase 3 clinical development program for the treatment of moderate to severe atopic dermatitis in adolescent and adult patients, ages 12 years and older. The acquisition also expands Lilly's portfolio of marketed dermatology medicines with the addition of QBREXZA, a medicated cloth approved by the FDA for the topical treatment of primary axillary hyperhidrosis. First-Quarter Reported Results In the first quarter of 2020, worldwide revenue was $5.860 billion, an increase of 15 percent compared with the first quarter of 2019. The increase in revenue was driven by a 22 percent increase due to volume, partially offset by a 6 percent decrease due to lower realized prices. The company estimates worldwide volume growth in the first quarter of 2020 was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic that increased worldwide revenue by approximately $250 million. Revenue in the U.S. increased 15 percent, to $3.329 billion, as increased volume of 19 percent was partially offset by lower realized prices. Increased U.S. volume for key growth products, including Trulicity,Taltz, Verzenio, Emgality, Basaglar, Jardiance, and BaqsimiTM, as well as for Humalog, was partially offset by decreased volume for Cialis due to loss of patent exclusivity. The company estimates that U.S. volume growth in the first quarter of 2020 was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic that increased U.S. revenue by approximately $200 million. Revenue outside the U.S. increased 15 percent, to $2.531 billion, driven by increased volume of 25 percent, which was primarily from key growth products, including Tyvyt, Trulicity, Olumiant, Taltz, Jardiance, Verzenio, Cyramza and Basaglar, as well as for Alimta, partially offset by decreased volume for Strattera due to loss of patent exclusivity. The increase in revenue due to volume was partially offset by lower realized prices and the unfavorable impact of foreign exchange rates. The company estimates that volume growth outside the U.S. in the first quarter of 2020 was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic that increased revenue outside the U.S. by approximately $50 million. Gross margin increased 18 percent, to $4.645 billion, in the first quarter of 2020 compared with the first quarter of 2019 and was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic. Gross margin as a percent of revenue was 79.3 percent, an increase of 1.7 percentage points compared with the first quarter of 2019. The increase in gross margin percent was primarily due to the prior year charges resulting from the withdrawal of Lartruvo, favorable product mix, and greater manufacturing efficiencies, partially offset by lower realized prices on revenue. Total operating expenses in the first quarter of 2020, defined as the sum of research and development and marketing, selling, and administrative expenses, increased 7 percent to $2.942 billion compared with the first quarter of 2019. Research and development expenses increased 13 percent to $1.392 billion, or 23.8 percent of revenue, driven by higher development expenses for late-stage assets. Marketing, selling, and administrative expenses increased 2 percent to $1.550 billion. In the first quarter of 2020, the company recognized acquired in-process research and development charges of $52.3 million related to the business development transaction with Sitryx. Inthe firstquarter of 2019, the company recognized acquired in-process research and development charges of $136.9 millionrelated to business development transactions with AC Immune SA and ImmuNext, Inc. In the first quarter of 2020, the company recognized asset impairment, restructuring and other special charges of $59.9 million. The charges were primarily related to acquisition and integration costs as part of the closing of the acquisition of Dermira. In the first quarter of 2019, the company recognized asset impairment, restructuring and other special charges of $423.9 million, primarily associated with accelerated vesting of Loxo Oncology employee equity awards as part of the closing of the acquisition of Loxo Oncology. Operating income in the first quarter of 2020 was $1.591 billion, compared to $645.1 million in the first quarter of 2019. The increase in operating income was primarily driven by higher gross margin and lower asset impairment, restructuring and other special charges and acquired in-process research and development charges, partially offset by higher research and development expenses. Other income was $89.1 million in the first quarter of 2020, compared with $86.0 million in the first quarter of 2019. The increase in other income was driven primarily by higher net gains on investment securities, partially offset by lower interest income. The higher net gains on investments were due primarily to increased market valuations of two companies in Lilly's investment portfolio that are currently developing potential vaccines against COVID-19. The effective tax rate was 13.3 percent in the first quarter of 2020, compared with 23.3 percent in the first quarter of 2019. The higher effective tax rate in the first quarter of 2019 was primarily due to the non-deductibility of the accelerated vesting of Loxo Oncology employee equity awards as part of the closing of the acquisition of Loxo Oncology, as well as tax expenses associated with the withdrawal of Lartruvo. In the first quarter of 2020, net income and earnings per share were $1.457billion and $1.60, respectively, compared with net income of $4.242billion and earnings per share of $4.31 in the first quarter of 2019. The decrease in net income and earnings per share in the first quarter of 2020 was primarily driven by the $3.681 billion gain recognized on the disposition of Elanco in the first quarter of 2019, partially offset by higher operating income in 2020. Earnings per share in the first quarter of 2020 benefited from lower weighted-average shares outstanding as a result of the Elanco exchange offer. First-Quarter Non-GAAP Measures On a non-GAAP basis, first-quarter 2020 gross margin increased 15 percent, to $4.703 billion compared with the first quarter of 2019 and was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic. Gross margin as a percent of revenue was 80.3 percent, an increase of 0.1 percentage points. The increase in gross margin percent was primarily due to favorable product mix and manufacturing efficiencies, offset by the impact of lower realized prices on revenue. Operating income on a non-GAAP basis increased $427.5 million, or 32 percent, to $1.762 billion in the first quarter of 2020 compared with the first quarter of 2019, due to higher gross margin, partially offset by higher research and development expenses. The effective tax rate on a non-GAAP basis was 13.6 percent in the first quarter of 2020, compared with 12.9 percent in the first quarter of 2019. The higher effective tax rate for the first quarter of 2020 was driven primarily by a mix of earnings in higher tax jurisdictions, partially offset by an increase in net discrete tax benefits. On a non-GAAP basis, in the first quarter of 2020 net income increased 29 percent, to $1.599 billion, while earnings per share increased 32 percent, to $1.75, compared with $1.237 billion and $1.33, respectively, in the first quarter of 2019. The increase in net income and earnings per share was driven primarily by higher operating income, partially offset by higher income taxes. For further detail of non-GAAP measures, see the reconciliation below as well as the \"Reconciliation of GAAP Reported to Selected Non-GAAP Adjusted Information\" table later in this press release. First Quarter 2020 2019 % Change Earnings per share (reported) $ 1.60 $ 4.31 (63)% Discontinued operations (3.74) Earnings per share from continuing operations (reported) 1.60 0.57 Asset impairment, restructuring and other special charges .06 .44 Lartruvo charges .13 Amortization of intangible assets .05 .04 Acquired in-process research and development .05 .12 Impact of reduced shares outstanding for non-GAAP reporting(a) .03 Earnings per share (non-GAAP) $ 1.75 $ 1.33 32% Numbers may not add due to rounding. (a) Non-GAAP earnings per share assume that the disposition of Elanco occurred at the beginning of 2019 and, therefore, exclude the approximately 65.0 million shares of Lilly common stock retired in the Elanco exchange offer. Selected Revenue Highlights (Dollars in millions) First Quarter Selected Products 2020 2019 % Change Trulicity $ 1,229.4 $ 879.7 40% Humalog(a) 695.8 730.8 (5)% Alimta 560.1 499.2 12% Taltz 443.5 252.5 76% Humulin 315.7 297.7 6% Basaglar 303.7 251.4 21% Forteo 272.4 312.9 (13)% Jardiance(b) 267.5 203.6 31% Cyramza 239.0 198.3 21% Cymbalta 210.4 164.1 28% Verzenio 188.0 109.4 72% Olumiant 139.7 82.1 70% Emgality 74.0 14.2 NM Tyvyt 57.4 9.9 NM Baqsimi 17.8 NM Total Revenue 5,859.8 5,092.2 15% (a)Humalog includes Insulin Lispro (b)Jardiance includes Glyxambi, Synjardy, and Trijardy XR NM not meaningful; Numbers may not add due to rounding Impact of COVID-19 on First-Quarter 2020 Revenue The company estimates that revenue in the first quarter of 2020 for many of its products was favorably impacted by increased customer buying patterns and patient prescription trends resulting from the COVID-19 pandemic that increased revenue by approximately $250 million worldwide, including approximately $200 million in the U.S. and approximately $50 million outside the U.S. The company believes that the increase in U.S. revenue from COVID-19 primarily impacted its portfolio of diabetes medicines, with estimated increases of approximately $70 million to $80 million for insulin products and approximately $30 million to $40 million for Trulicity. The company also estimates that U.S. revenue for Taltz was favorably impacted by approximately $20 million to $25 million. Trulicity First-quarter 2020 worldwide Trulicity revenue was $1.229 billion, an increase of 40 percent compared with the first quarter of 2019. U.S. revenue increased 40 percent, to $929.5 million, driven by increased volume, partially offset by lower realized prices. Trulicity's lower realized prices in the U.S. were primarily due to higher contracted rebates and changes in segment mix, partially offset by higher list prices. Revenue outside the U.S. was $299.9 million, an increase of 40 percent, driven by increased volume, partially offset by the unfavorable impact of foreign exchange rates and lower realized prices. Humalog For the first quarter of 2020, worldwide Humalog revenue decreased 5 percent compared with the first quarter of 2019, to $695.8 million. Revenue in the U.S. decreased 11 percent, to $398.6 million, driven primarily by lower realized prices due to changes in estimates for rebates and discounts and changes in segment mix, partially offset by increased volume. Revenue outside the U.S. increased 5 percent, to $297.2 million, primarily driven by increased volume, partially offset by the unfavorable impact of foreign exchange rates. Alimta For the first quarter of 2020, worldwide Alimta revenue increased 12 percent compared with the first quarter of 2019, to $560.1 million. U.S. revenue increased 15 percent, to $324.2million, primarily driven by increased volume and, to a lesser extent, higher realized prices. Revenue outside the U.S. increased 8 percent to $235.8 million, primarily driven by increased volume, partially offset by lower realized prices and, to a lesser extent, the unfavorable impact of foreign exchange rates. Taltz For the first quarter of 2020, worldwide Taltz revenue increased 76 percent compared with the first quarter of 2019, to $443.5million. U.S. revenue increased 81 percent, to $327.5million, driven by increased volume and, to a lesser extent, higher realized prices primarily due to changes in estimates for rebates and discounts. Revenue outside the U.S. increased 62 percent, to $116.0 million, primarily driven by increased volume, partially offset by lower realized prices and the unfavorable impact of foreign exchange rates. Humulin For the first quarter of 2020, worldwide Humulin revenue increased 6 percent compared with the first quarter of 2019, to $315.7 million. U.S. revenue increased 6 percent, to $214.1 million, driven by increased volume, partially offset by lower realized prices due to changes in segment mix. Revenue outside the U.S. increased 5 percent, to $101.5 million, due to increased volume and, to a lesser extent, higher realized prices, partially offset by the unfavorable impact of foreign exchange rates. Basaglar For the first quarter of 2020, worldwide Basaglar revenue increased 21 percent compared with the first quarter of 2019, to $303.7 million. U.S. revenue increased 16 percent,to $230.4 million, primarily driven by increased volume. Revenue outside the U.S. increased 38 percent, to $73.3million, driven by increased volume, partially offset by the unfavorable impact of foreign exchange rates. Basaglar is part of the company's alliance with Boehringer Ingelheim. Lilly reports as cost of sales payments made to Boehringer Ingelheim for royalties and for its portion of the gross margin in 2020 and 2019, respectively. Forteo For the first quarter of 2020, worldwide Forteo revenue decreased 13 percent compared with the first quarter of 2019, to $272.4 million. U.S. revenue decreased 3 percent, to $122.5 million, driven by lower realized prices primarily due to the unfavorable impact of higher contracted rates. Revenue outside the U.S. decreased 20 percent to $149.8million, primarily driven by decreased volume and, to a lesser extent, lower realized prices. The company expects further volume declines for Forteo as a result of competitive dynamics in the U.S. and the entry of generic and biosimilar competition following the loss of patent exclusivity in the third quarter of 2019 in the U.S., Japan and major European markets. Jardiance The company's worldwide Jardiance revenue during the first quarter of 2020 was $267.5 million, an increase of 31 percent compared with the first quarter of 2019. U.S. revenue increased 15 percent, to $144.6 million, driven by increased volume. Revenue outside the U.S. was $122.9 million, an increase of 57 percent, driven by increased volume. Jardiance is part of the company's alliance with Boehringer Ingelheim. Lilly reports as revenue royalties received on net sales of Jardiance and its portion of Jardiance's gross margin in 2020 and 2019, respectively. Cyramza For the first quarter of 2020, worldwide Cyramza revenue was $239.0million, an increase of 21 percent compared with the first quarter of 2019. U.S. revenue was $89.1million, an increase of 19 percent, primarily driven by increased volume. Revenue outside the U.S. was $149.9million, an increase of 22 percent, primarily driven by increased volume. Cymbalta For the first quarter of 2020, worldwide Cymbalta revenue increased 28 percent compared with the first quarter of 2019, to $210.4 million. U.S. revenue was $11.6 million in the first quarter. Revenue outside the U.S. increased 29 percent to $198.8 million, driven by increased volume, partially offset by lower realized prices. The increase in volume outside the U.S. was primarily driven by the company's sale of its rights for Xeristar in Spain. Verzenio For the first quarter of 2020, worldwide Verzenio revenue increased 72 percent compared with the first quarter of 2019, to $188.0 million. U.S. revenue was $129.4 million, an increase of 38 percent, primarily driven by increased volume. Revenue outside the U.S. was $58.6 million, an increase of $42.7 million compared with the first quarter of 2019 driven by increased volume. Olumiant For the first quarter of 2020, Olumiant generated worldwide revenue of $139.7 million. U.S. revenue was $11.3 million. Revenue outside the U.S. was $128.4 million, an increase of 70 percent compared with the first quarter of 2019, driven by increased volume. Emgality For the first quarter of 2020, Emgality generated worldwide revenue of $74.0 million, an increase of $7.8 million compared with the fourth quarter of 2019. U.S. revenue was $67.3 million, an increase of $4.2 million compared with the fourth quarter of 2019, primarily driven by increased volume, partially offset by lower realized prices due to changes to estimates in rebates and discounts. Revenue outside of the U.S. was $6.7 million in the first quarter of 2020. Tyvyt The company's Tyvyt revenue during the first quarter of 2020 was $57.4 million, an increase of $20.0 million compared with the fourth quarter of 2019. Tyvyt is part of the company's alliance with Innovent Biologics, Inc. in China. Lilly reports total sales of Tyvyt made by Lilly as revenue, with payments made to Innovent for its portion of the gross margin reported as cost of sales. Lilly also reports as revenue a portion of the gross margin for Tyvyt sales made by Innovent. Baqsimi For the first quarter of 2020, Baqsimi generated worldwide revenue of $17.8 million. U.S revenue was $15.8 million, while revenue outside the U.S. was $2.0 million. 2020 Financial Guidance The company has updated certain elements of its 2020 financial guidance on a reported basis and a non-GAAP basis to reflect both management's expectations for operational performance and the uncertainty surrounding the extent and duration of the impact of the COVID-19 pandemic. Key management assumptions supporting the updated guidance include: The increased customer buying patterns and patient prescription trends associated with COVID-19 that were experienced in the first quarter of 2020 will largely be reversed over the course of 2020; The reduction in new-to-brand prescription trends will peak in the second quarter of 2020 in the U.S. and much of Europe; Healthcare activity, including non-COVID-19 related patient visits with their physicians, will align more closely with historical levels in the second half of 2020; Increased utilization of patient affordability programs and changes in segment mix due to increased U.S. unemployment will negatively impact U.S. pricing; Clinical trial enrollment in existing studies, as well as initiation of new clinical trials, will resume in the second half of 2020; and Investment in COVID-19 related research, testing and support will continue throughout 2020. Based on the key assumptions outlined above, the company has adjusted earnings per share for 2020 to now be in the range of $6.20 to $6.40 on a reported basis and $6.70 to $6.90 on a non-GAAP basis. 2020 Expectations % Change from 2019 Earnings per share (reported)(a) $6.20 to $6.40 25% to 29% Amortization of intangible assets .37 Acquired IPR&D(b) .07 Asset impairment, restructuring and other special charges .06 Earnings per share (non-GAAP) $6.70 to $6.90 11% to 14% Numbers may not add due to rounding (a)Reported earnings per share percent change from 2019 calculated based on change from 2019 earnings per share from continuing operations. (b)Includes upfront payments for acquired in-process research and development transactions with Sitryx and AbCellera. The company still anticipates 2020 revenue between $23.7 billion and $24.2 billion. Revenue growth is still expected to be driven by volume from key growth products including Trulicity, Taltz, Basaglar, Jardiance, Verzenio, Cyramza, Olumiant, Emgality, Baqsimi and Tyvyt, as well as the addition of QBREXZA revenue and the potential launch of other new medicines. Revenue growth is expected to be partially offset by lower revenue for products that have lost patent exclusivity. Revenue growth is also expected to be partially offset by a low-single digit net price decline in the U.S. driven primarily by rebates and legislated increases to Medicare Part D cost sharing, patient affordability programs, and net price declines in China, Japan and Europe. Gross margin as a percent of revenue is still expected to be approximately 79.0 percent on a reported basis and approximately 81.0 percent on a non-GAAP basis. Marketing, selling and administrative expenses are still expected to be in the range of $6.2 billion to $6.4 billion. Research and development expenses are still expected to be in the range of $5.6 billion to $5.9 billion. Operating margin percentage, defined as operating income as a percent of revenue, is still expected to be approximately 28 percent on a reported basis and 31 percent on a non-GAAP basis. Other income (expense) is now expected to be in the range of $0 to $150 million of expense. The 2020 effective tax rate is still expected to be approximately 15 percent on both a reported basis and a non-GAAP basis. The following table summarizes the company's 2020 financial guidance: 2020 Guidance Prior Updated Revenue $23.7 to $24.2 billion Unchanged Gross Margin % of Revenue (reported) Approx. 79% Unchanged Gross Margin % of Revenue (non-GAAP) Approx. 81% Unchanged Marketing, Selling & Administrative $6.2 to $6.4 billion Unchanged Research & Development $5.6 to $5.9 billion Unchanged Other Income/(Expense) $(250) to $(100) million $(150) to $0 million Tax Rate Approx. 15% Unchanged Earnings per share (reported) $6.18 to $6.28 $6.20 to $6.40 Earnings per share (non-GAAP) $6.70 to $6.80 $6.70 to $6.90 Operating Income % of Revenue (reported) 28% Unchanged Operating Income % of Revenue (non-GAAP) 31% Unchanged Non-GAAP guidance reflects adjustments presented in the earnings per share table above. Webcast of Conference Call As previously announced, investors and the general public can access a live webcast of the first-quarter 2020 financial results conference call through a link on Lilly's website at www.lilly.com. The conference call will begin at 9:00 a.m. Eastern time (ET) today and will be available for replay via the website. Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. F-LLY This press release contains management's current intentions and expectations for the future, all of which are forward- looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words \"estimate\", \"project\", \"intend\", \"expect\", \"believe\", \"target\", \"anticipate\" and similar expressions are intended to identify forward-looking statements. Actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees that pipeline products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. The company's results may also be affected by such factors as the timing of anticipated regulatory approvals and launches of new products; market uptake of recently launched products; competitive developments affecting current products and our pipeline; the expiration of intellectual property protection for certain of the company's products; the company's ability to protect and enforce patents and other intellectual property; the impact of actions of governmental and private payers affecting the pricing of, reimbursement for, and access to pharmaceuticals; regulatory compliance problems or government investigations; regulatory actions regarding currently marketed products; unexpected safety or efficacy concerns associated with the company's products; issues with product supply stemming from manufacturing difficulties or disruptions; regulatory changes or other developments; changes in patent law or regulations related to data-package exclusivity; litigation involving past, current or future products; unauthorized disclosure, misappropriation, or compromise of trade secrets or other confidential data stored in the company's information systems, networks and facilities, or those of third parties with which the company shares its data; changes in tax law and regulations, including the impact of U.S. tax reform legislation enacted in December 2017 and related guidance; changes in inflation, interest rates, and foreign currency exchange rates; asset impairments and restructuring charges; changes in accounting standards promulgated by the Financial Accounting Standards Board and the Securities and Exchange Commission (SEC); acquisitions and business development transactions and related integration costs; information technology system inadequacies or operating failures; the impact of the evolving COVID-19 pandemic, and the global response thereto; reliance on third-party relationships and outsourcing arrangements; and global macroeconomic conditions. For additional information about the factors that could cause actual results to differ materially from forward-looking statements, please see the company's latest Form 10-K and subsequent Forms 8-K and 10-Q filed with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. Except as is required by law, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this release. Alimta (pemetrexed disodium, Lilly)Baqsimi (glucagon, Lilly)Basaglar (insulin glargine injection, Lilly)Cialis (tadalafil, Lilly)Cymbalta (duloxetine, Lilly)Cyramza (ramucirumab, Lilly)Emgality (galcanezumab-gnlm, Lilly)Forteo (teriparatide of recombinant DNA origin injection, Lilly)Glyxambi (empagliflozin/linagliptin, Boehringer Ingelheim)Humalog (insulin lispro injection of recombinant DNA origin, Lilly)Humulin (human insulin of recombinant DNA origin, Lilly)Jardiance (empagliflozin, Boehringer Ingelheim)Lartruvo (olaratumab, Lilly)Olumiant (baricitinib, Lilly)QBREXZA (Glycopyrronium cloth, Dermira)Strattera (atomoxetine, Lilly)Synjardy (empagliflozin/metformin, Boehringer Ingelheim)Taltz (ixekizumab, Lilly)Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets, Boehringer Ingelheim)Trulicity (dulaglutide, Lilly)Tyvyt (sintilimab injection, Lilly)Verzenio (abemaciclib, Lilly) Third party trademarks used herein are trademarks of their respective owners. Eli Lilly and Company Employment Information March 31, 2020 December 31, 2019 Worldwide Employees 33,815 33,755 Eli Lilly and Company Operating Results (Unaudited) REPORTED (Dollars in millions, except per share data) Three Months Ended March 31, 2020 2019 % Chg. Revenue $ 5,859.8 $ 5,092.2 15% Cost of sales 1,215.1 1,138.7 7% Research and development 1,392.1 1,230.5 13% Marketing, selling and administrative 1,549.6 1,517.1 2% Acquired in-process research and development 52.3 136.9 (62)% Asset impairment, restructuring and other special charges 59.9 423.9 (86)% Operating income 1,590.8 645.1 NM Net interest income (expense) (78.2) (55.9) Net other income (expense) 167.3 141.9 Other income (expense) 89.1 86.0 4% Income before income taxes 1,679.9 731.1 NM Income tax expense 223.4 170.0 31% Net income from continuing operations 1,456.5 561.1 NM Net income from discontinued operations 3,680.5 NM Net income $ 1,456.5 $ 4,241.6 (66)% Earnings from continuing operations - diluted 1.60 0.57 NM Earnings from discontinued operations - diluted 3.74 NM Earnings per share - diluted $ 1.60 $ 4.31 (63)% Dividends paid per share $ 0.7400 $ 0.6450 15% Weighted-average shares outstanding (thousands) - diluted 911,713 984,001 NM not meaningful Eli Lilly and Company Reconciliation of GAAP Reported to Selected Non-GAAP Adjusted Information (Unaudited) (Dollars in millions, except per share data) Three Months Ended March 31, 2020 Three Months EndedMarch 31, 2019 GAAP Reported Adjustments(b) Non-GAAP Adjusted(a) GAAP Reported Adjustments(c) Non-GAAP Adjusted(a) Cost of sales $ 1,215.1 $ (58.6) $ 1,156.5 $ 1,138.7 $ (128.2) $ 1,010.5 Acquired in-process research and development 52.3 (52.3) 136.9 (136.9) Asset impairment, restructuring and other special charges 59.9 (59.9) 423.9 (423.9) Income tax expense 223.4 28.5 251.9 170.0 13.4 183.4 Net income from continuing operations 1,456.5 142.3 1,598.8 561.1 675.6 1,236.7 Net income from discontinued operations 3,680.5 (3,680.5) Net income 1,456.5 142.3 1,598.8 4,241.6 (3,004.9) 1,236.7 Earnings per share - diluted 1.60 0.15 1.75 4.31 (2.98) 1.33 Weighted-average shares outstanding (thousands) - diluted 911,713 911,713 984,001 (54,167) 929,834 Numbers may not add due to rounding. The table above reflects only line items with non-GAAP adjustments. (a) The company uses non-GAAP financial measures that differ from financial statements reported in conformity with U.S. generally accepted accounting principles (GAAP). The company's non-GAAP measures adjust reported results to exclude amortization of intangibles and items that are typically highly variable, difficult to predict, and of a size that could have a substantial impact on the company's reported operations for a period. The company believes that these non-GAAP measures provide useful information to investors. Among other things, they may help investors evaluate the company's ongoing operations. They can assist in making meaningful period-over-period comparisons and in identifying operating trends that would otherwise be masked or distorted by the items subject to the adjustments. Management uses these non-GAAP measures internally to evaluate the performance of the business, including to allocate resources and to evaluate results relative to incentive compensation targets. Investors should consider these non-GAAP measures in addition to, not as a substitute for or superior to, measures of financial performance prepared in accordance with GAAP. (b) Adjustments to certain GAAP reported measures for the three months ended March 31, 2020, include the following: (Dollars in millions, except per share data) Amortization (i) IPR&D(ii) Other specified items(iii) Total Cost of sales $ (54.4) $ $ (4.2) $ (58.6) Operating expenses Acquired in-process research and development (52.3) (52.3) Asset impairment, restructuring and other special charges (59.9) (59.9) Income taxes 11.3 11.0 6.2 28.5 Net income 43.1 41.3 57.9 142.3 Earnings per share - diluted 0.05 0.05 0.06 0.15 Numbers may not add due to rounding. The table above reflects only line items with non-GAAP adjustments. i. Exclude amortization of intangibles primarily associated with costs of marketed products acquired or licensed from third parties. ii. Exclude costs associated with upfront payments for acquired in-process research and development projects acquired in a transaction other than a business combination. These costs were related to a business development transaction with Sitryx. iii. Asset impairment, restructuring and other special charges exclude primarily acquisition and integration costs as part of the closing of the acquisition of Dermira. (c) Adjustments to certain GAAP reported measures for the three months ended March 31, 2019, include the following: (Dollars in millions, except per share data) Amortization (i) IPR&D (ii) Other specified items(iii) Reduced shares outstanding(iv) Lartruvo charges (v) Discontinued operations(vi) Total Cost of sales $ (43.6) $ $ $ $ (84.6) $ $ (128.2) Acquired in-process research and development (136.9) (136.9) Asset impairment, restructuring and other special charges (411.8) (12.1) (423.9) Income taxes 8.9 28.7 4.2 (28.5) 13.4 Net income 34.7 108.1 407.6 125.2 (3,680.5) (3,004.9) Earnings per share - diluted 0.04 0.12 0.44 0.03 0.13 (3.74) (2.98) Numbers may not add due to rounding. The table above reflects only line items with non-GAAP adjustments. i. Exclude amortization of intangibles primarily associated with costs of marketed products acquired or licensed from third parties. ii. Exclude costs associated with upfront payments for acquired in-process research and development projects acquired in a transaction other than a business combination. These costs were related to business development transactions with AC Immune SA and ImmuNext, Inc. iii. Exclude charges primarily associated with the accelerated vesting of Loxo Oncology employee equity awards as part of the closing of the acquisition of Loxo Oncology. iv. Non-GAAP earnings per share assume that the disposition of Elanco occurred at the beginning of 2019 and therefore include the benefit from the reduction in shares of common stock outstanding. v. Exclude charges related to the withdrawal of Lartruvo. vi. Exclude discontinued operations of Elanco. Refer to: Mark Taylor; [emailprotected]; (317) 276-5795 (Media) Kevin Hern; [emailprotected]; (317) 277-1838 (Investors) SOURCE Eli Lilly and Company Related Links lilly.com", "role": "user" }, { "content": "Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ALISO VIEJO, Calif., Nov. 24, 2020 /PRNewswire/ --Syxsense, a global leader in SaaS IT and security management solutions, extends support of its cloud-native, real-time architecture to Amazon Web Service (AWS) Linux devices. AWS Linux assets are protected with a single lightweight agent allowing real-time patching and management from the Syxsense Management Cloud. \"With the addition of AWS Linux support, Syxsense now allows IT departments to manage and secure their entire premise, cloud and remote homeworking environment from a single easy-to-use SaaS tool,\" commented Ashley Leonard, CEO Syxsense Inc. In under 5 minutes, Syxsense customers can be up and running, managing their Windows, Mac, and Linux devices, whether on-premise, remote, or in the cloud, providing 100% visibility. Once added to the console, Syxsense evaluates your exposed risk with dashboards, device health, and reports that prioritize the immediate or automatic remediation of issues to reduce an attack surface. Full patching support includes severity, content, inventory, troubleshooting tools, compliance proof and device status for all major Linux flavors in the RPM and DEB based Distributions including RedHat, Debian, Ubuntu, CentOS and AWS, among others. Syxsense is offering free, fully featured trials for up to 50 devices for 14 days. More information on the software and trial can be found here: https://www.syxsense.com/start-a-free-trial-of-syxsense/ About Syxsense Syxsense is the leading provider of innovative, intuitive technology that sees all and knows everything about every endpoint, in every location, everywhere inside and outside the network, as well as in the cloud. It combines the power of artificial intelligence with industry expertise to manage and secure endpoints by stopping threats before they occur and neutralizing threats when they happen. The Syxsense Endpoint Security Cloud always-on technology performs in real-time so businesses can operate free of disruption from security breaches that cripple productivity and expose them to financial risk and reputational harm. www.syxsense.com Photo(s):https://www.prlog.org/12847930 Press release distributed by PRLog SOURCE Syxsense Related Links https://www.syxsense.com", "role": "user" }, { "content": "Syxsense Announces New Support for Amazon Web Service (AWS) Linux Devices", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, Jan. 27, 2021 /PRNewswire/ -- Medicine thought leaders,entrepreneurs and board-certified osteopathicpractitioners, Dr. Vincent Apicella and Dr. Mariaclara Bago, known asDr. A & B,areredefining the currenthealthcare system by combining the best of traditional and alternative medical strategies. Utilizingtheir comprehensive knowledge and passion for health and wellness, the husband-and-wife duo arestarring in the documentary,The Blob Blob Fish: A Journey Through Obesity,set to be released this summer.Produced and directed by Andrew Mossop (DreamsWorks, MTV, VH1), the filmis an upliftingand thought-provokingdocumentary which highlights the flaws in our current healthcare model. The Blob Blob Fish: A Journey Through Obesitybeautifully demonstrates Dr. A & B's methodsbyexamining the benefits of drastic lifestyle changes on weight loss. In it, three patients, including a teenage boy who is deemed the \"blob blob fish\" by his peers, embark on a transformative, inspiring, and heartwarming journey to improve their health, self-esteem and overallquality of life. \"I wish everyone understood that they don't need to depend upon insurance, drugs, or the government for better health,\" says Dr. A. \"We want to show the differences people can make in their own healthcare by starting with a moreholistic approach, andthentraditional medicine second. \"Or on an as-needed basis,\" adds Dr. B. The mission of the film is to redefine how health is perceived in this country. With a culture stuck on the path of least resistance, thismentality has led to trillions of dollars of healthcare spending and very minimal impact on chronic diseases. Dr. A & B practice functional medicine,a root-cause, holistic, and natural approach that addresses the body as a whole when treating specific medical problems. Their preventative method can often target and cure healthailmentsbeforetraditional medicine techniques like drugs andsurgery arerequired. Tointerview Dr. A & B, contact EKC PR at 310-441-1000 or email -[emailprotected]. About Dr. A & B Dr. A & B have been applying their \"life changing through lifestyle altering\" treatments by way of theirintegrative medicalpractice for the last 15 years, including running their own renowned health and wellness center in Wellington, FL. SOURCE Dr. A & B Related Links https://draandb.com", "role": "user" }, { "content": "Husband-and-Wife Medical Duo Confront the Deficiencies of America's Healthcare System in New Documentary Dr. A & B star in the uplifting new documentary: The Blob Blob Fish: A Journey Through Obesity", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA, July 21, 2020 /PRNewswire/ -- With the challenges of a pandemic, many people are choosing to skip vacation, while others are opting for a \"staycation.\"Meggan Kaiser, the travel expert who literally wrote the book about free or affordable trips, EVERYWHERE FOR NOTHING: FREE TRAVEL FOR THE MODERN NOMAD, provides a timely roadmap for researching, creating, and enjoying an affordable vacation.A SAFE VACATION Continue Reading Meggan Kaiser shares her ideas for a great Summer Staycation. Road trips are everything in the travel world now. It is the perfect way to get away while keeping the family safe. If the family is hitting the road this summer, check out what industry leaders like Wyndham Hotels & Resorts have to offer. Wyndham has enhanced health and safety protocols and flexible cancellation policies, so people can book with confidence and peace of mind. With thousands of hotels across 20 brands of family-friendly names like Days Inn, Super 8, and La Quinta, wherever you want to travel, whatever your budget, Wyndham is there. Another tip: register for their latest promotion atWyndhamHotels.comand receive 2,000 bonus Wyndham Rewards points on upcoming stays, up to 10,000 points, good towards free nights, gift cards and more. TIPS FOR THE DRIVEPeople might not realize it, but intense summer heat can be just as damaging to a car's battery as freezing winter temperatures, so make sure to get the battery tested for free at the local Batteries Plus Bulbs store before the next road trip. If a new battery is needed, Batteries Plus Bulbs has a $10mail-in rebate in July and August on Duracell Ultra Gold or Platinum AGM batteries. For the kids, make sure their devices are charged up. Then, whetheron the roador staying home in a backyard oasis, Batteries Plus Bulbs has everything needed to stay powered up and connected all summer long. For more information, visitwww.BatteriesPlusBulbs.com.SOME STAYCATION FUNActivities that bring the entire family together are the best for staycations, and two of the newest games from hit-party-game-creator Exploding Kittens are the perfect staycation addition. Throw Throw Burrito Extreme and Poetry for Neanderthals both feature inflatables, but not just for the pool. Throw Throw Burrito Extreme, a dodgeball card game, features two THREE-FOOT-TALL Burritos to throw at opponents. In Exploding Kittens' first word guessing game, Poetry for Neanderthals, players have to explain complex words or phrases using only single syllables, or they get whacked with a TWO-FOOT-long inflated NO Stick. For ages 7 and up, you can find these games at Target or order at ExplodingKittens.com and have them sent straight to the house.Contact: [emailprotected]Related Imagessummer-staycation-ideas.jpg Summer Staycation Ideas Meggan Kaiser shares her ideas for a great Summer Staycation. Related LinksVideo Blog post SOURCE Tips On TV", "role": "user" }, { "content": "Travel Expert Meggan Kaiser Shares Staycation Inspiration on Tips on TV Blog Unique options to create a fun, relaxing, and economical trip during these challenging times.", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, May 27, 2020 /PRNewswire/ --BlueVoyant, a global expert-driven cybersecurity services company, has today launched its \"Sector 17 - The State of Cybersecurity in the Legal Sector\" report. It reveals that despite excellent standards of cybersecurity, 15% of a global sample of law firms showed signs of compromised networks. These compromises result from an overwhelming attack rate on law firms globally: 100% of law firms analyzed were targeted in attacks by threat actors. The detailed analysis of cybersecurity in the legal sector undertaken by BlueVoyant analyzed thousands of law firms worldwide between January and March 2020. These results were compared with companies in the 16 sectors defined as critical to securing national infrastructure, resources, and resiliency by the Department of Homeland Security. BlueVoyant contends that the legal sector should be designated as \"sector 17\" due to the high-value data law firms contain and their role as arbiters and safekeepers of public trust. The study revealed that 100% of law firms have been subject to targeted threat activity not surprising given the sector's estimated worth of nearly $1 trillion, making it a prime target for financially-motivated attacks, as well as their handling of sensitive information. This month alone, 193 law firms were exposed in a massive data breach due to an insecure database; and the NY law firm GSMLaw was victimized by a ransomware group that is now threatening to release sensitive information about the firm's roster of celebrity clients, including President Trump. The investigation revealed the most common attack methods across the sector's threat landscape. This included criminal pursuit of sensitive financial information and PII, extortion (non-ransomware), ransomware, third-party risks, password breaches and insider leaks and hacktivism. It also analyzed how the attack surface for illicit actors to share and use information sourced from cyber-attacks has expanded through the Dark Web, providing examples of how this information can be used to conduct ransomware attacks and subsequent breaches. Jim Rosenthal, CEO, BlueVoyant, commented: \"The stakes could not be higher. While the legal sector is performing well in comparison to the other 16 sectors, attacks against law firms constitute some of the most sensational and damaging cyberattacks in history. We have already seen how recent incidents can cause substantial geopolitical fallout, not to mention tremendous direct and indirect financial repercussions for law firms.\" Furthermore, detailed analysis into 20 law firms, including an examination of defense metrics, inbound threat targeting and evidence of compromise, revealed that 15% of these firms were likely to have been compromised based upon strong evidence of suspicious traffic and many more (almost half) showed signs of suspicious activity, including malicious proxy use. Rosenthal added: \"Threat actors are aggressively targeting law firms, and they are doing so daily. Threats against law firms are high volume, multi-faceted, and organized; threat actors use multiple sophisticated tools and techniques; and, notwithstanding industry-leading efforts, law firms have been successfully compromised.\" BlueVoyant recommends that law firms benchmark existing cybersecurity best practice against its recommended ten steps to mitigate future attacks. Further strengthening the sector's defense against potential compromises is more crucial than ever, due to how the obtained information can be subsequently utilized. Rosenthal concludes: \"These findings are designed to support and empower law firms globally. By recognizing the legal sector as critical to national and international defense and infrastructure, BlueVoyant aims to put a spotlight on measuring and improving cybersecurity across the industry.\" To download BlueVoyant's \"Sector 17 The State of Cybersecurity in the Legal Sector\" report, visit https://www.bluevoyant.com/sector-17-bluevoyant-legal-sector-report. About the Report To source these findings, BlueVoyant analyzed proprietary and third-party feeds to identify traffic between law firm domains and blacklisted IP ranges, and engaged in deep and dark web surveillance, seeking evidence of malicious probing or scanning from potential malicious actors. It also identified any interactions between law firms and known malicious infrastructure. Using these different sources of information, BlueVoyant detected multiple variations of potentially malicious inbound traffic over a one-month observation period, including: Blacklisted IPs and domains reaching out to law firm assets Large volumes of sessions targeting vulnerable webpages, observed in known malicious infrastructure Evidence of attempted brute force attacks Sector 17 WebinarOn June 16th at 2.00 pm EDT, BlueVoyant will host a webinar to review the findings of its global legal sector analysis and provide helpful insight to law firms. Topics covered will include: The legal industry threat landscape Dark Web activity relative to the industry Comprehensive cybersecurity review of the industry The webinar will be chaired by Milan Patel, Global Co-Head of Managed Security Services and Tom Lind, Co-Head of Strategic Intelligence. Register for BlueVoyant's webinar, here. About BlueVoyantBlueVoyant is an expert-driven cybersecurity services company whose mission is to proactively defend organizations of all sizes against today's constant, sophisticated attackers and advanced threats. Led by CEO, Jim Rosenthal, BlueVoyant's highly skilled team includes former government cyber officials with extensive frontline experience in responding to advanced cyber threats on behalf of the National Security Agency, Federal Bureau of Investigation, Unit 8200 and GCHQ, together with private sector experts. BlueVoyant services utilize large real-time datasets with industry leading analytics and technologies. Founded in 2017 by Fortune 500 executives and former Government cyber officials and headquartered in New York City, BlueVoyant has offices in Maryland, Tel Aviv, San Francisco, London and Latin America. PR Contact:Danielle Ostrovsky (US)C8 Consulting for BlueVoyant[emailprotected]+1-410-302-9459 SOURCE BlueVoyant Related Links https://www.bluevoyant.com", "role": "user" }, { "content": "Over 15% of a Global Sample of Law Firms Show Signs of Compromise, According to BlueVoyant \"Sector 17\" Report 100% have evidence of daily targeting by threat actors", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Moodys Analytics has won Best Decision Management Solution at the 2020 AI Breakthrough Awards. We won this award for the QUIQspread solution, our automated financial spreading tool, and for our CreditLens credit lifecycle management solution. The QUIQspread solution uses machine learning to understand an institution's financial data spreading policies. The tool is built on our financial spreading expertise and expansive data resourcesits trained on the financials of more than 22 million private firms, which helps immediately improve the accuracy of clients spreads. The more spreads it runs, the smarter it becomes and the less time and resources it requires. To ensure scalability, the QUIQspread tool was built as a software-as-a-service solution. The QUIQspread solution integrates easily with clients' internal loan systems, and seamlessly with the Moodys Analytics CreditLens solution. This cloud-based solution combines access to our unparalleled data and analytics with digitization and automation capabilities, enabling businesses to make better, faster credit decisions. Firms using the CreditLens solution are able to run financial statements through the QUIQspread tool without leaving the platform. \"We're honored to win this AI Breakthrough Award,\" said Eric Grandeo, Senior Director at Moody's Analytics. Across everything we do at Moodys Analytics, our shared goal is to help customers make better decisions. Taking the prize for Best Decision Management Solution is especially gratifying. The QUIQspread solution was developed by the Moody's Analytics Accelerator, the companys innovation engine. The Accelerator uses emerging technologies to create new risk management solutions. Last year, we won Best Financial Services AI Solution at the Artificial Intelligence Awards for the QUIQspread solution. Learn more about the AI Breakthrough Awards. This win adds to our growing list of industry recognition. About Moodys Analytics Moodys Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moodys Analytics, visit our website or connect with us on Twitter and LinkedIn. Moody's Analytics, Inc. is a subsidiary of Moody's Corporation (NYSE: MCO). Moodys Corporation reported revenue of $4.8 billion in 2019, employs approximately 11,200 people worldwide and maintains a presence in 40 countries.", "role": "user" }, { "content": "Moodys Analytics Wins Best Decision Management Solution at AI Breakthrough Awards", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TI Fluid Systems -, . , 17 2021 . /PRNewswire/ -- TI Fluid Systems (LSE:TIFS) . . (William L. Kozyra) - (Hans Dieltjens) . 1 2021 , , . . , 25 . , . (Manfred Wennemer) : TI Fluid Systems 2008 . 2017 , , . 12 . . , . : , . . , , . 12 . . . , TI Fluid Systems . TI Fluid Systems TI Fluid Systems , , . TI Fluid Systems, 100- , 108 28 , OEM- . : www.tifluidsystems.com. SOURCE TI Fluid Systems", "role": "user" }, { "content": "TI Fluid Systems - P USA - English Espaa - espaol Polska - Polski France - Franais Deutschland - Deutsch esko - etina", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Nov. 30, 2020 /PRNewswire/ -- The \"Microdisplay Market Research Report: By Technology, Product Type, Brightness, End User - Global Industry Analysis and Growth Forecast to 2030\" report has been added to ResearchAndMarkets.com's offering. The global microdisplay market generated a revenue of $1.0 billion in 2019Furthermore, due to the rising incorporation of heads-up display (HUD)-integrated advanced driver assistance systems (ADASs) in vehicles and the ballooning number of NTE (near-to-eye) applications, the market is predicted to attain a valuation of $4.0 billion in 2030, exhibiting a CAGR of 13.4% between 2020 and 2030.The rising prevalence of road accidents has made road safety a priority concern area for many governments and traffic regulatory authorities. As a result, the governments of many countries such as the U.S., Japan, and China are rapidly implementing stringent regulations and policies regarding vehicular safety. These policies mandate the integration of ADASs in automobiles. According to the Federal Motor Carrier Safety Administration (FMCSA), the U.S. launched a project in 2019 aimed at promoting the integration of ADASs in trucks.The main purpose of the project is to reduce the occurrence of road crashes, injuries, and deaths in the trucking industry in the country. Furthermore, the rising public awareness about vehicular safety is making the original equipment manufacturers (OEMs) install HUDs in their vehicles. These HUDs will enhance the driving experience by providing the driver with essential driving-related information. The growing integration of HUDs is massively pushing up the demand for microdisplays and driving the growth of the market.Another key factor fueling the growth of the market is the rising usage of NTE devices such as augmented reality (AR)/virtual reality (VR), HUD, and personal electronics such as cameras, full-color projection systems, and mobile phones across the world. The rapid advancements in technology are boosting the usage of VR and AR devices in the gaming and media and entertainment industries. Additionally, the rising utilization of HUDs in the automotive and military industries is propelling the expansion of the market.Depending on technology, the microdisplay market is categorized into liquid crystal on silicon (LCOS), digital light processing (DLP), liquid crystal display (LCD), and organic light-emitting diode (OLED). Out of these, the LCD division is predicted to dominate the market in the forthcoming years. The growing consumer preference for LCDs over other devices, on account of their several advantages such as compact size, low cost, and less power requirements is the primary factor responsible for the advancement of this category.Historically, the Asia-Pacific (APAC) microdisplay market was the most prosperous one in the entire world, mainly because of the existence of numerous microdisplay manufacturing companies in the regional countries and the subsequent fall in the costs of these devices. In addition to this, the surge of the automotive and consumer electronics industries in India, Japan, and China positively impacted the sales of microdisplays, which, in turn, caused the growth of the industry in the region.Thus, it can be said without any doubt that the market will demonstrate rapid expansion all over the world in the upcoming years, mainly due to the rising integration of HUDs-integrated ADASs in automobiles, growing usage of NTC devices in various industries, and the presence of flourishing consumer electronics and automotive industries, especially in the APAC region.Key Topics Covered: Chapter 1. Research BackgroundChapter 2. Research Methodology2.1 Secondary Research2.2 Primary Research2.3 Market Size Estimation2.4 Data Triangulation2.5 Currency Conversion Rates2.6 Assumptions for the Study2.7 Notes and Caveats2.8 COVID-19 ImpactChapter 3. Executive SummaryChapter 4. Introduction4.1 Definition of Market Segments4.1.1 By Technology4.1.1.1 LCD4.1.1.2 LCoS4.1.1.3 OLED4.1.1.4 DLP4.1.2 By Product Type4.1.2.1 NTE device4.1.2.1.1 EVF4.1.2.1.2 HMD4.1.2.1.2.1 AR4.1.2.1.2.2 VR4.1.2.2 HUD4.1.2.3 Projector4.1.2.3.1 Pico projector4.1.2.3.2 Data projector4.1.2.4 Others4.1.3 By Brightness4.1.3.1 Less than 500 nits4.1.3.2 500-1,000 nits4.1.3.3 More than 1,000 nits4.1.4 By End User4.1.4.1 Consumer electronics4.1.4.2 Industrial4.1.4.3 Automotive4.1.4.4 Military & defense4.1.4.5 Sports and entertainment4.1.4.6 Retail and hospitality4.1.4.7 Medical4.1.4.8 Others4.2 Value Chain Analysis4.3 Market Dynamics4.3.1 Trends4.3.1.1 Increasing use of OLED microdisplays in consumer electronics industry4.3.2 Drivers4.3.2.1 Growing adoption of HUD-integrated ADAS4.3.2.2 Increasing number of NTE applications4.3.2.3 Impact analysis of drivers on market forecast4.3.3 Restraints4.3.3.1 Mature market for digital cameras affecting microdisplay market growth4.3.3.2 Effect of COVID-19 outbreak4.3.3.3 Impact analysis of restraints on market forecast4.3.4 Opportunities4.3.4.1 Development of next-generation micro-LED technology4.4 Porter's Five Forces AnalysisChapter 5. Global Market Size and Forecast5.1 By Technology5.2 By Product Type5.2.1 NTE Device, by Type5.2.1.1 HMD, by type5.2.2 Projector, by Type5.3 By Brightness5.4 By End User5.5 By RegionChapter 6. North America Market Size and ForecastChapter 7. Europe Market Size and ForecastChapter 8. APAC Market Size and ForecastChapter 9. LATAM Market Size and ForecastChapter 10. MEA Market Size and ForecastChapter 11. Competitive Landscape11.1 List of Players and Their Offerings11.2 Ranking Analysis of Key Players11.3 Competitive Benchmarking of Key Players11.4 Global Strategic Developments of Key Players11.4.1 Product Launches11.4.2 Partnerships11.4.3 Client WinsChapter 12. Company Profiles12.1 Business Overview12.2 Product and Service Offerings12.3 Key Financial Summary eMagin Corporation Himax Technologies Inc. Jasper Display Corp. Yunnan OLiGHTEK Opto-Electronic Technology Co. Ltd. WiseChip Semiconductor Inc. Micron Technology Inc. Seiko Epson Corporation Kopin Corporation Microtips Technology Inc. LG Display Co. Ltd. Universal Display Corporation Sony Corporation For more information about this report visit https://www.researchandmarkets.com/r/g4k8mz Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global $4 Billion Microdisplay Market to 2030: Opportunities with the Development of Next-Generation Micro-LED Technology", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SOUTH SAN FRANCISCO, Jan. 8, 2021 /PRNewswire/ -- Frontier Medicines, Corp., a precision medicine company drugging challenging protein targets to develop breakthrough medicines that change the course of human diseases, today announced that Chris Varma, Ph.D., Frontier's co-founder, chairman, and CEO, will present a webcasted company overview at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 2:35 p.m. ET. A live audio webcast of the presentation will be available for access in the News & Media section of Frontier's website at https://frontiermeds.com/latest-news#presentations. An archived replay will be accessible for 30 days following the event. About Frontier MedicinesFrontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered undruggable. The company is deploying its groundbreaking scientific approaches in chemoproteomics, covalent drug discovery, and machine learning to develop medicines to treat a number of debilitating diseases, starting with cancer. In its quest to \"drug the undruggable,\" Frontier Medicines seeks to significantly broaden the therapeutic landscape with novel small molecule alternatives to change the course of a broad range of diseases. For more information, visitwww.frontiermeds.comand follow us on LinkedIn. Frontier Medicines Media:[emailprotected] SOURCE Frontier Medicines Related Links http://www.frontiermeds.com", "role": "user" }, { "content": "Frontier Medicines to Present at the 39th Annual J.P. Morgan Healthcare Conference", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Western Asset Municipal Defined Opportunity Trust Inc. (the Fund) announced today that the Fund terminated as scheduled on April 30, 2021. The proportionate interests of stockholders in the assets of the Fund were determined as of that date. The Funds liquidating distribution of $21.1993 per share is anticipated to be paid on or about May 5, 2021. Prior to the opening of business on May 3, 2021, the Fund ceased trading on the New York Stock Exchange. The Fund, a non-diversified, closed-end management investment company, is managed by Legg Mason Partners Fund Advisor, LLC (LMPFA) and is sub-advised by Western Asset Management Company, LLC (Western Asset), an affiliate of LMPFA. Both LMPFA and Western Asset are indirect, wholly-owned subsidiaries of Franklin Resources, Inc. (Franklin Resources). The Fund files its semi-annual and annual reports with the Securities and Exchange Commission (the SEC). These reports are available on the SECs website at www.sec.gov. Contact the Fund at 1-888-777-0102 for additional information, or consult the Fund's web site at www.lmcef.com. Hard copies of the Funds complete audited financial statements are available free of charge upon request. Data and commentary provided in this press release are for informational purposes only. This press release may contain statements regarding plans and expectations for the future that constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the Funds current plans and expectations, and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Additional information concerning such risks and uncertainties are contained in the Funds filings with the SEC. Franklin Resources and its affiliates do not engage in selling shares of the Fund. Category: Fund Announcement Source: Franklin Resources, Inc. Source: Legg Mason Closed End Funds", "role": "user" }, { "content": "Western Asset Municipal Defined Opportunity Trust Inc. (NYSE: MTT) Announces Completed Termination", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HARRISON, N.Y., Jan. 27, 2021 /PRNewswire/ -- Nutrition21, LLC (\"Nutrition21\") has announced that its clinically substantiated ingredient nooLVLis a key component in Player1, the latest introduction by Rule One Proteins, a leader in protein supplements. For its new line, Rule One Proteins sought out nooLVL for its cognitive benefits, specifically reaction time, accuracy, alertness, visual attention, and focus. Billed as a \"Gaming Performance Booster\", Player1 is available in Rainbow Respawn and Gummy Grenade varieties. Some of the other ingredients in the product include L-theanine, carotenoids (lutein/zeaxanthin), natural-source, delayed-release caffeine, theacrine, choline and huperzine. nooLVL is comprised of two components: Bonded Arginine Silicate combined with an additional dose of inositol. Found at high levels in the brain, inositol is a nutrient known for its important role in brain health and function. Most recently, nooLVL was the subject of a clinical study published in Nutrients, which compared it to placebo following acute ingestion by gamers. Researchers evaluated subjects before and after prolonged video game playing. The double-blind placebo-controlled study showed that nooLVL is both fast and effective working within 15 minutes and increasing energy, focus and accuracy. More specifically, it showed that nooLVL as an oral supplement significantly increased cognitive function and reduced errors as compared to placebo. Another unique advantage for gamers is that nooLVL is stimulant-free, safely increasing energy without negatively affecting heart rate or blood pressure. About this new launch, Todd Spear, VP of Sales, Nutrition21, said, \"As the esports market grows, we are excited to see increased demand for innovation for dietary supplements in the space.We are thrilled to have our clinically substantiated nooLVL featured in Rule One Proteins' gamer product for its cognitive performance benefits.\" Connor Costello, CMO, Rule One Proteins, said Player1 represents the company's debut in the esports market. \"We have a solid position in protein supplements and saw this category as a good opportunity for us. We target gamers, who also share an interest in fitness and health. But other relevant demographics include college students, business professionals, weekend warriors, and anyone looking to stay mentally sharp and focused.\" About nooLVL nooLVL is a patented, non-stimulant, nutritional ingredient that boosts cognitive performance and energy in esports athletes. nooLVL has been clinically studied in a population of gamers to demonstrate its safety and efficacy. The first esports gaming ingredient on the market, nooLVL is both fast and effective working within 15 minutes and increasing energy, focus and accuracy. About Nutrition21, LLC:Nutrition21, is an industry-leading developer and marketer of efficacious, high-value, clinically substantiated ingredients for use in dietary supplements, medical foods, and beverages. With over 30 years of biotechnology and pharmaceutical experience, the company's scientific platform has continued to create unique, patented products that are both safe and clinically effective. To build consumer trust, Nutrition21 ensures product efficacy and safety through a product development strategy that involves rigorous preclinical and clinical research. The company currently holds over 100 domestic and international issued and pending patents for its ingredients which support unique claims associated with glucose metabolism, weight management, cognition, and sports nutrition, among others. For more information, please visitwww.Nutrition21.com. Compared to baseline Perceived energy measured by the validated Profile of Mood States (POMS) questionnaire Contact InformationBecky WrightMedia Contact[emailprotected]201-675-0197 2021 Nutrition21, LLC nooLVL is a registered trademark of Nutrition21, LLC. Nutrition21, LLC, 500 Mamaroneck Ave., Suite 510, Harrison, New York 10528 Source: Nutrition21, LLC DRA3124011521 Related Imagesnutrition21.jpg Nutrition21 SOURCE Nutrition21", "role": "user" }, { "content": "Nutrition21's nooLVL Earns Top Spot in Player1 Launch nooLVL supports cognitive performance in a new line of gamer supplements", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WEST PALM BEACH, Florida, May 28, 2020 /PRNewswire/ --The possibility of a global pandemic virus spreading out of control is indeed terrifying. There is a very specific feeling of helplessness that accompanies fighting an enemy that is invisible, relentless and able to move among us silently, without remorse or hesitation. The investing public is rarely concerned about other catastrophes such as earthquakes that can spawn tidal surges, dirty bombs or even war. The fear of societal breakdown, in part or in whole, due to an unchecked superbug is a different kind of nightmare, one that can impact public markets. Again, the fear is generally greater than the danger. Historically, it is not the outbreak that dents the indexes; it is the fear of the unimpeded spread that does the damage. Initially ignored as a \"Chinese problem,\" investors and issuers alike are now taking the coronavirus seriously and factoring it into their action plans. This logical reaction is more prevalent among issuers whose companies rely heavily upon China, but Pubcos with no China ties are also considering the ramifications of quarantines and other events that could impact operations. Virus scares may cause a hiccup in the public sector but any corrections, historically speaking, are quickly shaken off. Between 2003 and 2016 viruses such as SARS, avian flu, swine flu, cholera and most recently the Zika virus seem to have come out of nowhere. Each, understandably so, caused widespread concern and was met with an immediate intervention from medical first responders. In a recent CNBC article by Natasha Turak, billionaire hedge fund giant Ray Dalio, founder of Bridgewater Associates, which manages $160 billion in global investments, expressed his own opinion. Simply stated, he believes that any market volatility created by the coronavirus outbreak is likely exaggerated. The CDC, and other similar agencies, have safeguards in place to protect the global population from pandemic viruses. The public markets hinge on the optimism and participation of global participants. Consequently, the better the CDC, and parallel agencies, can protect the general public, the better they ensure the health of the public markets. According to the CDC, the 1918 influenza pandemic was the most severe pandemic in recent history. It was caused by an H1N1 virus with genes of avian origin. Although there is not universal consensus regarding where the virus originated, it spread worldwide during 1918-1919. In the United States, it was first identified in military personnel in spring 1918. It is estimated that about 500 million people or one-third of the world's population became infected with this virus. The number of deaths was estimated to be at least 50 million worldwide with about 675,000 occurring in the United States. The US population in 1918 was a mere 103,208,000. The super flu reduced this figure by approximately 6.5%, a staggering figure when held in comparison to any viral outbreak ever since. To put this figure in perspective, the virus killed more Americans than were lost in WWI. Somehow, from November 1918 to June 1919, theDow Jones Industrial index rallied from 1,275 to 1,626, a staggering increase of more than 30%. Why a robust stock market existed during an epidemic that generated so many fatalities is virtually inexplicable. Yet it occurred. The one true danger to public health and public markets in times of viral contagion is the proliferation of bad information; rumors, unfounded speculation and fearmongering can do far more damage than the virus itself. Depending on the overall economic environment, the public markets can also interpret viral outbreaks as a growth opportunity because research and development must be initiated to develop new treatments and vaccines. R&D sectors rally as other sectors fail. Some Outbreaks Get All the Breaks The influenza outbreak of 1918 is the one that gets all the attention. One explanation for this may be that after WWI there wasn't much going on. Newspapers had little to report, so the 1918 flu generated an abundance of coverage. This is not meant to trivialize the damage done by the 1918 pandemic, but it is a valid point to consider. Fifty years later, the 1968 pandemic, more commonly known as the Hong Kong Flu, originated in China and lasted until 1970. The 1968 flu pandemic resulted in an estimated one million deaths, approximately 100,000 of which occurred in the U.S. These numbers are indeed smaller than the 1918 outbreak, but they are still quite considerable. The major reason the Hong Kong Flu is far less memorable than its 1918 counterpart is due to the fact that it came on the scene during a tumultuous period in U.S. history. The flu hit the same year that Martin Luther King and Robert F. Kennedy were assassinated and the Vietnam War was rapidly escalating. There was plenty of news to go around, most of it bad, and the Hong Kong Flu never received the amount of media coverage it would have had it occurred in less eventful times. Brave New World On February 12, 2020, the date this article was originally published, there were a total of 14 documented cases of COVID-19 in the U.S. Since then, many things have changed. Homeschooling and online education, two practices that were viewed with a certain degree of suspicion and skepticism, are now the norm. In order for \"alternative education\" to transcend from being the exception to the standard, it was necessary to shed unappealing imagery left over from episodes of Little House on the Prairie and news footage of eccentric parents preparing their children for the mother ship to arrive. As always, rebranding saved the day. Terms such as synchronous e-learning and virtual classrooms make the practice formerly known as homeschooling sound rather futuristic. Remote learning is more than just socially acceptable, it is socially responsible. Parents who are anxious to get their kids back into crowded classrooms are regularly criticized, or even vilified. Westerners were perpetually amused by news footage depicting hundreds of thousands of Chinese commuting to and from work wearing surgical masks. This ethnocentric delight was quickly replaced with widespread alarm once N95 masks were needed by many and none could be found. Americans quickly learned that high-end brands such as Louis Vuitton, Gucci, and Fendi have been producing stylish face masks for years. These retailers were simply selling them far, far away, in Eastern cities with high population densities. They didn't ignore us in the process; we ignored them. Improvise, Adapt, Overcome As if taking orders from Clint Eastwood, Master Sergeant Gunny Highway in Heartbreak Ridge, Americans improvised, adapted and overcame. The more resourceful citizens, during the spontaneous self-quarantine, blew the dust off of sewing machines they didn't even know they owned. These S-Class survivalists downloaded face mask sewing templates, scared up cotton fabric, and got to work piecing together protective face gear. Other equally resourceful, but slightly less skilled, folks tied silk scarves and paisley bandanas around their faces and filled plastic squirt bottles with grain alcohol. Times got tough. Purell and all other traditional forms of hand sanitizer, if any could be located, was selling for exorbitant prices akin to Levi's jeans on the Soviet black market in the 1980's. A few scalawags exploited the needs of the many to turn a quick buck, but the majority pooled their resources. Neighbors shared supplies, outright strangers did what they could for one another, and petty differences were set aside. It was exhilarating to see who rose to meet the new challenges and who shied away. Stock Market Bruised, Not Broken As was expected, the public markets exhibited just a bit of volatility. The DJIA hit a record high of 29,568 on February 12, 2020 again, the same day this article was originally published. Over the proceeding 40 days, the index shed an unimaginable 11,355 points, an astonishing 38% drop. Generation Z got their very own Black Monday, one that will not be soon forgotten. Fortunately, March 23, 2020 seems to have been the bottom. Currently, the DJIA has leveled out north of a very respectable 25,000, about 18% off of its record high, but not even close to the economic Armageddon investors feared would occur. Let's keep in mind that there are still six months to go until the end of the year. We may still pull out a winner. Anything is possible. It was heartening to see how fast and how well everyone could work together to avert an outright catastrophe. Americans most definitely enjoy the highest standard of living in the world, but that does not mean we are soft or complacent. Our organized response to the COVID-19 outbreak has demonstrated to the world that we still have the grit and tenacity to do what needs to be done and the ability to do it well. We may not be out of the woods just yet, but we now know if and when we get hit by another curveball viral, economic or otherwise we'll make the best of it and ultimately come through the other side. About the Author Laura Anthony, Esq. is the founding partner of Anthony, L.G., PLLC, a national corporate, securities and business transactions law firm. For more than two decades Ms. Anthony has focused her law practice on small and mid-cap private and public companies, capital markets, NASDAQ, NYSE American, the OTC markets, going public transactions, mergers and acquisitions, registered public and exempt private offerings and corporate finance transactions, Regulation A/A+, securities token offerings, Exchange Act and other regulatory reporting requirements, FINRA requirements, state and federal securities laws, general corporate law and complex business transactions. The Anthony, L.G. PLLC team has represented issuers, buyers, sellers, underwriters, placement agents, investors, and shareholders in mergers, acquisitions and corporate finance transactions valued in excess of $1 billion. ALG has represented in excess of 200 companies in reverse merger, initial public offering and direct public offering transactions. Palm Beach Attorney Laura Anthony is also the creator and author of SecuritiesLawBlog.com, the host of LawCast, Corporate Finance in Focus and a contributor to The Huffington Post and Law360. Contact: Laura Anthony, Esq.Founding Partner Anthony, L.G., PLLC561-514-0936[emailprotected]AnthonyPLLC.comSecuritiesLawBlog.comLawCast.com SOURCE Anthony, L.G., PLLC Related Links http://www.anthonypllc.com/", "role": "user" }, { "content": "Palm Beach Attorney Laura Anthony Recaps COVID-19's Impact on People and the Public Markets Updated - The original version of this article was published February 12, 2020.", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Dec. 17, 2020 /PRNewswire/ -- The \"Experiential Networking Market by Technology, Use Case, and Solutions 2020 - 2025\" report has been added to ResearchAndMarkets.com's offering. This report investigates experiential networking market opportunities. The report evaluates companies anticipated to be influential in ENI as well as market positioning and strategies. It includes analysis by technology, use case, and solution. It also assesses experiential networking market opportunities by industry vertical. Quantitative analysis includes global and regional forecasts as well as by leading countries within each region for 2020 through 2025. The report also provides specific recommendations across the ICT and digital technology ecosystem relative to ENI.Based on a European Telecommunications Standards Institute (ETSI) let initiative, experiential networking is a relatively new concept with ETSI forming an Industry Specification Group (ISG) focused on \"Experiential Network Intelligence\" (ENI) and holding an initial ISG ENI meeting in 2017. These efforts define an \"observe-orient-decide-act\" control model with the intent that networks will become increasingly more adaptive, supporting intelligent service operations by way of cognitive network management. Accordingly, the core of the experiential networking market is the use of Artificial Intelligence (AI) and cognitive computing.More specifically, ENI will leverage data and contextual information (such as AI-based decision making) to take actions based on device and system-related events. Responses to events, related processes, and machine learning allows ENI to make automated decisions and provide recommendations for use by other systems such as management and orchestration platforms. This event-driven approach allows the experiential networking market to use various technologies to engage in intelligent analysis necessary for network and service policies and modeling.This policy-based and model-driven approach to the experiential networking market means that data will be leveraged from many sources, and processed by disparate technologies, with a goal of simplifying complex device configuration and monitoring systems. This will also enable improved scalability for telecom and IT networking, which will be a boon for rapidly expanding Internet of Things (IoT) networks and systems as IoT becomes increasingly more voluminous and complex.Like the Intent-Based Networking market for enterprise, ENI is focused on improving man-machine interaction for communications networks. A key goal of ENI is to automate network operations, which will have the effect of fewer errors as well as greater overall operational efficiency and effectiveness. Accordingly, the experiential networking market is intended to use a context-aware, meta-data approach to policy management that takes into consideration changes in user needs, environmental adaptation, and evolution of business goals.To achieve these goals, proponents propose an ENI framework that takes into consideration policy management, data sources and the ability to leverage data learning, cognitive computing-based upon context-aware information, and interaction on an inter-system basis (e.g. communications and data sharing between different systems). This approach is intended to leverage available resources with several experiential networking market goals in mind including improving network planning and deployment, optimizing operations, and enhanced service orchestration and management.More tangibly speaking, ENI is intended to de-risk Service Level Agreement (SLA) commitments by removing errors in key human-machine interfaces as well as automating important decision functions such as resource allocation and prioritization necessary to uphold SLAs in support of Quality of Service (QoS) and Quality of Experience (QoE) requirements. As previously mentioned, ENI will use a data-driven approach, using AI and data analytics for automated decision making. For instances requiring human interaction, the experiential networking market incorporates cognitive computing to enhance decision making. This can be important for delicate areas such as balancing network QoS with end-user QoE, which are sometimes mutually exclusive goals.Use cases within the experiential networking market range from optimizing existing communications service provider applications to offering completely new business customer solutions focused on stringent QoS requirements. Many of these use cases will involve data and decision-making from many sources including the LTE and 5G RAN as well as core network capabilities such as network slicing. Networks will also benefit by including mobile edge computing infrastructure and systems. Specific use cases include intelligent carrier-managed SD-WAN, optimized 5G network slicing management, automatic address allocation for operation IP managed networks, and RF coverage and capacity optimization.Target Audience: Managed services companies Systems integration companies Communication service providers ICT equipment and IaaS providers Operational support systems providers Select Report Findings: Experiential networking relies upon a Publish/Subscribe Data Distribution Process Key supporting experiential networking technologies include AI and advanced data analytics Context-Aware Processing in experiential networking will become a $3.6B global market by 2025 Essential Support, Maintenance, and Training for experiential networking will reach $42M globally by 2025 North America will lead the experiential networking market followed by Asia Pac and Europe through 2025 Key Topics Covered: 1.0 Executive Summary2.0 Overview2.1 Research Objectives2.2 Select Findings3.0 Introduction3.1 Experiential Network Management3.1.1 Experiential Computing Systems3.1.2 Augmented Intelligence3.2 Network Types3.3 Market Trends3.4 Standardization3.4.1 European Telecommunications Standards Institute3.4.2 Experiential Networked Intelligence Industry Specification Group4.0 Technologies Supporting Experiential Networking4.1 AI and Cognitive Technologies4.1.1 Deep Machine Learning4.1.2 Context-Aware Processing4.1.3 Artificial Neural Networks4.1.4 Cognitive Computing4.2 Experiential Solutions4.2.1 Network Configuration and Traffic Management4.2.2 Performance Monitoring and Management4.2.3 Security Management4.2.4 Network Device Management4.2.5 Fault Management4.2.6 IP Address Management4.3 Telecom, Cloud Service Providers, and Enterprise4.4 Traditional vs. IoT Networks4.5 Public vs. Hybrid Cloud Deployment4.6 Virtualization and Integration Service4.7 Network Optimization and Orchestration4.8 Standalone vs. Platform Solutions4.9 SDN, NFV, Network Slicing, and Edge Computing4.10 AI-Driven Network4.11 Self-Driven Networks4.12 Human-Machine Interaction4.13 Communications Service Provider Experience4.14 Data-Driven Network Management4.15 Network Management Analytics5.0 Company Analysis5.1 Accedian5.2 AppNeta5.3 Aruba Network5.4 Avaya Inc.5.5 BMC Software5.6 Broadcom (CA Technologies)5.7 Cisco5.8 Colasoft5.9 Cubro5.10 Compuware Corporation5.11 Dell EMC5.12 ExtraHop Networks5.13 Extreme Networks5.14 Flowmon Networks5.15 HelpSystems5.16 HPE5.17 Huawei Technology5.18 IBM5.19 Ipswitch5.20 Juniper Networks5.21 Kaseya5.22 Kentik5.23 LiveAction5.24 Zoho Corporation (ManageEngine)5.25 Micro Focus5.26 NETSCOUT5.27 Nokia5.28 Paessler5.29 Riverbed Technology5.30 SevOne5.31 SolarWinds5.32 VIAVI Solutions6.0 Experiential Networking Market Analysis and Forecasts 2020 - 20256.1 Global Experiential Network Management Market 2020 - 20256.1.1 Total Global Market 2020 - 20256.1.2 Market by Segment 2020 - 20256.1.2.1 Market by Solution 2020 - 20256.1.2.2 Market by Solution Offering 2020 - 20256.1.2.3 Market by Service 2020 - 20256.1.3 Market by Technology 2020 - 20256.1.4 Market by Network Type 2020 - 20256.1.5 Market by Industry Vertical 2020 - 20256.1.5.1 Market by Service Provider 2020 - 20256.1.5.1.1 Market by Service Type 2020 - 20256.1.5.1.2 Market by Communications Network 2020 - 20256.1.6 Market by Network Platform 2020 - 20256.1.7 Market by Organization Type 2020 - 20256.1.8 Market by Deployment Type 2020 - 20256.2 Regional Experiential Network Management Market 2020 - 20257.0 Conclusions and Recommendations For more information about this report visit https://www.researchandmarkets.com/r/wlg8lo Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Experiential Networking Market Report 2020-2025: Essential Support, Maintenance, and Training for Experiential Networking will Reach $42M Globally", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Dried Figs Market - Growth, Trends, and Forecast (2020-2025)\" report has been added to ResearchAndMarkets.com's offering. The global dried figs consumption was peaked at 146,469 metric tons in 2019. The United States, Iran, Germany, France, India, and the United Kingdom were the largest consumers of dried figs in the same period, accounting for nearly 12.3%, 12.2%, 9.8%, 9.6%, 9.4%, and 5.4% respectively. As per the National Agricultural Statistics Service, the United States is a mere importer and exporter of figs. For instance, during 2017-18, the country produced 31,200 metric tons of figs, of which 27,300 metric tons have been directed to the processed industry. Thus, the rising inclusion of figs in the processed industry is further likely to accelerate the demand over the forecast period. Key Market Trends Rising Per Capita Consumption from High-Income Economies The global per capita consumption of dried figs had modestly increased from 0.017 kg per year in 2016 to 0.019 per year by 2019. Although, a relatively higher per capita consumption has been observed in the high-income economies. For instance, as per the facts revealed by the International Nut & Dry Fruit Council, dried figs account for 6% of the overall dried fruit consumption in high-income economies, whereas, they account for merely 3% of the overall dried fruit consumption across the middle-income economies. For instance, over the period 2016-18, the per capita consumption of dried figs settled at 0.203, 0.158, 0.196, 0.118, 0.399, and 0.277 kg per year, in Iran, Germany, France, Canada, Switzerland, and Greece respectively. This clearly unveils the potential opportunity from the high-income economies over the middle-income economies. Iran to Dominate the Global Dried Figs Market Iran is one of the largest consumers of dried figs, attributing nearly 17,352 metric tons of consumption during 2018-19. Moreover, as per the information revealed by International Nuts & Dry Fruit Council, the per capita consumption of dried figs toggled during 2016-18. For instance, the per capita consumption of dried figs was registered at 0.248 kg per year in 2016-17 and had significantly fallen by 18.1% to 0.203 kg per year by 2017-18. Despite being a major consumer, the country is one of the largest producers of figs in the world. For instance, as per the statistics released by the Tropical and Subtropical Fruits Department of Agriculture Ministry, Iran produced nearly 80,000 metric tons of figs in 2018. Thus, the country's status as a mere producer paralleled with the ongoing trade crisis pertaining to the COVID-19 disease outbreak is likely to be treated as a potential opportunity to serve the domestic markets. This could potentially enhance the per capita consumption of dried figs over the coming years. Reasons to Purchase this report: Key Topics Covered: 1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions & Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.3 Market Restraints 4.4 Supply Chain Analysis 5 MARKET SEGMENTATION 5.1 Geography 5.1.1 North America 5.1.2 Europe 5.1.3 Asia-Pacific 5.1.4 Middle East 6 MARKET OPPORTUNITIES AND FUTURE TRENDS 7 IMPACT OF COVID-19 For more information about this report visit https://www.researchandmarkets.com/r/1on723", "role": "user" }, { "content": "Global Dried Figs Market (2020 to 2025) - Growth, Trends, and Forecast - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Cold Chain Monitoring - Global Market Outlook (2019-2027)\" report has been added to ResearchAndMarkets.com's offering. Global Cold Chain Monitoring market accounted for $4.01 billion in 2019 and is expected to reach $11.94 billion by 2027 growing at a CAGR of 14.6% during the forecast period. Some of the key factors propelling the market growth include increasing global demand for temperature-sensitive drugs, surging demand for better food quality, intensifying need to reduce food wastage, and surging demand for generic drugs owing to higher accessibility. However, high cost of implementation is likely to hamper the market. The cold chain monitoring is the logistic solution for monitoring and recording the data seamlessly, which enables to follow the strict instructions and guidelines for the validated solutions. The monitoring systems are introduced to maintain the effectiveness and freshness of the food, vaccines, under the required temperature, and prevent spoilage. This system plays an important role in the warehouses which is utilized for cold storage applications. It widely finds its application in industries such as food and beverage, healthcare, pharmaceuticals, agriculture, and others. By logistics, the storage segment is expected to grow at the significant rate during the forecast period. Growing consumer inclination toward packaged food, changing lifestyles and dietary patterns, and the intensifying need to protect pharmaceutical products from unsuitable climatic conditions are the prime factors that are favoring the deployment of storage solutions at production sites, distribution centers, and at final delivery points. A well-structured cold storage monitoring setup reduces wastage and facilitates better resource utilization, thereby reducing the cost of operations. On the basis of geography, APAC is expected to be the significant-growing cold chain monitoring market during the forecast period, due to rising demand for high-quality food products and government initiatives in the emerging economies to bring maximum people under the modern healthcare umbrella. Additionally, increasing government investments towards logistics infrastructure development and penetration of warehouse management systems are other major factors supporting the growth of the market in APAC. What the Report offers: Key Topics Covered: 1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.5 Research Sources 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Application Analysis 3.7 Technology Analysis 3.8 Emerging Markets 3.9 Impact of COVID-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Cold Chain Monitoring Market, By Temperature Type 5.1 Introduction 5.2 Frozen 5.3 Chilled 6 Global Cold Chain Monitoring Market, By Offering 6.1 Introduction 6.2 Software 6.2.1 Cloud-based 6.2.2 On-premise 6.3 Hardware 6.3.1 Telematics & Telemetry Devices 6.3.2 Networking Devices 6.3.3 Sensors & Data Loggers 6.3.4 RFID Devices 6.4 Services 6.4.1 Professional Services 6.4.2 Managed Services 7 Global Cold Chain Monitoring Market, By Logistics 7.1 Introduction 7.2 Transportation 7.2.1 Airways 7.2.2 Roadways 7.2.3 Waterways 7.2.4 Railways 7.3 Storage 7.3.1 Cold Containers 7.3.2 Warehouses 8 Global Cold Chain Monitoring Market, By Application 8.1 Introduction 8.2 Chemicals 8.3 Food & Beverages 8.3.1 Fish, Meat and Seafood 8.3.2 Processed Food 8.3.3 Poultry and Dairy Products 8.3.4 Fruits & Vegetables 8.3.5 Fruit Pulp & Concentrates 8.3.6 Bakery & Confectionaries 8.3.7 Nuggets 8.4 Pharmaceuticals & Healthcare 8.4.1 Biobanks 8.4.2 Vaccines 8.4.3 Medicines and Drugs 8.5 Other Applications 8.5.1 Manufacturing 8.5.2 Agriculture 9 Global Cold Chain Monitoring Market, By Technology 9.1 Introduction 9.2 Eutectic 9.3 Air blown 10 Global Cold Chain Monitoring Market, By Geography 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 Italy 10.3.4 France 10.3.5 Spain 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 New Zealand 10.4.6 South Korea 10.4.7 Rest of Asia Pacific 10.5 South America 10.5.1 Argentina 10.5.2 Brazil 10.5.3 Chile 10.5.4 Rest of South America 10.6 Middle East & Africa 10.6.1 Saudi Arabia 10.6.2 UAE 10.6.3 Qatar 10.6.4 South Africa 10.6.5 Rest of Middle East & Africa 11 Key Developments 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 11.2 Acquisitions & Mergers 11.3 New Product Launch 11.4 Expansions 11.5 Other Key Strategies 12 Company Profiling For more information about this report visit https://www.researchandmarkets.com/r/uhgjf6", "role": "user" }, { "content": "Global Cold Chain Monitoring Market Outlook Report 2019-2027 - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Oct. 29, 2020 /PRNewswire/ --iQSTEL, Inc. (USOTC: IQST) an international telecommunication and fintech service provider, today announced the company will report $13.2 million in revenue in its upcoming Q3 financial report, a 17.8% increase over the $11.2 million in revenue reported in Q2. The company set a revenue record for the month of September reaching $4.5 million. The company will report a total of $29.3 million in revenue for the nine months ending September 30, 2020 realizing a 134% increase over the $12.5 million reported for same period for the previous year. IQST is a fully reporting company with audited financials. IQST confirms the 2020 $42 million estimated revenue outlook published in the Goldman Small Cap Research Analyst Report issued earlier this week on Tuesday, October 27, 2020: IQST iQSTEL Announces Analyst Report With $0.54 Target PPS See the full report at www.goldmansmallcapresearch.com/IQST About iQSTEL Inc.:iQSTEL Inc (OTC: IQST)www.iQSTEL.comis a US-based publicly listed company offering leading-edge 21stCentury Enhanced Telecommunications Services with a focus on a wide range of cloud-based enhanced services to the Tier-1 and Tier-2 carriers, corporate, enterprise, as well as the retail market. iQSTEL through its subsidiaries Etelix, SwissLink, QGlobal SMS, SMSDirectos, IoT Labs, IoT Smart Gas Platform, itsBchain offers a \"one-stop-shopping\" for international and domestic VoIP services, IP-PBX services, SMS exchange for A2P and P2P, OmniChannel Marketing, Internet of Things (IoT) applications (IoT Smart Gas Platform), 4G & 5G international infrastructure connectivity, as well as blockchain-based platforms: Mobile Number Portability Application (MNPA) and Settlement & Payments Marketplace for VoIP, SMS and Data. About Etelix.com USA, LLC:Etelix.com USA LLCwww.etelix.comis a wholly owned subsidiary of iQSTEL Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with commercial presence in North America, Latin America, and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception. About SwissLink Carrier AG:SwissLink Carrier AGwww.swisslink-carrier.comis a 51% owned subsidiary of iQSTEL Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presence in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level. About QGlobal SMS LLC.:QGlobal SMS LLCwww.qglobalsms.comis a 51% owned subsidiary of iQSTEL Inc. QGlobal SMS is a USA based company and a commercial brand founded in 2020 specialized in international and domestic SMS termination, with emphasis on the Applications to Person (A2P) and Person to Person (P2P) for Wholesale Carrier Market and Corporate Market in US. QGlobal SMS has commercial presence in US, Mexico, Latin America, EMEA (Europe, Middle East, Asia) and Africa, through our SMS service providers based in Austin, TX and Miami, FL Our Austin-based SMS service provider is specialized in the SMS traffic exchange between US and Mexico, and our Miami-based SMS service provider is focused in the development of Latin America and the rest of the world. QGlobal SMS has robust international interconnection with Tier1 SMS Aggregators, guarantying its customers high quality and low termination rates, over more than 100 countries worldwide. About Alcyon Cloud SMS S.A.S (Commercial BrandSMSDirectos.com):Alcyon Cloud SMS S.A.S. (Commercial BrandSMSDirectos.com), is a whole subsidiary of QGlobal SMS, a Colombian-based Application and Content Provider. Alcyon Cloud SMS (SMSDirectos.com) is registered with the Secretary of Information and Communication Technology (ICT) in Colombia, offering services to government, enterprises, small and medium business, as well as end-users. Using SMSDirectos' existing network, they plan to expand services from SMS to offer omnichannel products and services such as: SMS, Emails, RCS (Rich Communications Services), Social Media Channels (Whats App, Messenger, etc), WebRTC (Web Real-Time Communication), VoIP (IP-PBX, SIP Trunking) ChatBots (Artificial Intelligence Based), SMS to Email, and Email to SMS. About IoT Labs MX SAPI:IoT Labs MX SAPIwww.iotlabs.mx, a subsidiary of iQSTEL Inc, is an Internet of Things (IoT) Mexican technology development company, creator of the \"IoT Smart Gas\" Platform and Application. The IoT Smart Gas platformwww.iotsmartgas.comconsists of an IoT field device installed on the LP gas tank (adaptable to virtually any gas or liquid storage tank) and, thanks to the Internet of Things (IoT) technology via Sigfox or GSM network connectivity, allows remote managed and improved logistic processes of refilling, usage tracking and tank monitoring in real-time by the Smart Gas mobile app. The new GSM tracking feature allows for mobile use including ground, air, and sea tank monitoring. About itsBchain LLC.:itsBchainLLCwww.itsBchain.comis a 75% owned subsidiary of iQSTEL Inc. itsBchain is a blockchain technology developer and solution provider, with a strong focus on the telecom sector. The company is the final stage of development of a series of blockchain solutions aimed at using the blockchain ledgerand smart contract solutions to enable more efficiency, quickness in execution and fraud-prevention in the telco industry. Specifically, the company is developing a solution that will enable users and carriers to transfer mobile phone numbers with just a few clicks, allowing users and carriers the ability to transfer retailusers from one mobile carrier to another instantly. Additionally, the company is finalizing a carrier-grade marketplace solution to procure payments between carriers for cross-traffic of VoIP, SMS and data realtime as traffic is crossed between carriers. This marketplace will allow for instant payment settlement as well as the prevention of fraud between carriers. Safe Harbor Statement:Statements in this news release may be \"forward-looking statements\". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. iQSTEL Inc. IR US Phone: 646-740-0907, IR Email: [emailprotected] Source: iQSTEL Inc. and its subsidiaries:www.iqstel.com;www.etelix.com;www.swisslink-carrier.com;www.qglobalsms.com;www.smsdirectos.com;www.iotlabs.mx;www.iotsmartgas.com;www.itsBchain.com SOURCE iQSTEL, Inc.", "role": "user" }, { "content": "IQST - iQSTEL Announces 134% YTD Revenue Growth And 2020 $42 Million Estimated Revenue Outlook", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEWARK, Calif.--(BUSINESS WIRE)--RMS, the worlds leading catastrophe risk modeling and solutions company, today announces new models. Speaking at the annual RMS Exceedance conference, Mohsen Rahnama Ph.D., chief risk modeling officer and executive vice president, said: Risk is increasingly complex and connected. RMS is focused on providing the highest quality and most transparent, robust catastrophe models to the industry in this environment. With the new inland flood models and global flood hazard maps, we address an important set of regions where flood is the most important peril, and now cover 100 percent of flood premiums written worldwide. The significant update to the RMS North Atlantic Hurricane Models incorporates the latest science, and applies the learnings from 2017 onward. Global Flood Coverage Key flood models and maps announced today at Exceedance 2021 include: With this significant expansion, the RMS Global Flood Solution Suite now offers unmatched high-resolution flood model coverage and a unified approach to manage all global flood risk. These models and maps cover 100 percent of global property gross written premiums for flood. North Atlantic Hurricane Significant updates to the industry-leading North Atlantic Hurricane (NAHU) Models were also announced. The North Atlantic Hurricane Models Version 21.0 now include medium-term event rates, lessons learned from the 2017-2020 hurricane seasons, and a new alternative view of vulnerability for Florida Residential Lines. Importantly, RMS incorporated an alternative view of risk accounting for the Florida Building Code 25 percent Roof Replacement Rule, which was expanded from the High Velocity Hurricane Zone (HVHZ) to cover the entire state of Florida in the 2017 Florida Building Code. These key updates empower customers to make more informed rate setting decisions. Additional 2021 RMS Models RiskLink Version 21.0 RiskLink 21.0 will be available June 2021. All RiskLink models will be available concurrently on both RiskLink and Risk Modeler. About RMS Risk Management Solutions, Inc. (RMS) helps insurers, financial markets, corporations, and public agencies evaluate and manage global risk from natural and man-made catastrophes, including hurricanes, earthquakes, floods, climate change, cyber, and pandemics. RMS models underlie the nearly $2 trillion Property & Casualty industry and many insurers, reinsurers, and brokers around the world rely on RMS model science. RMS helped pioneer the catastrophe risk industry, and continues to lead in innovation by marrying data and advanced model science with leading-edge SaaS technology. Leaders across multiple industries can address the risks of tomorrow with RMS Risk Intelligence (RI), our open, unified cloud platform for global risk, enabling them to tap into RMS HD models, rich data layers, intuitive applications, and APIs. RMS is a trusted solutions partner enabling effective risk management for better business decision making across risk identification and selection, mitigation, underwriting, and portfolio management. Visit RMS.com to learn more and follow us on LinkedIn and Twitter. (C) 2021 Risk Management Solutions, Inc. RMS, the RMS logo, and RMS Risk Intelligence are trademarks of Risk Management Solutions, Inc. All other trademarks are property of their respective owners.", "role": "user" }, { "content": "RMS Announces New Models and RiskLink Version 21.0 High-Performance Models Enable Better Risk Selection, Better Pricing, and Stronger Portfolios", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MINNEAPOLIS, Feb. 10, 2021 /PRNewswire/ --The ResCap Liquidating Trust (the \"Trust\") announced its unaudited Consolidated Financial Statements, as of and for the period ended December 31, 2020, along with its year-end Beneficiary Letter and tax letter. These documents will be filed with the courts and posted to the Kurtzman Carson Consultants website at https://www.kccllc.net/rescapSOURCE ResCap Liquidating Trust View PDF View PDF View PDF Related Links http://www.rescapliquidatingtrust.com", "role": "user" }, { "content": "ResCap Liquidating Trust Announces Posting of Q4 2020 Financial Statements", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer announced today a formal agreement with plaintiffs class counsel on a class plan designed to manage and resolve future Roundup cases. Plaintiffs class counsel are filing today a motion for preliminary approval of the class agreement with Judge Vince Chhabria of the U.S. District Court for the Northern District of California, who presides over the Monsanto Roundup multi-district litigation. As part of the agreement, the company would be committed to pay up to $2 billion, provision for which was made and disclosed last year, to support the claims and programs covered by the class plan. The class plan is intended to be one part of a holistic solution designed to provide further closure to the Monsanto Roundup litigation. The filing of a motion for preliminary approval today begins the review process by the court. In structuring the plan, the parties have worked diligently to address questions previously raised by the court. Elements of the revised plan include the establishment of a fund to compensate qualified claimants during an initial four year program, an advisory science panel whose findings would not be preclusive but can be used as evidence in potential future litigation involving class members, and a robust notice program. The plan also includes research and diagnostic programs that were part of the original class agreement. Consistent with recent actions taken by Bayer to provide greater transparency and access to glyphosate studies, the company also will seek permission from the Environmental Protection Agency (EPA) to add a reference link on the labels for its glyphosate-based products that will provide consumers with access to scientific studies and information that the company has permission to disclose or are in the public domain. Qualifying class members over the next four years will be eligible for levels of compensatory awards based on guidelines set forth in the agreement. Read the full class plan agreement here. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com. Bayer and the Bayer Cross are registered trademarks of Bayer. Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.", "role": "user" }, { "content": "Bayer announces agreement with plaintiffs counsel on class plan Motion for preliminary approval is being filed for program designed to manage and resolve future Roundup litigation", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CARMIEL, Israel, Feb. 18, 2021 /PRNewswire/ --Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cellbased protein expression system, today announced it has completed a raise bringing in gross proceeds of approximately $40 million, before deducting the underwriting discount and estimated expenses of the offering. BofA Securities acted as book-running manager for the offering with Oppenheimer & Co. acting as co-manager. \"I am very proud of our team for all our accomplishments this past year, especially having executed on our strategic plans during the global pandemic. We are on a new trajectory as a company with the potential upcoming commercial launch in a significant market with a new, exciting treatment option for patients, if approved; a pipeline of proprietary assets designed to enhance shareholder value supported by a strong balance sheet allowing us to execute on our strategic goals,\" said Dror Bashan, President and Chief Executive Officer of Protalix. Eyal Rubin,Chief Financial Officer of Protalix added, \"With this financing, we were able to accomplish our goal of bringing in new institutional investors to the Company while strengthening our balance sheet to accelerate clinical trial development. We are grateful for the commitment and the confidence in our strategic plans and goals and look forward to continuing to execute and achieve our milestones planned for this year.\" Protalixintends to use the net proceeds from the offering to fund clinical trials for its product candidates, to fund its research and development activities and for working capital and other general corporate purposes. About Protalix BioTherapeutics, Inc. Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. Protalix was the first company to gain U.S.Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights. Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified version of the recombinant human GalactosidaseA protein for the proposed treatment of Fabry disease; OPRX106, an orallydelivered anti-inflammatory treatment; alidornase alfa or PRX-110, for the treatment of various human respiratory diseases or conditions; PRX115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and others. Protalix has partnered with Chiesi Farmaceutici S.p.A., both in the United States and outside the United States, for the development and commercialization of pegunigalsidase alfa, and with SarcoMed USA, Inc. for the worldwide development and commercialization of PRX110 for use in the treatment of any human respiratory disease or condition including, but not limited to, sarcoidosis, pulmonary fibrosis, and other related diseases via inhaled delivery. Forward-Looking Statements To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. The terms \"expect,\" \"anticipate,\" \"believe,\" \"estimate,\" \"project,\" \"plan,\" \"should\" and \"intend,\" and other words or phrases of similar import are intended to identify forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk and the final results of a clinical trial may be different than the preliminary findings for the clinical trial. Factors that might cause material differences include, among others: failure or delay in the commencement or completion of our preclinical and clinical trials which may be caused by several factors, including: risks that the FDA will not accept an application for accelerated approval of PRX102 with the data generated to date or will request additional data or other conditions of our submission of any application for accelerated approval of PRX102; unforeseen safety issues; determination of dosing issues; lack of effectiveness during clinical trials; inability to monitor patients adequately during or after treatment; inability or unwillingness of medical investigators and institutional review boards to follow our clinical protocols; and slower than expected rates of patient recruitment; risks associated with the novel coronavirus disease (COVID19) outbreak, which may adversely impact our business, preclinical studies and clinical trials; risks related to any transactions we may effect in the public or private equity markets to raise capital to finance future research and development activities, general and administrative expenses and working capital; the risk that the results of the clinical trials of our product candidates will not support our claims of safety or efficacy, that our product candidates will not have the desired effects or will be associated with undesirable side effects or other unexpected characteristics; risks related to our ability to maintain and manage our relationship with our collaborators, distributors or partners; risks related to the amount and sufficiency of our cash and cash equivalents; risks relating to our ability to make scheduled payments of the principal of, to pay interest on or to refinance our outstanding notes or any other indebtedness; our dependence on performance by third party providers of services and supplies, including without limitation, clinical trial services; delays in our preparation and filing of applications for regulatory approval; delays in the approval or potential rejection of any applications we file with the FDA or other health regulatory authorities, and other risks relating to the review process; the inherent risks and uncertainties in developing drug platforms and products of the type we are developing; the impact of development of competing therapies and/or technologies by other companies and institutions; potential product liability risks, and risks of securing adequate levels of product liability and other necessary insurance coverage; and other factors described in our filings with the U.S.Securities and Exchange Commission. The statements in this press release are valid only as of the date hereof and we disclaim any obligation to update this information, except as may be required by law. Logo - https://mma.prnewswire.com/media/999479/Protalix_Biotherapeutics_Logo.jpg Investor ContactChuck Padala, Managing DirectorLifeSci Advisors+1-646-627-8390[emailprotected] SOURCE Protalix BioTherapeutics, Inc. Related Links https://protalix.com", "role": "user" }, { "content": "Protalix BioTherapeutics Completes Raise of Approximately $40 Million in Gross Proceeds USA - English USA - English", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BURLINGTON, Mass., Jan. 15, 2021 /PRNewswire/ --Nuance Communications, Inc. (NASDAQ: NUAN) today announced that it will release its first quarter fiscal 2021 results on Monday, February 8, 2021 after the market close. In addition to a press release, Nuance will provide a copy of prepared remarks. The prepared remarks are offered as additional detail and will not be read on the call. The materials will be available at https://investors.nuance.com/. The conference call will begin at 5:00 p.m. ET. The call can be accessed via webcast here, or by dialing 1-888-317-6003 (US and Canada) or 1-412-317-6061 (international) and referencing code 9035615. About Nuance Communications, Inc.Nuance Communications (NASDAQ: NUAN) is a technology pioneer with market leadership in conversational AI and ambient intelligence. A full-service partner trusted by 90 percent of U.S. hospitals and 85 percent of the Fortune 100 companies worldwide, Nuance creates intuitive solutions that amplify people's ability to help others. Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners. Contact Information For InvestorsMichael MaguireSenior Director of Investor RelationsNuance Communications, Inc.+1 781.565.4855[emailprotected] SOURCE Nuance Communications Related Links http://www.nuance.com", "role": "user" }, { "content": "Nuance to Release First Quarter Fiscal 2021 Results on Feb. 8, 2021", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- Ap27 FORM 38.5(b) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY 1. KEY INFORMATION BARCLAYS CAPITAL INC OSMOTICA PHARMACEUTICALS PLC US$0.01 ordinary shares 11 February 2021 2. INTERESTS AND SHORT POSITIONS a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Interests Short Positions Number (%) Number (%) (1) 565 0.00% 0 0.00% (2) 0 0.00% 0 0.00% (3) 0 0.00% 0 0.00% 565 0.00% 0 0.00% b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total Ap28 3. DEALINGS (Note 3) a. Purchases and sales Purchase/sale Number of Price per unit securities Purchase 1 4.7000 USD Purchase 246 4.5300 USD Sale 1 4.7000 USD Sale 1 4.5300 USD b. Derivatives transactions (other than options transactions) Product name, e.g. CFD Nature of transaction (Note 5) Number of relevant securities (Note 6) Price per unit (Note 4) c. Options transactions in respect of existing relevant securities i. Writing, selling, purchasing or varying Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 4) ii. Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 4) d. Other dealings (including transactions in respect of new securities) (Note 3) Nature of transaction (Note 7) Details Price per unit (if applicable) (Note 4) Ap29 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None 12 Feb 2021 Large Holdings Regulatory Operations 020 3134 7213", "role": "user" }, { "content": "FORM 38.5(b) - OSMOTICA PHARMACEUTICALS PLC", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DALLAS, Aug. 26, 2020 /PRNewswire/ --Austin-based cosmetic and reconstructive plastic surgeon Dr. Robert Whitfield is now offering a must-have noninvasive service for women and men looking to tighten skin while restoring the shape and youthfulness of their body. Unlike other makeovers on the market, Evolve & Evoke is a fast, hands-free service with no pain, swelling, redness, or downtime. It's an ideal procedure for people looking for a refresh post-quarantine without having to deal with any recovery. Before & after results from Evolve & Evoke The Evolve service tightens skin, targets adipose tissue, and tones muscles on one platform. Using artificial intelligence, treatments can be customized and tailored to address specific needs and multiple body areas can be treated at once by using several hands-free applicators and adjustable belts. Evolve has three components: Trim, Tite, and Tone. The Trim function can be put anywhere on the body to help reduce fat, the Tite function helps tighten skin, improve texture and quality of skin, and the Tone component will essentially exercise the muscles in a noninvasive way. The Evoke service specifically targets facial tissue and tightens skin along the border of jaw, cheek, and underneath the chin. The technology harnesses the power of RF energy to remodel facial tissue and achieve more defined facial features and jawline. With its ability to maintain a constant temperature, Evoke remodels the dermis and subdermal tissue. The end results are more defined features and an improved appearance leaving you looking and feeling your best again! \"Evolve & Evoke, which were developed by InMode, are quick and painless procedures with no downtime. In under an hour, patients can help restore a more youthful appearance. We're getting tremendous feedback from our clients,\" shared Dr. Whitfield.Most clients find the service comfortable, and there is also a \"Patient Call Button\" available to easily pause the treatment at any time for staff to make adjustments to ensure comfort. Georgia Nelson was one of the people who tried the Evolve service at Dr. Whitfield's office. She was treated with the Evolve Trim & Tite applicators for 3 sessions with one week in between each session. Each session took about an hour.\"I am amazed at the results I've gotten from Evolve & Evoke. The procedure wasn't painful, and it works! I no longer have unwanted bra fat and my skin feels tighter and firmer than ever,\" shared Nelson.Evolve & Evoke is an ideal \"social distancing\" treatment as it's hands-free and requires minimal patient-physician contact during the procedure. During this time of COVID-19, Dr. Whitfield's office is taking extra safety precautions and following all guidelines outlined by the state. Screening is done prior to arrival. All consents for treatments and surgery are completed via DocuSign prior to the appointment, including a COVID-19 consent. Using an app, patients can let staff know when they have arrived. Staff can then instruct the patient on how and when they can enter the office. Outside the office there are tables set up with kits that include a KN95 mask and two sets of gloves. Patients must use the common area restroom to wash their hands and apply the mask and gloves before entering the office. All team members wear N95 masks and gloves. The air quality of the office has been addressed with 7 additional air purifiers and a Peroxyl oral rinse which allows staff to safely treat patients who need to remove their masks for procedures that require it. Upon completion of treatment, the patient is checked out by a team member behind a plexiglass screen via a touchless payment system.To schedule a consultation or ton make an appointment for Evolve & Evoke, call 877-758-2832 or head to www.drrobertwhitfield.com. Evolve costs between $1,500-$6,800 depending on the number of treatments and areas being targeted. Evoke costs between $1,799-$4,499 depending on the number of treatments and areas being targeted.Hi-res images of the service are available here: https://www.dropbox.com/sh/2bwwwvezch3hkew/AADVlNAGA7prTVKD5qHOKso1a?dl=0ABOUT DR. ROBERT WHITFIELD:Dr. Robert Whitfield is a cosmetic and reconstructive plastic surgeon who specializes in cutting-edge techniques for breast, face and body. His philosophy is simple: He always takes the time to do it the right way. Dr. Whitfield treats every patient, whether for injectables, a Mommy Makeover, or other aesthetic procedure with personal care and attention. His goal is to deliver the highest quality care. He wants his patients to leave the office happy, with results that exceed their expectations.SOURCE Dr. Robert Whitfield", "role": "user" }, { "content": "Tighten and Firm with Dr. Robert Whitfield's Latest Noninvasive Makeover Service Austin's Top Plastic Surgeon Offers Cutting Edge \"Evolve & Evoke\" Service That's A Quick and Easy Non-Surgical Solution With No Downtime", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TEL AVIV, Israel--(BUSINESS WIRE)--Grip Security, a startup revolutionizing SaaS security, today announced $6 million in seed funding led by YL Ventures with participation from CrowdStrike CEO and Co-founder, George Kurtz and seasoned cybersecurity executives. Founded by security veterans Lior Yaari (CEO), Idan Fast (CTO) and Alon Shenkler (VP R&D), Grip Security is offering the industrys most comprehensive SaaS security solution, enabling organizations to discover and secure all SaaS applications with no exceptions, from any device and any location. Joining this seed round are Andy Ellis, former CSO of Akamai; Michael Sutton, former CISO of Zscaler; Sounil Yu, former Chief Security Scientist at Bank of America; Omkhar Arasaratnam, former executive director, Data Protection Engineering at JPMorgan Chase; Sameer Sait, CISO at Amazon (Whole Foods); Adi Sharabani, former SVP & GM, Endpoint Solutions at Symantec; and additional industry leaders. The adoption of SaaS applications has increased massively in recent years, with an average of almost 300 unique SaaS applications in use per enterprise in 20201. The global pandemic and widespread WFH policies have dramatically increased enterprise dependence on SaaS. While the usage of SaaS applications by organizations continues to soar, there has been little innovation in SaaS security solutions and that has failed to inspire confidence with security teams. In 2019, 68% of organizations reported they are mostly or all SaaS-driven while more than half of enterprises cite security as the top concern2. Existing solutions, such as CASBs and other SaaS Security tools, have tried to address pieces of the problem, but have failed their basic objective: visibility and control across the full spectrum of all SaaS applications, users and devices. These solutions protect only a portion of the hundreds of SaaS applications in use in most organizations, leaving them blind to the rest. As companies add more SaaS applications to their portfolio, CASBs cannot scale and effectively leave enterprises with yesterdays technology, said Omkhar Arasaratnam, former executive director, Data Protection Engineering at JPMorgan Chase. Grip Securitys innovative solution is going to reimagine SaaS security, he said. Armed with a deep understanding of the problems enterprises face securing SaaS today, Grip Securitys founders have created a novel approach to SaaS security, providing organizations with full visibility into their entire SaaS portfolio, known and unknown, and enforceable endpoint-centric access and data governance capabilities regardless of device or location. Current SaaS solutions cover a fraction of applications, or only monitor connections originating from the corporate network and are cumbersome to deploy, said Lior Yaari, Grip Securitys CEO and co-founder. Our platform helps organizations get a grip on their SaaS security by cost-effectively providing them with the most comprehensive SaaS coverage and governance with zero touch. The Grip Security platforms key capabilities include: The founding team at Grip Security brings deep technical acumen to disrupt the SaaS security market, said Ofer Schreiber, partner at YL Ventures. Grip will not only upend antiquated SaaS security solutions, but theyll also help enterprises implement much needed automated and granular security for SaaS, the fastest growing segment in information technology. About Grip Security Grip Security, the pioneer in SaaS security, brings the industrys most comprehensive visibility across an enterprises entire SaaS portfolio known or unknown for SaaS applications, users, and their interactions with extreme accuracy and deployment in minutes. Armed with deep visibility, Grips enforceable endpoint-centric approach secures all SaaS application access regardless of device or location as well as maps data flows to apply security policies including data loss prevention. Grip works as a standalone platform or complements any CASB deployment with nominal resourcing and no performance degradation so enterprises can get a grip on their SaaS security. For more information, visit grip.security. About YL Ventures YL Ventures funds and supports brilliant Israeli tech entrepreneurs from seed to lead. Based in Silicon Valley and Tel Aviv, YL Ventures manages over $300 million and specializes in cybersecurity. YL Ventures accelerates the evolution of portfolio companies via strategic advice and U.S.-based operational execution, leveraging a powerful network of Chief Information Security Officers and global industry leaders. The firm's track record includes successful, high-profile portfolio company acquisitions by major corporations including Palo Alto Networks, Microsoft, CA and Proofpoint. For more information, visit ylventures.com. 1Blissfully, SaaS Trends 2020 - https://www.blissfully.com/saas-trends/2020-annual-report/ 2Blissfully, SaaS Trends 2020 - https://www.blissfully.com/saas-trends/2020-annual-report/", "role": "user" }, { "content": "Grip Security Raises $6M from YL Ventures, CrowdStrikes George Kurtz and Cybersecurity Luminaries to Revolutionize SaaS Security Pioneering approach discovers nearly 100% of enterprise SaaS applications, governs, monitors and secures employee access and usage, and prevents data loss", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MUMBAI, India, March 17, 2020 /PRNewswire/ -- Vakrangee Limited introduces vHealth by Aetna primary care services through its network of Vakrangee Kendras. vHealth is a fully owned subsidiary of Aetna Inc, a CVS Health Company, one of the world's leading health services providers (Fortune 8 Enterprise). vHealth brings a strong focus on clinical excellence, leveraging digital technology and a comprehensive network of healthcare partners to offer health checkups, blood tests and pharmacy services. Commenting on this partnership, Mr Dinesh Nandwana, MD & Group CEO, Vakrangee said, \"We are happy to introduce affordable vHealth telemedicine services to our customers in underserved rural locations. The service is set to give patients in rural locations a very different experience when they see a doctor, to listen to their concerns, and do a virtual consultation.\" \"Further, we shall also be able to arrange home blood tests and doorstep delivery of medicines through vHealth's partner network. With this partnership, we have expanded the range of services available at our exclusive Nextgen Vakrangee Kendras making them into a one stop shop for all the requirements of our customers.\" Commenting on this partnership, Mr Damian Delaney, MD, Aetna India said, \"vHealth by Aetna is committed to making quality healthcare accessible across India. We are delighted to join forces with Vakrangee on this important journey. Our partnership will help us expand our reach well beyond urban centers and into the most rural parts of India where primary healthcare plays an important role in the development and growth of these regions.\" About Vakrangee Limited(BSE: 511431)(NSE: VAKRANGEE) Vakrangee is the unique technology driven company focused on building India's largest network of last-mile retail outlets to deliver real-time BFSI, ATM & E-Commerce services to the unserved markets. The Assisted Digital Convenience stores are called as 'Vakrangee Kendra' which acts as the \"One-stop shop\" for availing various services and products. Media Contact:Ammeet SabarwalChief Corporate Communications & Strategy Officer[emailprotected] 91-22-67765100Vakrangee Limited www.vakrangee.in SOURCE Vakrangee Limited Related Links http://www.vakrangeesoftwares.com/", "role": "user" }, { "content": "Vakrangee Revolutionizes Rural Healthcare by Introducing vHealth By Aetna's (a CVS Health Company) Telemedicine Services at Vakrangee Nextgen Kendras English English Deutsch Franais Brazil - Portugus Latin America - espaol espaol", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Dec. 23, 2020 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for OCGN, KOPN, MOGO, SUPN, and EMAN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. OCGN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=OCGN&prnumber=122320201 KOPN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=KOPN&prnumber=122320201 MOGO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MOGO&prnumber=122320201 SUPN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SUPN&prnumber=122320201 EMAN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=EMAN&prnumber=122320201 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment. SOURCE InvestorsObserver Related Links http://www.investorsobserver.com", "role": "user" }, { "content": "Thinking about buying stock in Ocugen, Kopin Corp, Mogo Inc, Supernus Pharmaceuticals, or eMagin Corp?", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2020\" report has been added to ResearchAndMarkets.com's offering. The Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2020 report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies. This report provides an overview of diagnostic imaging dealmaking, the common clauses, rights and options in the partnering agreement, and also a comprehensive review of deals signed in since 2014. This report provides a comprehensive and detailed review of all diagnostic imaging deals announced since 2014. The comprehensive agreements chapter is organized by company A-Z, stage of development at signing, deal type, and therapy focus. Each deal title links via Weblink to an online version of the actual deal, providing easy access to each deal on demand. Where available, the full deal contract document is also provided and indicated by a document symbol. Contract documents provide unsurpassed access to the detail of a deal normally announced in brief summary through a press release. Detailed analysis of a contract allow better understanding of the terms agreed between the parties, and importantly the basis under which monies and licensing rights are exchanged. Key benefits Global Diagnostic Imaging Partnering Terms and Agreements provides the reader with the following key benefits: In Global Diagnostic Imaging Partnering Terms and Agreements, the available contracts are listed by: This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Key Topics Covered: Executive Summary Chapter 1 Introduction Chapter 2 Trends in Diagnostic Imaging dealmaking 2.1. Introduction 2.2. Diagnostic Imaging partnering over the years 2.3. Most active Diagnostic Imaging dealmakers 2.4. Diagnostic Imaging partnering by deal type 2.5. Diagnostic Imaging partnering by therapy area 2.6. Deal terms for Diagnostic Imaging partnering 2.6.1 Diagnostic Imaging partnering headline values 2.6.2 Diagnostic Imaging deal upfront payments 2.6.3 Diagnostic Imaging deal milestone payments 2.6.4 Diagnostic Imaging royalty rates Chapter 3 Leading Diagnostic Imaging deals 3.1. Introduction 3.2. Top Diagnostic Imaging deals by value Chapter 4 Most active Diagnostic Imaging dealmakers 4.1. Introduction 4.2. Most active Diagnostic Imaging dealmakers 4.3. Most active Diagnostic Imaging partnering company profiles Chapter 5 Diagnostic Imaging contracts dealmaking directory 5.1. Introduction 5.2. Diagnostic Imaging contracts dealmaking directory Chapter 6 Diagnostic Imaging dealmaking by technology type Chapter 7 Partnering resource center 7.1. Online partnering 7.2. Partnering events 7.3. Further reading on dealmaking For more information about this report visit https://www.researchandmarkets.com/r/gm0qa6", "role": "user" }, { "content": "Global Diagnostic Imaging Partnering Terms and Agreements Report 2020 with access to Over 650 actual Diagnostic Imaging Deals Since 2014 - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, April 19, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstEHang Holdings Limited (\"EHang\" or \"the Company\") (NASDAQ: EH)for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 12, 2019 and February 16, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before April 19, 2021. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website atwww.schallfirm.com, or by email at[emailprotected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. EHang's approvals in North America and Europe for the EH216 were for use as a drone and not as a passenger vehicle. The Company's purported relationship with its primary customer is in fact fraudulent. In fact, the Company has only collected on a small fraction of its reported sales since December 2019. The Company's manufacturing facilities appeared empty, lacking both advanced manufacturing equipment and employees. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about EHang, investors suffered damages. Join the caseto recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law FirmBrian Schall, Esq.,www.schallfirm.com Office: 310-301-3335 [emailprotected] SOURCE The Schall Law Firm Related Links www.schallfirm.com", "role": "user" }, { "content": "DEADLINE TODAY: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against EHang Holdings Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DENVER--(BUSINESS WIRE)--D.A. Davidson & Co. has secured nearly $92 million of tax-exempt bonds to fund new development at the southeast corner of the high-profile intersection of Interstate 70 and E-470 and at the intersection of E-470 and 64th Avenue in Aurora. The financings, issued in two separate transactions secured by property under development by Westside Investment Partners, provide funding for the Aurora Crossroads and High Point developments. These financings are the latest in a successful series of special district transactions in recent years that have raised $1.2 billion in capital to finance public infrastructure in and surrounding the airport growth corridor, which spans developments in Denver, Aurora and Commerce City. Projects in early stages of development have benefited from a low interest rate environment, with the Aurora Crossroads bonds being issued at 4.625 percent and 4.875 percent rates. The Davidson team was pleased to raise significant infrastructure dollars for the Aurora Crossroads and High Point developments, which will ensure the continued development of these high-profile locations in the City of Aurora and the greater airport growth corridor notwithstanding current uncertainties, said Laci Knowles, senior vice president, Special District Group at D.A. Davidson. Growth in our state pays its own way, and these early stage financings continue to pave the way for incredible new projects that will provide important services and a sense of community for city residents and airport visitors alike. Aurora Crossroads includes about 209 acres of land under development at the southeast intersection of I-70 and E-470. The portion of High Point securing this latest financing is approximately 272 acres along 64th Avenue north of Painted Prairie and intersected by E-470. Upon completion, the projects are planned to include: These early stage bond transactions were managed by the Special District Group at D.A. Davidson, comprised of 17 individuals exclusively dedicated to financing public infrastructure across the country. The group has extensive transaction experience, with over 100 transactions and over $2 billion of par amount issued in the past year. D.A. Davidson & Co.s Fixed Income Capital Markets group is a national leader in raising capital through fixed income banking, distribution and depository strategy. With 30 locations in 19 states, the group is consistently ranked among the top firms in the country. The fixed income team serves new issue clients in public finance and taxable debt issuance, and maintains a diverse sales and trading group interacting with taxable and tax-exempt investors including banks, credit unions, insurance companies, bond funds, money managers and trust companies. About D.A. Davidson Companies D.A. Davidson Companies is an employee-owned financial services firm offering a range of financial services and advice to individuals, corporations, institutions and municipalities nationwide. Founded in 1935 and headquartered in Montana, with corporate offices in Denver, Los Angeles, Portland and Seattle, the company has approximately 1,400 employees and offices in 26 states. Subsidiaries include: D.A. Davidson & Co., the largest full-service investment firm headquartered in the Northwest, providing wealth management, investment banking, equity and fixed income capital markets services, and advice; Davidson Investment Advisors, a professional asset management firm; D.A. Davidson Trust Company, a trust and wealth management company; and Davidson Fixed Income Management, a registered investment adviser providing fixed income portfolio and advisory services. For more information, visit dadavidson.com.", "role": "user" }, { "content": "D.A. Davidson Secures Funding to Pave the Way for Aurora Developments Along High-Profile Airport Corridor Financing blends low interest rates with important commercial, medical development", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WASHINGTON, March 4, 2021 /PRNewswire/ --If you use data, you may know a person, a team, or an organization that has made an impact. DAMA International wants nominations for the DAMA Achievement Awards. We accept entries from members and non-members alike. We have granted these awards since 2001 to more than 60 individuals or organizations, which are described on the Awards Historyon our site. We look for examples of great data management as well as significant real world impact. Please consider nominating before the window closes March 15, 2021. Data underlies decisions good data, good decisions. DAMA International has a mission of promoting data management best practices, as documented by the DAMA Data Management Body of Knowledge. We are interested in promoting work for projects in Analytics, Business Intelligence, Machine Learning, Data Science, Data Architecture, Data Modeling, Data Integration, Data Interoperability, Metadata Management, Data Visualization, Master Data Management and any strategic use of data that creates business value or reduces business risk. This helps both novices in data and professionals by providing guidance and clarity on how to create high quality data that enables great outcomes. We inspire improved work through sharing the stories of data heroes each year. We need your help. Here is a sampling of previous winners, join us celebrating: Senior Data Architect lead a global warehouse to help save newborn babies with HIV using data Thought leader in the practice of Data Governance Or just watch the 2020 Award Presentation! \"The data is important, but it is the people who manage it well and the organizations that focus on it who make a difference,\" said Peter Aiken, President at DAMA International. \"I know that many who work in data are the unsung heroes of the digital age. Tell us your story, so we can sing your song!\" About DAMA DAMA Internationalis a not-for-profit, vendor independent association of technical and business professionals dedicated to advancing the concepts and practices for data resource management and enterprise information. The primary purpose of DAMA International is to promote the understanding, development and practice of managing data and information to support business strategies. DAMA International has chapters and members throughout the world. DAMA membership provides you with a network of data management professionals who share ideas and solutions to some of the most difficult issues in data management. DAMA International provides the globally recognized Certified Data Management Professional (CDMP) qualification which acknowledged as the leading data management professional certification. Chapter members receive vendor andtraining discountsprovided to DAMA International by selected vendors and publishers. Chapters may bulk purchase DAMA International products such as theDAMA Dictionary and the DAMA Data Management Body of Knowledge at discounted rates. If you are interested in data management, we want to meet you and help you grow in your chosen profession! To find a local DAMA chapter, go to the main website at www.dama.org and select Chapter. SOURCE DAMA International Related Links https://www.dama.org/", "role": "user" }, { "content": "DAMA International Achievement Awards soliciting Nominations through March 15, 2021 USA - English USA - English", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WATERLOO, ON, Dec. 23, 2020 /PRNewswire/ --BlackBerry Limited (NYSE: BB; TSX: BB) today announced it has been recognized with eleven \"employer\" awards in 2020, honoring the company's comprehensive employee enrichment programs, community and culture building initiatives, and wellness and work-life balance priorities, as a global 'employer of choice'. \"We are thrilled that BlackBerry's ongoing commitment to our employees and top talent has been recognized by numerous institutions at the local, national and international level,\" said John Chen, Executive Chairman and CEO, BlackBerry. \"These achievements are affirmation for our efforts to continuously seek ways to strengthen our diverse mix of HR resources and build a strong, inclusive workplace for each and every BlackBerry employee. As the various awards recognize and employees around the world would agree it's an exciting time to work at BlackBerry. The company has firmly established itself as a leading and trusted security software company; one that is seen by people around the world as one of the industry's most attractive companies to work for.\" The company has added the following honors in 2020: Best and Brightest Awards North America 2020 Best and Brightest Companies to Work for in the Nation 2020 National Best and Brightest in Wellness San Francisco Bay Area's 2020 Best and Brightest Companies to Work For Best Ottawa Business North America Best Performing Co-Op Program 2020 Brandon Hall Group Global Silver Award for the Best Unique or Innovative Leadership Development Program 2020 Canada's Future Workforce North America Top Employers: Computer Science 2021 Canada's Top 100 North America Canada's Greenest Employer 2020 Waterloo Area's Top Employers 2021 Great Places to Work Europe Great Places to Work Germany 2020 Hong Kong Labour Department Asia Pacific Good Employer Charter 2020 Family-friendly Good Employer 2020 \"We know the foundation of a great workplace lies in our people, in a culture of engagement, with opportunities abound,\" said Nita White-Ivy, EVP, Human Resources at BlackBerry. \"Our HR programs and benefits continue to distinguish BlackBerry in an industry known for the best HR practices and employee initiatives. We are extremely proud of these awards and what this signifies to our employees, prospective employees, our partners and customers, and the industry.\" BlackBerry has over 3,600 employees with offices in 27 countries. We are currently recruiting for top talent in the areas of Sales, Engineering/IT/Research, Marketing, Legal/Compliance, Consulting Services, Accounting/Finance, Human Resources, and more. Please visit our careers page at: https://www.blackberry.com/us/en/company/careers. About BlackBerryBlackBerry (NYSE: BB; TSX: BB) provides intelligent security software and services to enterprises and governments around the world.The company secures more than 500M endpoints including over 175M cars on the road today.Based in Waterloo, Ontario, the company leverages AI and machine learning to deliver innovative solutions in the areas of cybersecurity, safety and data privacy solutions, and is a leader in the areas of endpoint security management, encryption, and embedded systems.BlackBerry's vision is clear - to secure a connected future you can trust. BlackBerry. Intelligent Security. Everywhere. For more information, visit BlackBerry.com and follow @BlackBerry. Trademarks, including but not limited to BLACKBERRY, EMBLEM Design and QNX are the trademarks or registered trademarks of BlackBerry Limited, its subsidiaries and/or affiliates, used under license, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services. Media Contact:BlackBerry Media Relations+1 (519) 597-7273[emailprotected] SOURCE BlackBerry Limited Related Links https://www.blackberry.com", "role": "user" }, { "content": "BlackBerry Receives Eleven \"Employer of Choice\" and \"Best Place to Work\" Awards in 2020 Recognized as 'Best and Brightest' Company to Work For, 'Top Employer', and Awarded for 'Family-Friendly Culture'", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, April 21, 2021 /PRNewswire/ -- The \"Global Organs-on-chips Market (2020-2025) by Type, Application, End-user Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis\" report has been added to ResearchAndMarkets.com's offering. The Global Organs-on-chips Market is estimated to be USD 23.86 Mn in 2020 and is expected to reach USD 98.9 Mn by 2025, growing at a CAGR of 32.9%.Market DynamicsThe growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure. Recent Developments CN Bio and Imperial College London collaborated to harness CN Bio's liver-on-chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development. InSphero AG and ETH Bio Engineering Laboratory announced the license agreement for InSphero's Akura Flow organ-on-a-chip platform. Researchers at the US Army Combat Capabilities Development Command (CCDC) and Chemical Biological Center (CBC) used Emulat's lung on chip technology for research on COVID-19. Javelin Biotech and Pfizer entered a three-year development of a platform to evaluate absorption, distribution, metabolism, and excretion (ADME) properties of small molecules on an organ-on-a-chip platform. The platform will help inform human pharmacokinetic (PK) predictions, which are often crucial measurements evaluating new drug candidates in preclinical research. This further increased the growth in the market studied. Company ProfilesSome of the companies covered in this report are 4DCell, Ascendance Biotechnology, Inc., AxoSim Technologies LLC, BeonChip, BiomimX SRL, Cherry Biotech, CN Bio Innovations, CN Biosystems, Elveflow, Emulate, Inc., HemoShear, TissUse GmbH, uFluidix Inc., etc. Competitive QuadrantThe report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report? The report offers a comprehensive evaluation of the Global Organs-on-chips Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report. The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool. Key Topics Covered: 1 Report Description2 Research Methodology3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers4.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models4.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips4.2.1.3 Technological Advancements and New Products Launches4.2.1.4 Growing Number of Partnerships and Collaborations between Pharmaceutical Companies and Organs-on-Chips Manufacturers4.2.1.5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure4.2.1.6 Growing Initiatives to Increase Awareness about Organs-on-Chips Technologies4.2.2 Restraints4.2.2.1 Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows4.2.3 Opportunities4.2.3.1 Increasing Focus on Drug Discovery Activities4.2.3.2 Application of Organs-on-Chips in Oncology Research4.2.3.3 Development of Multiple-Organs-on-A-Chip Models4.2.4 Challenges4.2.4.1 Complexity of Organs-on-Chips Models4.2.4.2 Dearth of Skilled Professionals4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Organs-on-chips Market, By Type6.1 Introduction6.2 Liver6.3 Heart6.4 Lung6.5 Other Organ Types7 Global Organs-on-chips Market, By Application7.1 Introduction7.2 Drug Discovery7.3 Toxicology Research7.4 Other Applications8 Global Organs-on-chips Market, By End User8.1 Introduction8.2 Pharmaceutical and Biotechnology Companies8.3 Academic and Research Institutes8.4 Other End Users9 Global Organs-on-chips Market, By Geography10 Competitive Landscape10.1 Competitive Quadrant10.2 Market Share Analysis10.3 Competitive Scenario10.3.1 Mergers & Acquisitions10.3.2 Agreement, Collaborations, & Partnerships10.3.3 New Product Launches & Enhancements10.3.4 Investments & Funding11 Company Profiles11.1 4DCell11.2 Ascendance Biotechnology, Inc.11.3 AxoSim Technologies LLC11.4 BeonChip11.5 BiomimX SRL11.6 Cherry Biotech11.7 CN Bio Innovations11.8 CN Biosystems11.9 Elveflow11.10 Emulate, Inc.11.11 HemoShear11.12 Hurel Corporation11.13 InSphero AG,11.14 Kirkstall11.15 Mesobiotech11.16 Micronit11.17 Mimetas B.V.11.18 Nortis Inc.11.19 Organovo Holdings, Inc.11.20 SynVivo11.21 Tara Biosystems Inc.11.22 TissUse GmbH11.23 uFluidix Inc.For more information about this report visit https://www.researchandmarkets.com/r/6huj39 Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Organs-on-chips Market 2020-2025 - Increasing Focus on Drug Discovery Activities / Application of Organs-on-Chips in Oncology Research / Development of Multiple-Organs-on-A-Chip Models", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SOLON, Ohio, March 8, 2021 /PRNewswire/ --Global storage, home dcor and organizational products company, iDESIGN announced a new product line available exclusively on Amazon. iDESIGN Signature Series is centered around partnerships in product development and marketing with emerging experts in their fields. The first, is a sustainable beauty organization collection in collaboration with celebrity makeup artist, and Haus Labs Global Artistry Director, Sarah Tanno Celebrity makeup artist, Sarah Tanno, shows off her new cosmetic organization collection - iDESIGN Signature Series x Sarah Tanno available exclusively on Amazon. The iDESIGN Signature Series x Sarah Tanno collection comes in two color ways clear & smoke with a total of 28 modular, ingeniously designed organizers that offer complete and customizable solutions. This new collection is the first launch by iDESIGN as the company pivots to sustainable and renewable product materials. The clear products are made of recyclable PET and the smoke is made of recycled PET. Visitwww.amazon.com/idesign for more information about the product collection. With more than 20 years of beauty industry experience, Tanno saw a white space to create complete organizing solutions that are innovative, sustainable, chic and could transcend into different beauty and fashion categories such as, hair, wardrobe styling, jewelry, and skincare. \"I have encountered many issues trying to find quality products with smart design throughout my years as a working makeup artist,\" said Haus Labs Global Artistry Director, Sarah Tanno. \"I wanted to innovate on products that would also be good for the environment and iDESIGN was the perfect collaborator looking to do the same thing. We could not be more aligned, which made the process a dream come true.\"Vanity organizationis one of the brand's best-selling categoriesof the50+it develops, seeing close to triple-digit growth YoY.The multi-phased approach of product launches planned for iD x Sarah Tanno demonstrates the deep commitment to continued growth and innovation. This is a long-term partnership with a second-round professional line coming in Q3 2021and a planned third travel line to launch in2022, both available only on Amazon. The exclusive partnership with Amazon will enable iDESIGN to drive category leading ecommerce growth with this key digitally native retailer. \"iDESIGN is known for product quality and innovation within the housewares industry,\" said Senior Vice President of global eCommerce, Aaron Taylor. \"Sarah's passion for product development and the need for functional, beautiful and sustainable solutions made this the perfect partnership.\"About InterDesign, Inc.iDESIGN began as a housewares design company over 45 years ago with a core goal in mindto offer innovative storage products for the home at a reasonable price. We design products that provide solutions for organizing your everyday living space. Our product solutions are designed for the bathroom, kitchen, pantry, closet, laundry room, home office and more. iDESIGN is a global leader in housewares with products in over 100 countries.SOURCE iDESIGN", "role": "user" }, { "content": "iDESIGN Launches Sustainable Beauty Organization Line with Celebrity Makeup Artist, Sarah Tanno The home organization company releases a new collection of products available exclusively on Amazon", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, June 24, 2020 /PRNewswire/ -- The \"Cybersecurity Global Market Report 2020-30: COVID-19 Growth and Change\" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global cybersecurity market. This report focuses on cybersecurity market which is experiencing strong growth. The report gives a guide to the cybersecurity market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic. The global cybersecurity market is expected to grow from $149.46 billion in 2019 to $152.21 billion in 2020 at a compound annual growth rate (CAGR) of 1.83%. The slow growth is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities that led to decline in the bottom line. As a result, companies' budgets for cybersecurity software is expected to decline. The market is then expected to recover and reach $208.28 billion in 2023 at CAGR of 11.02%. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market research findings. Benchmark performance against key competitors. Utilize the relationships between key data sets for superior strategizing. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Where is the largest and fastest growing market for the cybersecurity? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cybersecurity market global report from the publisher answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cybersecurity market, and compares it with other markets. The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth. Market segmentations break down market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets. Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. The cybersecurity market section of the report gives context. It compares the cybersecurity market with other segments of the cybersecurity market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cybersecurity indicators comparison. The cybersecurity market consists of sales of cybersecurity software and related services. Cybersecurity is a practice of protecting the network, computers, mobile devices, hardware, electronic systems and data from digital or malicious attacks. It is also known as electronic information security and information technology security. Cybersecurity can be segregated into categories including network security, application security, information security, operational security and others.North America was the largest region in cybersecurity market in 2019.In August 2019, Cisco Systems Inc., an American multinational technology conglomerate completed the acquisition of Sentryo, a France-based company that is engaged in providing cybersecurity solutions and assets visibility for industrial control systems (ICS). This acquisition is expected to enhance Cisco's security with unparalleled device visibility in operational technology (OT) environment which would provide engineers with deeper visibility into assets to secure and optimize their industrial networks. Sentryo is engaged in designing and developing threat intelligence and network monitoring platforms that offer cyber-resilience for data acquisition networks, supervisory control, and industrial control systems.The increasing use of unlicensed or pirated software is a significant threat to the cybersecurity market. Pirate software refers to the unauthorized copy of the software, which is a replica of the original software. Internet-based piracy of software and solutions is an emerging issue for the industry. According to the BSA global software survey published in June 2018, despite the 2% drop in the pirated software installation rates, the unlicensed software was being installed at alarming rates during 2016 and 2017, accounting for 37% of software installed on personal computers. The organizations purchasing unlicensed software packages and a computer with pirated software installed can impede the growth of bottom line and induce unprecedented security risk. Thus, this high rate of software piracy is hindering the growth of the cybersecurity market. Increasing government investments in cybersecurity solutions is a major trend shaping the growth of the cybersecurity industry. For instance, in October 2019, the UK government has announced a multi-million investment project of $48 million (36 million) to protect the country's businesses from cyberattacks. This scheme combines the government's partnership with leading tech firms such as ARM as a part of the government's digital security by design initiative, which was backed previously by Microsoft and Google. The government funding will help to detect future threats and mitigate their effects including terrorism, financial extortion and damaging established systems. Thus, increasing investments by the governments globally are likely to create large avenues for expansion for the players operating in the cybersecurity market over the forthcoming years.Key Topics Covered: 1. Executive Summary 2. Cybersecurity Market Characteristics 3. Cybersecurity Market Size And Growth 3.1. Global Cybersecurity Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Cybersecurity Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market 4. Cybersecurity Market Segmentation 4.1. Global Cybersecurity Market, Segmentation By Solution, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion4.2. Global Cybersecurity Market, Segmentation By Enterprise Size, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion4.3. Global Cybersecurity Market, Segmentation By Deployment Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion4.4. Global Cybersecurity Market, Segmentation By End-Use, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion5. Cybersecurity Market Regional And Country Analysis 5.1. Global Cybersecurity Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion 5.2. Global Cybersecurity Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion 6. Asia-Pacific Cybersecurity Market7. China Cybersecurity Market8. India Cybersecurity Market9. Japan Cybersecurity Market10. Australia Cybersecurity Market11. Indonesia Cybersecurity Market12. South Korea Cybersecurity Market13. Western Europe Cybersecurity Market14. UK Cybersecurity Market15. Germany Cybersecurity Market16. France Cybersecurity Market17. Eastern Europe Cybersecurity Market18. Russia Cybersecurity Market19. North America Cybersecurity Market20. USA Cybersecurity Market21. South America Cybersecurity Market22. Brazil Cybersecurity Market23. Middle East Cybersecurity Market24. Africa Cybersecurity Market25. Cybersecurity Market Competitive Landscape And Company Profiles 25.1. Cybersecurity Market Competitive Landscape 25.2. Cybersecurity Market Company Profiles 25.2.1. AVG Technologies NV 25.2.1.1. Overview 25.2.1.2. Products and Services 25.2.1.3. Strategy 25.2.1.4. Financial Performance 25.2.2. Check Point Software Technologies 25.2.2.1. Overview 25.2.2.2. Products and Services 25.2.2.3. Strategy 25.2.2.4. Financial Performance 25.2.3. Cisco Systems 25.2.3.1. Overview 25.2.3.2. Products and Services 25.2.3.3. Strategy 25.2.3.4. Financial Performance 25.2.4. CyberArk 25.2.4.1. Overview 25.2.4.2. Products and Services 25.2.4.3. Strategy 25.2.4.4. Financial Performance 25.2.5. F5 Networks 25.2.5.1. Overview 25.2.5.2. Products and Services 25.2.5.3. Strategy 25.2.5.4. Financial Performance 26. Key Mergers And Acquisitions In The Cybersecurity Market 27. Cybersecurity Market Trends And Strategies 28. Cybersecurity Market Future Outlook and Potential Analysis 29. Appendix 29.1. Abbreviations 29.2. Currencies 29.3. Research Inquiries 29.4. About the Publisher 29.5. Copyright And DisclaimerFor more information about this report visit https://www.researchandmarkets.com/r/4galp5 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Cybersecurity Market Report (2020 to 2030) - COVID-19 Growth and Change", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON, June 2, 2020 /PRNewswire/ --Deliveroo and EduMe today announced an exclusive new global partnership that will drive the success of the food delivery giant with effective onboarding, training and continuous learning by using EduMe's platform. The initiative is being rolled out to Deliveroo's entire global network of riders. It will take advantage of EduMe's experience as the training provider of choice by other leading technology companies. This will help facilitate effective onboarding at scale for new riders. Furthermore, an integration with hiring platform Fountain will be leveraged to present a seamless engagement and onboarding experience for new riders. This move demonstrates the increasing desire from the on-demand sector to offer easy-to-use remote training opportunities when face-to-face is not scalable or simply an option, and self-employed riders expect access to knowledge when and where they need it. Jacob Waern, Founder and CEO of EduMe said: \"The success of modern ways of working is at the heart of what we do at EduMe and giving simple, effective, mobile-based tools that equip people with the information they require to be upskilled, motivated and engaged has never been a more critical consideration for successful companies. Deliveroo is a pioneer in the on-demand sector, and this fantastic new partnership will enable their growth through successful and motivated delivery riders.\" Sophia Fellowes, Global Operational Excellence Manager at Deliveroo added: \"We're delighted to be working with EduMe and taking advantage of their vast experience in remote learning for the on-demand sector. The integration capabilities, simplicity of design and focus on the success of our restaurant partners and riders makes this collaboration a huge win for everyone.\" About EduMe EduMe is a Workforce Success platform used by modern companies across 6 continents to train, inform and engage those who work with them. By having effective learning and relevant information in the palm of their hands these individuals working with companies like Airbnb, Deliveroo, Deloitte, Uber and Vodafone are empowered to perform at their best. EduMe is based in London, UK. Visit us at https://www.edume.com/ to learn more. About Deliveroo Deliveroo is one of the UK's leading tech unicorns and a British tech success story. It was founded in 2013 by William Shu and Greg Orlowski. Deliveroo works with over 80,000 best-loved restaurants and takeaways, as well as 60,000 riders to provide the best food delivery experience in the world.Deliveroo is headquartered in London. Deliveroo operates in over 500 towns and cities across 12 markets, including Australia, Belgium, France, Hong Kong, Italy, Ireland, Netherlands, Singapore, Spain, United Arab Emirates, Kuwait and the United Kingdom. Contact: Matthew Brew [emailprotected] +44-203-984-7250 SOURCE EduMe", "role": "user" }, { "content": "Deliveroo Chooses EduMe's Workforce Success Platform to Deliver Global Remote Training Program Deliveroo to launch their training program with industry leader EduMe", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, Dec. 17, 2020 /PRNewswire/ --On December 17, Dimer officially launched its UVHammer solution - the fastest and most effective UV disinfection device on the market. Dimer's UVHammer utilizes the same patented technology as it's GermFalcon product - the revolutionary germ-killing solution for aircraft cabins that has since been licensed by Honeywell, and more recently recognized in TIME's Best Inventions of 2020. Dimer's UVHammer is the fastest and most effective UVC solution on the market - capable of disinfecting all high-touch surfaces with an orders-of-magnitude advantage in efficiency and effectiveness over traditional UVC applications. The UVHammer is a first-of-its-kind operator driven UV solution. The UVHammer's proprietary design, including Dimer's patented adjustable wing technology, enables the user to deliver consistent UVC dosages to all high-touch surfaces in a room by simply maneuvering the wing and walking by surfaces at a casual pace. The UVHammer is 10x faster and orders of magnitude more effective than traditional UVC solutions - representing the first true opportunity for UVC technology to be brought into any environment. The UVHammer was designed to be simple and intuitive; easily controlled with only 3 switches. Any organization's janitorial personnel can be fully trained, certified, and ready to implement this groundbreaking technology within their sanitization routines in just four hours. With ease, an operator extends the UVHammer's adjustable wing parallel to targeted surfaces, delivering UVC dosages proven to inactivate 99.99% of all known disease-causing germs (including SARS-CoV-2/COVID-19) without chemicals or waste. \"The UVHammer redefines UVC disinfection - breaking the mold of how this technology has been used in the past. Our unique, mobile design expands the applications of UVC far beyond healthcare and into all commercial spaces. With the launch of UVHammer, we're excited to elevate public hygiene standards now, and for years to come.\" -Elliot M. Kreitenberg, Co-founder & PresidentMedia Contact: Max Solomon [emailprotected] SOURCE Dimer Related Links https://www.dimeruv.com/", "role": "user" }, { "content": "Dimer Introduces the UVHammer: The Next Generation of UVC Disinfection First of its Kind Mobile UV Solution for Any Commercial Setting", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MINNEAPOLIS--(BUSINESS WIRE)--Ameriprise Financial, Inc. (NYSE: AMP) recently added four advisors to its employee channel with $295 million in combined client assets. Ross Perkins joined from UBS and separately Thomas Rodman, Maureen Cioppi-Grill, and Paul Teufel of Rodman, Grill & Associates joined Ameriprise from Morgan Stanley. The advisors found that Ameriprise offered them high-touch support and industry-leading technology capabilities to deliver superior service to clients. UBS Advisor moves to Ameriprise to take advantage of the firms support approach Perkins, who joined Ameriprise in Carmel, Indiana from UBS, knew it was a big decision to make a move but decided now was the time. I wanted a place I felt I could spend the rest of my career at, and Ameriprise felt like that firm. I now have a support system in place that allows me to integrate new technology into my practice, he said. Perkins is supported by Ameriprise branch manager Jeff Hodges. We are excited to have Ross join our office. We have a strong, dynamic team supporting him to make a smooth transition, hes thrilled that the firms capabilities are making a meaningful difference in his practice, said Hodges. Perkins has $135 in assets under management. Advisors from Morgan Stanley find more capabilities and efficiency at Ameriprise We knew Ameriprise was the right firm for us because of their longstanding commitment to clients and reliable technology capabilities that are critical as were meeting with more clients virtually due to the pandemic, said Rodman. With Ameriprises technology, weve been able to be more efficient with our time while maintaining the strong client relationships that weve had for decades. We are thrilled with the wealth management and financial planning tools here. Ameriprises platform is more sophisticated and has the capabilities to help us meet our clients needs, added Cioppi-Grill. Rodman, Grill & Associates is located in Conshohocken, Pennsylvania and manages $160 million in assets under management. They are is supported by Ameriprise branch manager Mike Hartnett. More than 4,300 financial advisors have joined Ameriprise since 2008.1 To find out why experienced financial advisors are joining Ameriprise, visit ameriprise.com/why. About Ameriprise Financial At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 125 years. With extensive advisory, asset management and insurance capabilities and a nationwide network of approximately 10,000 financial advisors, we have the strength and expertise to serve the full range of individual and institutional investors' financial needs. For more information, or to find an Ameriprise financial advisor, visit ameriprise.com. Ameriprise Financial Services, LLC is an Equal Opportunity Employer. Ameriprise Financial Services, LLC. Member FINRA and SIPC. 2020 Ameriprise Financial, Inc. All rights reserved. 1 Company data as of Q2 2020.", "role": "user" }, { "content": "High-Touch Support and Leading Technology Capabilities Bring Four Advisors to Ameriprise Former Morgan Stanley and UBS advisors with $295 million in combined assets were attracted to Ameriprises resources for client service", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO--(BUSINESS WIRE)--Titan, a leading developer of software and services for advancing Bitcoin mining at scale, today announced that it has received a strategic investment from Coinbase Ventures as part of its current seed fundraising round. This investment will enable Titan to continue advancing its offerings that allow Bitcoin mining companies achieve efficiency, profitability, and growth. Investment Continues Titans Momentum Going into 2021 Last month, Titan announced that North American mining leaders CoinMint and CoreScientific were among the first to agree to join the Titan Pool the first enterprise-ready mining pool positioned for the challenges and opportunities that a professionalized cryptocurrency industry presents. With high-volume tests of the Titan Pool taking place now, the company anticipates launching its closed beta in January 2021. The investment from Coinbase Ventures serves as a powerful endorsement of the Titan team, roadmap and vision, said Ryan Condron, co-founder and CEO of Titan. Mining has advanced from hobby, to industry, to critical global computing infrastructure, and Titan is prepared to help world-class miners meet these challenges. Terms of the investment are undisclosed. About Titan Titan is a leading developer of software and services for advancing Bitcoin mining at scale. Built by miners for miners, Titan makes mining easy, profitable, and scalable through advanced mining management software and North Americas first enterprise-grade mining pool. Titan was formed and founded in September 2018 by Ryan Condron, Jeff Garzik and Matthew Roszak. For more information, please visit Titan.io or follow the company on Twitter.", "role": "user" }, { "content": "Titan Secures Strategic Investment From Coinbase Ventures Investment from Venture Capital Arm of Leading Cryptocurrency Exchange Underscores Industry Confidence in Professionalizing Bitcoin Mining in North America", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Feb. 10, 2021 /PRNewswire/ -- The \"Personal Protective Equipment Market Size, Share & Trends Analysis Report by Product (Respiratory Protection, Hand Protection), by End-use (Healthcare, Manufacturing), by Region, and Segment Forecasts, 2020-2027\" report has been added to ResearchAndMarkets.com's offering. The global personal protective equipment market size is expected to reach USD 123.38 billion by 2027 registering a CAGR of 9.6%. Market Growth & TrendsIncreasing focus on employee safety, coupled with favorable occupational safety regulations, is expected to drive the market growth over the forecast period. Rapid industrialization across the globe, particularly in developing regions, is projected to aid the penetration of personal protective equipment (PPE) in various end-use industries. Manufacturers have been investing in R&D initiatives to develop advanced products that adhere to the regulatory standards and have low external limitations.Technological advancements, coupled with changing consumer trends, have led to a drastic change in manufacturing techniques to obtain superior-quality finished products. The industry has been witnessing a rising demand for high-performance & engineered multifunctional protective clothing. Moreover, the COVID-19 pandemic is expected to have a positive impact on the market due to the increasing demand for a wide range of PPE, such as gloves, masks, face shields, and coveralls, especially from the healthcare sector, to avoid the spread of the virus.Report Highlights The hand protection product segment accounted for the maximum revenue share of over 28% in 2019 on account of increasing demand for gloves in the oil & gas, construction, and metal fabrication industries The PPE demand in the transportation end-use segment is anticipated to grow at a CAGR of 7.0% from 2020 to 2027 due to the growing awareness about the risks involved in activities including manual freight handling and climbing on heights, such as truck tops The PPE market in Europe accounted for the largest revenue share of more than 33% in 2019 and will expand further at a steady rate, due to stringent regulations, along with a rising number of occupational injuries and demand for high-utility protective equipment The market in India is likely to register a significant CAGR from 2020 to 2027 on account of growing concerns regarding high-risk activities in the construction and manufacturing industries Market participants focus on mergers & acquisitions to gain a higher market share In September 2020, Avon Rubber plc signed an agreement to acquire Team Wendy, LLC, a U.S.-based supplier of helmet liners & helmets, and retention systems for first responder and military markets Key Topics Covered:Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segmental Outlook2.3. Competitive InsightsChapter 3. Personal Protective Equipment Market Variables, Trends, & Scope3.1. Market Segmentation & Scope3.2. Penetration & Growth Prospect Mapping3.3. Industry Value Chain Analysis3.3.1. Growing significance of private label brands3.3.2. Growing preference for e-commerce3.4. Technological Trends3.5. Regulatory Framework3.5.1. North America Regulations3.5.2. Asia Pacific Regulations3.5.3. European Regulations3.6. Personal Protective Equipment Market-Market dynamics3.6.1. Market Driver Analysis3.6.1.1. Favorable occupational safety regulations3.6.1.2. Growing importance of safety and security at workplaces3.6.1.3. New manufacturing & construction projects in Asia Pacific & Middle East3.6.2. Market Restraint Analysis3.6.2.1. High raw material costs3.6.2.2. Complex manufacturing methods3.7. Business Environment Analysis: Personal Protective Equipment Market3.7.1. Industry Analysis-Porter's3.7.2. PESTEL Analysis3.8. Strategic Initiatives and Outcome Analysis3.8.1. Mergers & Acquisitions3.8.2. Joint Ventures/PartnershipChapter 4. COVID-19 Impact Analysis4.1. COVID-19 Spread Globally4.2. Impact of COVID-19 on Global GDP4.3. Impact of COVID-19 on Personal Protective Equipment Market4.4. Upside and Downside of the Pandemic4.5. PPE Requirement Based on Exposure Risk Level4.6. Regulatory Standards for PPE to be used during COVID-19Chapter 5. Personal Protective Equipment Market: Product Estimates & Trend Analysis5.1. Personal Protective Equipment Market: Product Movement Analysis, 2019 & 20275.2. Head, Eye & Face Protection5.3. Hearing Protection5.4. Protective Clothing5.5. Respiratory Protection5.6. Protective Footwear5.7. Fall Protection5.8. Hand Protection5.9. OthersChapter 6. Personal Protective Equipment Market: End-use Estimates & Trend Analysis6.1. Personal Protective Equipment Market: End-use Movement Analysis, 2019 & 20276.2. Construction6.3. Manufacturing6.4. Oil & Gas6.5. Chemicals6.6. Food6.7. Pharmaceuticals6.8. Healthcare6.9. Transportation6.10. Mining6.11. OthersChapter 7. Personal Protective Equipment Market: Regional Estimates & Trend Analysis7.1. Personal Protective Equipment Market: Regional Movement Analysis, 2019 & 20277.2. North America7.3. Europe7.4. Asia Pacific7.5. Central & South America7.6. Middle East7.7. AfricaChapter 8. Personal Protective Equipment Market: Competitive Analysis8.1. Key Players, Recent Developments & Their Impact on the Industry8.2. Key Company/Competition Categorization8.3. Vendor Landscape8.4. Competitive Environment8.5. Strategy FrameworkChapter 9. Company Profiles9.1. Honeywell International, Inc.9.2. Lakeland Industries, Inc.9.3. DuPont9.4. 3M9.5. Alpha Pro Tech Limited9.6. Ansell Ltd.9.7. Avon Rubber plc9.8. COFRA S.r.l.9.9. Oftenrich Holdings Company Limited9.10. Uvex Safety Group9.11. Rock Fall (U.K.) Limited9.12. BartelsRieger Atemschutztechnik GmbH9.13. Mine Safety Appliances (MSA) Company9.14. Lindstrom Group9.15. Mallcom (India) Ltd.9.16. Radians, Inc.9.17. Polison Corp.9.18. Cigweld Pty. Ltd.9.19. Gateway Safety, Inc.9.20. Delta Plus GroupFor more information about this report visit https://www.researchandmarkets.com/r/duzl8h Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Personal Protective Equipment (PPE) Market Analysis 2020-2027, Featuring Honeywell International, Lakeland Industries, DuPont and 3M Among Others", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MADISON, Miss., Feb. 16, 2021 /PRNewswire/ --Vertex Aerospace LLC, a global leader in the mid-level aerospace defense industry, announced today that it is Great Place to Work-Certified. This certification is a significant achievement for the BGOV200 Federal Industry Leader, which was acquired by American Industrial Partners and stood up as an independent company just over two years ago. Rigorous reviews of Vertex Aerospaces workplace culture, employee experience, and leadership behaviors have resulted in its certification as a Great Place to Work less than three years after acquisition by private equity firm. \"We are very pleased to be Great Place to Work-Certified. Our employees were recently surveyed and we're happy to report one of the areas where we scored highly indicates Vertex employees feel a sense of pride in our company and their work,\" said John \"Ed\" Boyington, CEO and president of Vertex Aerospace. \"We appreciate our employees' 'All In' spirit and high-quality performance that is substantiated in the multiple contracts we've held for over 20 years.\" Great Place to Work is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue and increased innovation. Using validated employee feedback gathered with Great Place to Work's rigorous, data driven For All methodology, Certification confirmed seven out of 10 employees have a consistently positive experience at Vertex. \"We congratulate Vertex Aerospace on their Certification,\" said Sarah Lewis-Kulin, vice president of Best Workplace ListResearch at Great Place to Work. \"Organizations that earn their employees' trust create great workplace cultures that deliver outstanding business results.\"Vertex's ethical business conduct, performance-based culture, and high-quality services have been the foundation for the company's success for over half a century. Richard Mendoza, Vertex senior vice president and chief people officer, said the company's values serve as guiding principles and empower Vertex employees to operate as one team.\"Based on the most recent survey, our employees reported a consistently positive experience with their coworkers, leaders, and with their jobs. We make a culture of continuous improvement a priority and want to take action on the feedback to keep improving our employee experience,\" said Mendoza. \"When our employees have a high-trust experience driven by our core values of professionalism, integrity, and respect, they are more productive and passionate about their work.\" About Great Place to WorkGreat Place to Work is the global authority on workplace culture.Since 1992, they have surveyed more than 100 million employees around the world and used those deep insights to define what makes a great workplace: trust. Great Place to Work helps organizations quantify their culture and produce better business results by creating a high-trust work experience for all employees. Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work For All. To learn more, visit greatplacetowork.com.About Vertex AerospaceVertex Aerospace offers a globalcapability and completesolution for government and commercial customers. The mid-level aerospace Company operates in over 100 locations worldwide providing aftermarket aerospace services for more than 2,400 fixed and rotary wing airframes. Vertex's agility, rapid deployment capability, and customer optimization have distinguished it from competitors for over half a century. With a 50 percent veteran workforce, the Mississippi-based company understands the challenges faced by the defense sector. More information can be found at vtxaero.com. POC: Rachel C. HensonCorporate Communications Manager[emailprotected]601-607-6552 SOURCE Vertex Aerospace Related Links http://www.vertexaerospace.com", "role": "user" }, { "content": "Vertex Aerospace Certified as 2020 Great Place to Work", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SUMMIT, N.J., Dec. 7, 2020 /PRNewswire/ --Lexerd Capital Management LLC (\"Lexerd\"), a New Jersey-based sponsor of private equity funds, announced today that one of its funds has acquired Emerald Pointe, a multifamily property in Birmingham, AL. The property consists of twenty-one (21) two-story and three-story multifamily apartment buildings and one (1) community building, totaling 192 individual units.The existing amenity package of the property consists of a clubhouse, a laundry center, a private pool with sundeck, picnic area, an outdoor playground, and an on-site childcare facility. Emerald Pointe Terms of the transaction were not disclosed. The property is optimally located just off Lorna Road on Rocky Ridge Ranch road half a mile from the junction of I-495 and I-65. It is also approximately two-miles from Hoover's Riverchase Galleria, the largest shopping mall in Alabama. Birmingham is an important regional hub due to its early century iron and steel production as a primary industrial center of the Southern United States. The University of Alabama at Birmingham is responsible for over 23,000 jobs in the region. The area is also world headquarters for Regions Financial, the second largest employer in the Birmingham metropolitan region. Other major employers in the region include AT&T, Honda, St. Vincent's Health System, Children's Hospital of Alabama, Blue Cross Blue Shield, Alabama Power Co., and Mercedes-Benz.\"We are enthusiastic about the acquisition of Emerald Pointe,\" said Albert Lord III, Founder and CEO of Lexerd. \"Birmingham is a growing market and central to the nation's fastest growing auto manufacturing region. Emerald Pointe is well-located with easy access to Hoover Public Library, various shopping and medical offices, neighborhood schools, and restaurants.\"Lord continued, \"We thoroughly understand the needs of the Birmingham market and the growing demand in the region. Emerald Pointe will serve the community in a meaningful way and be a valuable addition to Lexerd's portfolio, helping us to serve our mission of achieving strong risk adjusted returns for our investors.\" About Lexerd:Lexerd Capital Management LLC is a real estate firm that primarily sponsors investments in opportunistic multifamily assets throughout the United States.Lexerd was founded in 2006 by Albert L. Lord III while he was raising capital and advising on a $440 million bid to acquire the Washington Nationals baseball team from Major League Baseball.Lexerd has managed over $500 million in assets since its founding.Lexerd's core mission of preserving capital while generating appreciation and offering investors stable distributions begins with an approach that recognizes the distinctiveness of the multifamily real estate asset class and its unique features.The approach is based on the integration of three key considerations (a) a proprietary Model for property acquisition, (b) focus on small to middle Market properties to avoid larger competitors and (c) efficient Management of acquired properties.Since 2006 the 3M model has served Lexerd's investors by generating excess returns and stable annual distributions.Contact: Ronica Cleary Media & Press Relations [emailprotected] To learn more about Lexerd's approach and philosophy, visit Lexerd Capital and follow them on LinkedIn. SOURCE Lexerd Capital Management Related Links http://lexerdcapital.com/", "role": "user" }, { "content": "Lexerd Capital Management LLC Sponsored Fund Acquires Emerald Pointe in Birmingham, AL", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of STAAR Surgical Company (\"STAAR\" or the \"Company\") (NASDAQ: STAA) investors concerning the Companys possible violations of the federal securities laws. If you suffered a loss on your STAAR investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/staar-surgical-company/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights. On August 11, 2020, J Capital published a report, claiming the Company has overstated its sales in China by at least one-third (or $21.6 million), \"meaning all of the company's $14 mln in 2019 profit is fake.\" Citing over 75 interviews with former employees, site visits to China and Switzerland, as well as extensive review of public documents, the report concludes that STAAR reports fake sales revenues by overstating sales and then marking up actual marketing costs to hide \"phantom\" revenue. According to the report, the financial statements for STAARs largest Chinese client indicate that it bought only about half as many lenses as the Company reports. On this news, the Companys share price fell $3.17, or over 6%, to close at $48.25 per share on August 11, 2020, thereby injuring investors. Follow us for updates on LinkedIn, Twitter, or Facebook. Whistleblower Notice: Persons with non-public information regarding STAAR should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected]. About GPM Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 Report. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPMs nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPMs lawyers have handled cases covering a wide spectrum of corporate misconduct including cases involving financial restatements, internal control weaknesses, earnings management, fraudulent earnings guidance and forward looking statements, auditor misconduct, insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of corporate misconduct. GPMs attorneys have worked on securities cases relating to nearly all industries and sectors in the financial markets, including, energy, consumer discretionary, consumer staples, real estate and REITs, financial, insurance, information technology, health care, biotech, cryptocurrency, medical devices, and many more. GPMs past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barrons, Investors Business Daily, Forbes, and Money. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.", "role": "user" }, { "content": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of STAAR Surgical Company (STAA) on Behalf of Investors", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Peripheral Nerve Injuries - Epidemiology Forecast to 2030\" report has been added to ResearchAndMarkets.com's offering. This 'Peripheral Nerve Injuries (PNI ) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of the disease, historical and forecasted PNI epidemiology in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. Peripheral Nerve Injuries (PNI) Epidemiology Perspective The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Number of Annual Peripheral Nerve Injuries, Total Annual Number of PNI by Extremities and Total Number of PNI Surgeries Performed scenario of PNI in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2017 to 2030. PNI Detailed Epidemiology Segmentation Key Topics Covered: 1. Key Insights 2. Executive Summary of Peripheral Nerve Injuries (PNI) 3. Peripheral Nerve Injuries Epidemiology Overview at a Glance 3.1. Epidemiology Share (%) Distribution of PNI in 2017 3.2. Epidemiology Share (%) Distribution of PNI in 2030 4. Disease Background and Overview: Peripheral Nerve Injuries (PNI) 4.1. Introduction 4.2. Peripheral nerves and their Injuries 4.3. Causes of PNI 4.4. Symptoms of PNI 4.5. Grading of PNI 4.6. Pathophysiology of Nerve Injury 4.7. Mechanism of PNI 4.8. Diagnosis of PNI 4.9. PNI guidelines (NHS) 5. Epidemiology and Patient Population 5.1. Key Findings 5.2. KOL Views 5.3. Epidemiology Methodology 5.4. Total Number of Annual Peripheral Nerve Injuries (PNI) in the 7MM 5.5. Total Annual Number of PNI by extremities in the 7MM 5.6. Total Number of PNI Surgeries Performed in the 7MM 6. United States Epidemiology 6.1. Assumptions and Rationale 6.2. Total Number of Annual Peripheral Nerve Injuries in the United States 6.3. Total Annual Number of PNI by extremities in the United States 6.4. Total Number of PNI Surgeries Performed in the United States 7. EU5 Epidemiology 7.1. Germany Epidemiology 7.1.1. Assumptions and Rationale 7.1.2. Total Number of Annual Peripheral Nerve Injuries in Germany 7.1.3. Total Annual Number of PNI by extremities in Germany 7.1.4. Total Number of PNI Surgeries Performed in Germany 7.2. France Epidemiology 7.3. Italy Epidemiology 7.4. Spain Epidemiology 7.5. United Kingdom Epidemiology 8. Japan Epidemiology 8.1. Assumptions and Rationale 8.2. Total Number of Annual Peripheral Nerve Injuries in Japan 8.3. Total Annual Number of PNI by extremities in Japan 8.4. Total Number of PNI Surgeries Performed in Japan 9. Appendix For more information about this report visit https://www.researchandmarkets.com/r/hf2lho", "role": "user" }, { "content": "Peripheral Nerve Injuries Epidemiology Forecast Report 2017-2030 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, May 14, 2020 /PRNewswire/ --Wordeee is pleased to announce the debut novel by Jay Manuel, The Wig, The Bitch & The Meltdown, slated for an August 3, 2020 release. TV personality and producer, Manuel has spent over twenty years working with the world's most noted celebrities on both sides of the camera. Well-known as the Creative Director and Producer of America's Next Top Model, Manuel helped shape pop culture as a key figure in one of the most defining television shows of the early aughts. Jay appeared regularly on E!, showcasing the glamorous red carpet world of celebrity fashion and beauty at the Emmys, the SAG Awards, the Grammys, the Golden Globes and the Oscars. Manuel's laser-sharp keen observations and wit shine through in his novel The Wig, The Bitch & The Meltdown. Inspired by his experience on America's Next Top Model, Manuel invites readers into a world of his creation with this irresistible breakout book. He has woven an unforgettable, satirical tale that looks behind the scenes of Model Muse, a fictional, reality model competition show, and a global phenomenon. This twisted tale of ambition, jealousy, blackmail, mystery, and revenge is seen through the eyes of its moral compass, Pablo Michaelsthe heart of production in the helter-skelter world of Model Musewho fears he is losing his soul. \"This story has been in my heart for a long time. These are human stories that hopefully shift the paradigm about how we think about power, authority, and relationships. My book is truly one of fiction, but no one ever writes in a vacuum. We write what we know. As they say, art imitates life, and is often larger than life. Hence, my metafictional work was, of course, inspired by my career in the eccentric Reality TV world. We all know reality television is not real, but what it does provide is a wonderful platform to understand essential themes about identity, in all people,\" said Jay Manuel. \"It's exciting to share Jay's work with his audience. What struck me is not only that it is laugh out loud funny, but that it delivers a wonderful if a cautionary message about the seduction of fame,\"said Marva Allen, CEO, Wordeee. Advance praise from Hollywood insiders for Manuel's riveting and masterfully written debut novel, The Wig, The Bitch & The Meltdown has come from: Grammy, Tony, and Emmy award-winning performer, Billy Porter: \"I clutched my pearls through this page-turning read that's laugh-out-loud funnyshe's a ki-ki, darling! It's equally heartbreaking, suspenseful, and always fast-paced. The category is: legendary.\" Actress, singer, and fashion designer Vanessa Williams:\"Jay has a singular voice which manages to be indulgent and gossipy, while still smart and sharp.\" The Wig, The Bitch & The Meltdownis available now for pre-order on Amazon, Barnes & Noble, Apple Books, Wordeee.com, and wherever books are sold. About Jay Manuel Entrepreneur. Creative Director. TV personality. Visionary. Jay Manuel is all of these things in the business of managing the aesthetic. After moving to New York as a classically trained opera singer, Jay's career took off, in the direction of fashion and beauty. As an advocate and champion, Jay uses his celebrity to shine a light on today's most important causes. He serves as a Smile Ambassador for Operation Smile and has lent his talents to hosting the Red Carpet for the \"GLAAD Media Awards\" (Los Angeles), hosting \"Fashion Cares\" which benefits AIDS research and hosting the \"American Image Awards\" (New York) benefiting the Boys and Girls Clubs of America. https://vimeo.com/395841611 Learn more about Jay Manuel and watch his sizzle reel at www.jaymanuel.com. Media Contact:SLATE PRPolis Groutas[emailprotected]212.235.6811 Photos: https://www.prlog.org/12822279 Press release distributed by PRLog SOURCE Wordeee", "role": "user" }, { "content": "Jay Manuel To Release Debut Novel The Wig, The Bitch & The Meltdown", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NASHVILLE, Tenn.--(BUSINESS WIRE)--HireRight, a leading provider of global background screening services, drug testing, education verification, and electronic Form I-9 and E-Verify solutions, is pleased to launch a range of Electronic Medical Questionnaire templates embedded within its Applicant Center to offer a streamlined customer and candidate experience. These questionnaire options embedded within HireRights Applicant Center for U.S. customers focus on four areas: vaccination history, including COVID-19 vaccination, tuberculosis exposure, and respirator guidelines as defined by the Occupational Safety and Health Administration (OSHA). Employers can select which questionnaires best apply to their candidates or combine them to create a custom package; responses from candidates will be used to create a report for employers to inform their next steps in the health screening process. We are excited to offer this enhancement to our screening options within HireRights Applicant Center, said Todd Simo, HireRights Chief Medical Officer. These simple, easy-to-use questionnaires offer a more detailed health history of each candidate and streamline their vaccine record management, ultimately allowing employers to make important industry-specific screening decisions and assess candidates individual fitness for specific roles. To learn more about this enhanced screening experience, please visit: https://www.hireright.com/services/drug-health-screening/medical-questionnaire About HireRight HireRight helps employers hire the right candidates by delivering global employment background checks, drug testing, education verification, E-Verify solutions, and other workforce solutions. Employers can tailor HireRights extensive screening solutions to their unique needs, giving them peace of mind about their hiring and vetting processes. HireRights platform integrates with existing HR platforms and applicant tracking systems, giving organizations and candidates the best possible experience. HireRight has U.S. offices in Nashville, Tenn., Tulsa, Okla., Chapin, S.C., Dallas, Texas, and Irvine, Calif., and international offices in Australia, Canada, Estonia, Hong Kong, India, Japan, Mexico, the Philippines, Poland, Singapore, the UAE, and the UK. Learn more at www.HireRight.com.", "role": "user" }, { "content": "HireRight Launches New Questionnaires to Streamline Employer Health Screening", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PINE MOUNTAIN, Ga., May 14, 2020 /PRNewswire/ --Parks! America, Inc. (OTCPink: PRKA), today announced the results for its second fiscal quarter and six months ended March 29, 2020. Second Quarter Fiscal 2020 Highlights Total net sales for the second fiscal quarter ended March 29, 2020 were $742,957, a decrease of $261,065, compared to $1,004,022 for the prior year second fiscal quarter ended March 31, 2019. Park attendance based net sales were $730,522, resulting in a decrease of $273,275 or 27.2%, while animal sales increased by $12,210. The Company reported a net loss of $190,152 for the second fiscal quarter ended March 29, 2020 compared to a net loss of $34,207 for the prior year second fiscal quarter ended March 31, 2019, resulting in a net loss increase of $155,945. The increase in the Company's net loss during the second quarter of its 2020 fiscal year is primarily attributable to lower park attendance based revenues, higher legal and professional fee spending, and higher insurance expense, partially offset by higher animal sales, lower compensation and advertising expenses, and insurance claim proceeds, as well as an income tax benefit provision increase. \"The COVID-19 pandemic began to have a negative impact on attendance levels at our Parks beginning the week of March 9, 2020,\" commented Dale Van Voorhis, Chairman & CEO. \"For the first ten weeks of our second fiscal quarter of 2020, our Parks' combined attendance based net sales increased by approximately $80,000 or 18.9%.\" First Six Months Fiscal 2020 Highlights Total net sales for the first six months of the 2020 fiscal year were $1,738,442, a decrease of $282,279, compared to $2,020,721 for the first six months of the 2019 fiscal year. Park attendance based net sales decreased by $274,578 or 13.8% and animal sales decreased by $7,701. For the first twenty-threeweeks of the Company's 2020fiscal year,through March 8, 2020, prior to the negative impact of the COVID-19 crisis onits Park attendance levels, combined attendance based net sales increased by approximately $160,000 or 12.0%. The Company reported a net loss of $279,303 for the first six months of the 2020 fiscal year compared to a net loss of $49,690 for the first six months of the 2019 fiscal year, resulting ina net lossincrease of $229,613. The increase in the Company's net loss during the first six months of its 2020 fiscal year is primarily attributable to lower park attendance based revenues and lower animal sales, higher legal and professional fee spending, and higher insurance expense, partially offset by lower compensation and advertising expenses, and insurance claim proceeds, as well as an income tax benefit provision increase. Balance Sheet and Liquidity The Company had working capital of $2.91 million as of March 29, 2020, compared to working capital of $2.34 million as of March 31, 2019. The Company's debt to equity ratio was 0.15 to 1.0 as of March 29, 2020, compared to 0.19 to 1.0 as of March 31, 2019. COVID-19 Impacts The rapid acceleration of the COVID-19 pandemic in the United States occurred at the beginning of the Company's annual high season. The Company began to see a significant reduction in paid attendance at its Georgia and Missouri Parks beginning the week of March 9, 2020. Effective April 3, 2020, both Parks were closed as a result of shelter-in-place mandates in Georgia and Missouri. In compliance with respective state issued guidelines, our Georgia Park reopened on May 1, 2020 and our Missouri Park reopened on May 4, 2020. From March 9, 2020 through May 3, 2020, the Company's Park attendance revenues declined by approximately $1,140,000 compared to the comparable period in 2019, which it believesis directly attributable to the impacts of the COVID-19 pandemic. \"Prior to the negative impacts of COVID-19 crisis, our year-to-date Park attendance based revenues were trending very well,\" noted Mr. Van Voorhis. \"The closures of our Parks during the key Spring Break and early spring 2020 season will have a negative impact on our third quarter and total 2020 fiscal year financial results. There remain uncertainties regarding how our Park attendance levels will be impacted until the COVID-19 pandemic runs it's course. We have taken prudent steps to address the near-term liquidity needs of our business, while at the same time strengthening our Company for the long-term. As I noted when we announced the completion of our acquisition of Aggieland Safari, LLC, effective April 27, 2020, the COVID-19 crisis has added to the near-term challenges that were not anticipated when we began exploring acquiring Aggieland. However, I am confident that this acquisition represents a unique opportunity to grow and strengthen our Company for the long-term. We welcome the Aggieland Safari employees who recently joined our Company, and we commend them, as well as all our employees for the work they are doing during these challenging and uncertain times\". About Parks! America, Inc. Parks! America, Inc. (OTCPink: PRKA), through its wholly owned subsidiaries, owns and operates three regional theme parks - the Wild Animal Safari theme park in Pine Mountain, Georgia, the Wild Animal Safari theme park located in Strafford, Missouri, as well as the Aggieland Wild Animal Safari theme park, located in Bryan, Texas, which as acquired on April 27, 2020. Additional information, including our Form 10-K for the fiscal year ended September 29, 2019, is available on the Company's website, http://www.animalsafari.com. Cautionary Note Regarding Forward-Looking Statements Except for historical information contained herein, this news release contains certain \"forward-looking statements\" within the meaning of U.S. securities laws. You are cautioned to not place undue reliance on these forward-looking statements; actual results or outcomes could differ materially due to factors including, but not limited to: general market conditions, adverse weather, and industry competition. Additional risks have been added to the Company's business by the near-term and long-term impacts of the COVID-19 pandemic on the operations of its Parks, including customers perceptions of engaging in the activities involved in visiting its Parks, its ability to hire and retain employees in light of the issues posed by the COVID-19 pandemic, and its ability to maintain sufficient cash to fund operations due to the negative impact on its Park revenues associated with disruptions in demand as a result of the pandemic. The Company believes that expectations reflected in forward-looking statements are reasonable, however it can give no assurances that such expectations will be realized and actual results could differ materially. The Company assumes no obligation to update any of these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting these forward-looking statements, except as required by applicable law. A further description of these risks, uncertainties and other matters can be found in the Company's annual report and other reports filed from time to time with the Securities and Exchange Commission, including but not limited to the Company's Annual Report on Form 10-K for the fiscal year ended September 29, 2019. Contact: Todd R. White Chief Financial Officer (706) 663-8744 [emailprotected] PARKS! AMERICA, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) For the Three Months and Six Months ended March 29, 2020 and March 31, 2019 For the three months ended For the six months ended March 29, 2020 March 31, 2019 March 29, 2020 March 31, 2019 Net sales $ 730,522 $ 1,003,797 $ 1,713,930 $ 1,988,508 Sale of animals 12,435 225 24,512 32,213 Total net sales 742,957 1,004,022 1,738,442 2,020,721 Cost of sales 122,905 132,629 249,765 249,962 Selling, general and administrative 763,628 781,516 1,614,845 1,564,048 Depreciation and amortization 117,500 115,199 235,000 230,398 Tornado damage and expenses, net (24,373) - (24,373) - Loss from operations (236,703) (25,322) (336,795) (23,687) Other income, net 7,542 8,538 15,504 15,518 Interest expense (17,191) (19,223) (34,912) (38,821) Loss before income taxes (246,352) (36,007) (356,203) (46,990) Income tax provision (56,200) (1,800) (76,900) 2,700 Net loss $ (190,152) $ (34,207) $ (279,303) $ (49,690) Income per share - basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00) Weighted average shares outstanding (in 000's) - basic and diluted 75,005 74,805 74,808 74,763 PARKS! AMERICA, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (UNAUDITED) As of March 29, 2020, September 29, 2019 and March 31, 2019 March 29, 2020 September 29, 2019 March 31, 2019 ASSETS Cash $ 2,942,037 $ 3,787,815 $ 2,372,250 Accounts receivable 24,373 - - Inventory 238,801 195,201 278,684 Prepaid expenses 280,183 147,529 233,655 Total current assets 3,485,394 4,130,545 2,884,589 Property and equipment, net 6,698,734 6,620,405 6,683,429 Intangible assets, net 200 600 1,000 Other assets 115,021 11,786 12,050 Total assets $ 10,299,349 $ 10,763,336 $ 9,581,068 LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Accounts payable $ 36,324 $ 96,270 $ 26,875 Other current liabilities 326,729 384,160 319,140 Current portion of long-term debt, net 209,673 204,355 199,078 Total current liabilities 572,726 684,785 545,093 Long-term debt, net 1,047,388 1,154,013 1,257,665 Total liabilities 1,620,114 1,838,798 1,802,758 Stockholders' equity Common stock 75,021 74,821 74,821 Capital in excess of par 4,889,316 4,855,516 4,855,516 Treasury stock (3,250) (3,250) (3,250) Retained earnings 3,718,148 3,997,451 2,851,223 Total stockholders' equity 8,679,235 8,924,538 7,778,310 Total liabilities and stockholders' equity $ 10,299,349 $ 10,763,336 $ 9,581,068 SOURCE Parks! America, Inc. Related Links http://www.animalsafari.com", "role": "user" }, { "content": "Parks! America, Inc. Reports Q2 Fiscal 2020 Results", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BRUNSWICK, Ga., Feb. 19, 2021 /PRNewswire/ --Hodges Ward Elliott (\"HWE\"), the premier boutique real estate capital markets advisor, announced it represented a partnership of HOS Management and Hawkeye Hotels in the sale of the 175-key dual-brand Home2 Suites/Hilton Garden Inn, a newly constructed Hotel in Brunswick, GA. An HWE team composed of Clint Hodges and B.J. Patel advised the ownership group on the sale. HWE's Capital Markets Group advised on the financing structure for the acquisition as well. Conveniently located adjacent to I-95, the primary north-south thoroughfare of the Eastern Seaboard, the premium branded Hotel features 91 suites under the Home2 Suites flag, 84 rooms under the Hilton Garden Inn flag, a joint lobby, contemporary guest room amenities, a Garden Grille restaurant, fitness center, and business center. The Hotel is ideally positioned proximate to numerous demand generators including the Golden Isles, the Port of Brunswick, the Federal Law Enforcement Training Center, and Georgia Pacific. About Hodges Ward Elliott: Hodges Ward Elliott (\"HWE\") is the premier boutique real estate capital markets advisor, empowered to deliver exceptional results across a broad spectrum of business lines and product types. HWE's multi-disciplined platform includes commercial, hotel and debt capital markets teams, with offices in Atlanta, Chicago, Dallas, Los Angeles, New York, Miami, Washington D.C., and London. As a privately held company, HWE is dedicated to cultivating long-term client relationships and takes pride in the reputation and track record established over its 45-year history. HWE has closed over $70 billion of transactions, including more than $26 billion over the past 5 years. For more information, please visit https://hodgeswardelliott.com/. Contact: Great Ink 908-392-0333,Tom Nolan ([emailprotected]) SOURCE Hodges Ward Elliott", "role": "user" }, { "content": "Hodges Ward Elliott Brokers Sale of Dual-Brand Home2 Suites/Hilton Garden Inn in Brunswick, GA HWE represents ownership in the sale of the brand new 175-key hotel.", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION Barclays PLC. RWS HOLDINGS PLC 05 October 2020 YES: SDL PLC 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Interests Short Positions Number (%) Number (%) (1) 562,835 0.20% 676,456 0.25% (2) 518,717 0.19% 176,422 0.06% (3) 0 0.00% 0 0.00% 1,081,552 0.39% 852,878 0.31% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Purchase/sale Number of Price per unit securities Purchase 294 5.5905 GBP Purchase 337 5.6440 GBP Purchase 626 5.6588 GBP Purchase 692 5.6365 GBP Purchase 1,024 5.4733 GBP Purchase 1,628 5.6576 GBP Purchase 2,038 5.7302 GBP Purchase 2,443 5.7304 GBP Purchase 3,591 5.7297 GBP Purchase 4,859 5.6795 GBP Purchase 6,900 5.5716 GBP Purchase 13,496 5.4471 GBP Sale 3,634 5.7300 GBP Sale 13,010 5.7251 GBP Sale 93,681 5.3680 GBP (b) Cash-settled derivative transactions Product Nature of dealing Number of Price per description reference unit securities SWAP Long 939 5.6626 GBP CFD Long 2,433 5.7295 GBP SWAP Long 9,638 5.7300 GBP SWAP Long 93,681 5.3680 GBP SWAP Short 2 5.3800 GBP SWAP Short 83 5.6785 GBP SWAP Short 92 5.5986 GBP SWAP Short 102 5.6783 GBP SWAP Short 105 5.6787 GBP SWAP Short 117 5.5984 GBP SWAP Short 132 5.6805 GBP SWAP Short 134 5.6795 GBP SWAP Short 154 5.5971 GBP SWAP Short 157 5.5625 GBP SWAP Short 168 5.5835 GBP SWAP Short 169 5.6788 GBP SWAP Short 243 5.5690 GBP SWAP Short 248 5.6797 GBP SWAP Short 294 5.5905 GBP SWAP Short 337 5.6440 GBP SWAP Short 624 5.6598 GBP SWAP Short 692 5.6365 GBP SWAP Short 748 5.6806 GBP SWAP Short 865 5.6793 GBP SWAP Short 909 5.5980 GBP SWAP Short 991 5.5801 GBP CFD Short 1,024 5.4733 GBP SWAP Short 1,141 5.5613 GBP SWAP Short 1,628 5.6576 GBP SWAP Short 2,038 5.7302 GBP SWAP Short 2,273 5.6794 GBP CFD Short 2,400 5.7312 GBP SWAP Short 2,928 5.5614 GBP CFD Short 13,496 5.4471 GBP (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments 6 Oct 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. *If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panels Market Surveillance Unit. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.", "role": "user" }, { "content": "Form 8.3 - RWS Holdings Plc", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Aug. 18, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ofApplied Therapeutics, Inc.(\"GTT\" or the \"Company\")(NASDAQ:APLT). Such investors are advised to contact Robert S. Willoughby at [emailprotected] or 888-476-6529, ext. 7980. The investigation concerns whether Applied and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On or around May 13, 2019, Applied Therapeutics conducted its initial public offering (\"IPO\"), issuing 4 million shares of common stock priced at $10.00 per share. On August 17, 2020, Applied Therapeutics disclosed that the U.S. Food and Drug Administration (\"FDA\") has placed a partial clinical hold on the Company's ACTION-Kids study evaluating the Company's AT-007 product for the treatment of galactosemia. The FDA cited the need for additional technical information related to ensuring that every participant in the study has access to the drug's benefits. On this news, Applied Therapeutics' stock price fell $3.53 per share, or 12.07%, to close at $25.71 per share on August 17, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com. CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com", "role": "user" }, { "content": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HSINCHU, Taiwan, Oct. 8, 2020 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. (\"ChipMOS\"or the \"Company\") (Taiwan Stock Exchange:8150 andNASDAQ: IMOS),an industry leading provider of outsourced semiconductor assembly and test services (\"OSAT\"),today reported its unaudited consolidated revenue for the month of September 2020and for the thirdquarter ended September 30, 2020. All U.S. dollar figures cited in this press release are based on the exchange rate of NT$28.95 toUS$1.00 as ofSeptember 30, 2020. Revenue for thethird quarter of 2020 was NT$5,686.2 million or US$196.4 million, representing an increase of 5.3%from the thirdquarter of 2019, and an increase of 4.8%fromthe second quarter of 2020. Revenue for the month of September 2020was NT$1,897.1million or US$65.5 million, representing an increaseof8.4% fromSeptember2019, and a decreaseof0.3%fromAugust 2020. The Company noted this represents a quarterly sixyear high. ChipMOS continues to benefit from strong growth in its DDIC revenue following a tightening of the supply chain, inventory and capacity in the first half of 2020, as it works with customers to efficiently meet higher demand levels. Consolidated Monthly Revenues (Unaudited) September2020 August 2020 September2019 MoM Change YoY Change Revenues (NT$ million) 1,897.1 1,902.5 1,749.6 -0.3% 8.4% Revenues (US$ million) 65.5 65.7 60.4 -0.3% 8.4% Consolidated Quarterly Revenues (Unaudited) Third Quarter 2020 Second Quarter 2020 Third Quarter 2019 QoQ Change YoY Change Revenues (NT$ million) 5,686.2 5,428.1 5,399.1 4.8% 5.3% Revenues (US$ million) 196.4 187.5 186.5 4.8% 5.3% About ChipMOS TECHNOLOGIES INC.: ChipMOS TECHNOLOGIES INC.(\"ChipMOS\"or the \"Company\")(Taiwan Stock Exchange: 8150 andNASDAQ: IMOS) (https://www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS provide assembly and test services to a broad range of customers, including leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries. Forward-Looking Statements This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as 'believes,' 'expects,' 'anticipates,' 'projects,' 'intends,' 'should,' 'seeks,' 'estimates,' 'future' or similar expressions or by discussion of, among other things, strategy, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, due to various factors, including the potential impact of COVID-19. Further information regarding these risks, uncertainties and other factors are included in the Company's most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange commission (the \"SEC\") and in the Company's other filings with the SEC. Contacts: In Taiwan Jesse Huang ChipMOS TECHNOLOGIES INC. +886-6-5052388 ext. 7715 [emailprotected] In the U.S. David Pasquale Global IR Partners +1-914-337-8801 [emailprotected] SOURCE ChipMOS TECHNOLOGIES INC.", "role": "user" }, { "content": "ChipMOS REPORTS SEPTEMBER 2020 AND 3Q20 REVENUE, REPRESENTING A QUARTERLY SIX YEAR HIGH", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025\" report has been added to ResearchAndMarkets.com's offering. The global meningococcal vaccines market grew at a CAGR of around 10% during 2014-2019. Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future. The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, the publisher expects the global meningococcal vaccines market to exhibit strong growth during the next five years. Companies Mentioned Key Questions Answered in This Report: Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Meningococcal Vaccines Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Vaccine Type 6.1 Conjugate 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Polysaccharide 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Subcapsular 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Composition 7.1 Mono Vaccines 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Combination Vaccines 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Vaccine Serotype 8.1 MenACWY 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 MenB & Manic 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 MenC 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 MenA 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 MenAC 8.5.1 Market Trends 8.5.2 Market Forecast 8.6 Others 8.6.1 Market Trends 8.6.2 Market Forecast 9 Market Breakup by Distribution Channel 9.1 Hospital Pharmacies 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Retail Pharmacies 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Institutional Sales 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by End User 10.1 Pediatric 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Adult 10.2.1 Market Trends 10.2.2 Market Forecast 11 Market Breakup by Region 11.1 North America 11.2 Asia Pacific 11.3 Europe 11.4 Latin America 11.5 Middle East and Africa 12 SWOT Analysis 13 Value Chain Analysis 14 Porters Five Forces Analysis 15 Price Analysis 16 Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players For more information about this report visit https://www.researchandmarkets.com/r/e0rqw3", "role": "user" }, { "content": "Worldwide Meningococcal Vaccines Industry to 2025 - Impact Analysis of COVID-19 - ResearchAndMarkets.com", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TORONTO, March 9, 2021 /PRNewswire/ - What characteristics do resilient people have? What can we learn from them to build a positive mindset and help us cope with life's challenges? Janet Fanaki is a self-described Resilience Explorer and host of the RESILIENT PEOPLE podcast. Resilience Explorer Janet Fanaki is the host of the RESILIENT PEOPLE podcast. She interviews people around the world who are admired for their resilience. (CNW Group/RESILIENT PEOPLE) In February 2020 she lost her 51 year old husband Adam to glioblastoma, the most aggressive form of brain cancer. A people watcher, she spent much of her time doing just that in the waiting room of his surgery and treatments - wondering what makes some so strong in the face of adversity? In 2018 she created the website RESILIENT PEOPLE and later launched a podcast to share her conversations with folks from around the world who are admired for their resilience. Her guests have overcome a major life challenge and then created something to help others be resilient too. Guests have included: Terrence Rodriguez, a transgender man who started REX Pride to build a community for LGBTQ+ youth after facing his own isolation throughout his childhood; Jason Fiorotto who lost his wife to breast cancer and started a fundraiser to bring comfort to cancer patients; and crash survivor Dawne McKay, the founder of the Crash Support Network.Janet has been able to determine many common traits between her guests. Their lifestyle, social circles and capacity for empathy to name a few. She offers tips to build resilience thanks to the advice of her guests and experts. Each interview is unique, inspiring and relatable. \"I'm doing this for the people who I met on my own journey who said that they could never do it,\" says Janet Fanaki. \"The truth is, you don't know what you're capable of doing until you HAVE to do it.\"Janet Fanaki is the creator of RESILIENT PEOPLE. Established in 2018 as a blog and two years later as a podcast on all platforms. Janet is asked by organizations to speak on the power of purpose and the common traits of resilient people. She was recognized in USA Todayon World Humanitarian Day 2019. She lives in Toronto with her two children. SOURCE RESILIENT PEOPLE", "role": "user" }, { "content": "What makes people resilient to life's challenges? Resilience Explorer Janet Fanaki aims to find out", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MIAMI, Feb. 22, 2021 /PRNewswire/ --Board-certified Miami plastic surgeon, Adam J. Rubinstein, MD, FACS announces the launch of the latest video NewMeNowas part of the ongoing #ItsNotAllTheSame Social Media Series on Monday February 22nd, on his YouTube and Instagram accounts @drrubinstein and @plasticsurgerytruths. View the new episode here: https://youtu.be/h-1k-2R08g8 Continue Reading Adam J. Rubinstein, MD, FACS announces the launch of the latest video NewMeNow as part of the ongoing #ItsNotAllTheSame Social Media Series on Monday February 22nd The powerful tongue and cheek Instagram series discusses controversial topics in plastic surgery in a humorous yet truthful way to educate people on how to make informed decisions. The series is designed to make the point, with humor, that all plastic surgery is most definitely not the same. Through the series Dr Adam Rubinstein reminds patients to seek the appropriate doctors who are board certified and properly trained to ensure great results and safety. The new episode looks at \"fast and 'inexpensive\" procedures you can have done at home. Called NewMeNow, the story invites people to 'get the procedure they have always wanted\" without the stress of entering a Board-Certified Plastic Surgery Center or Doctors office. It advises to call 1 855 New Me Now and tell the operator the procedure you would like to have, and the warehouse will 'ship this directly to your door.'It continues that you can 'take your 'package and enjoy a New Me Now for just three installments of $19.95 with a special offer of 'if you call now' you get a free box of 'injectables' to use at home. \"I understand and appreciate how important looking good and feeling good about your appearance can be, however cheap fixes are not the right answer and convenience and cost will never take priority over good patient care,\" says Dr Rubinstein. \"This segment reminds us to slow down and remember always that health care starts with good health practices. \"That does not mean mail order facelifts or breast implants,\" says Rubinstein, \"obviously nobody would order a breast augmentation by mail. The point is, do your homework, check out your surgeon's credentials and track record, make safe choices. I launched the #ItsNotAllTheSame campaign because I am seeing too many people suffering after making questionable decisions when choosing their doctor, clinic or procedure.\"The series is designed to use humor as warning on 'fast and cheap' plastic surgery. With the pandemic still looming large, it is understandable that people are seeking a fast and easy way to look and feel their best. The series #itsnotallthesame forces people to slow down and with a sense of humor, guides them to make the right choices when choosing plastic surgery procedures. Other episodes include \"Drive Through Plastic Surgery\" jokingly asks the question \"Do You Want Fries with That?\" This episode demonstrates how the pandemic has changed the way we do many things, and often not always for the best. Dr. Rubinstein was inspired by other doctors doing drive through Botox. \"The idea of driving through a line to get injectables may sound convenient, during the pandemic, but it is just not good medicine.\"In another episode \"Pilot This!\" Dr Rubinstein demonstrates how some things seem obvious while others not so much. In this episode, a boat captain is asked to pilot more than a boat. From a boat to a plane, everyone knows #itsnotallthesame. However, when it comes to plastic surgery people sometimes need to be reminded. Dr. Rubinstein is committed to educating and keeping people safe.\"The COVID-19 epidemic has changed everyone's life around the world, and it is challenging time,\" says Dr. Adam J Rubinstein. \"We are trying to help people find a little humor, while learning about the importance of choosing properly when it comes to cosmetic surgery,\" adds Rubinstein. Watch the new #itsnotallthesame video on Youtube at https://youtu.be/h-1k-2R08g8. You can also learn more on his social channels including his YouTube and Instagram accounts, @drrubinstein and @plasticsurgerytruths, SnapChat @drrubinstein, and Facebook page @MiamiPlasticSurgeon. www.dr-rubinstein.comAbout Dr Adam J. RubinsteinDr Adam J. Rubinstein is a Board Certified and Award-Winning Plastic Surgeon. He has served as the Chief of Plastic Surgery and Chief of the Department of Surgery for Jackson North Medical Center in Miami; FL. Dr Rubinstein specializes in whole body surgical & non-surgical cosmetic treatments for both women and men. He can discuss the latest innovations and procedures to help people make proper and informed choices. Dr. Rubinstein is also a patient advocate and is passionate about sharing the good, the bad and the ugly about common plastic surgery practices to help patients navigate the world of plastic surgery effectively and safely. His goal is to help people make their best choices about the latest and most innovative procedures. He is also an outspoken patient advocate and believes people have the right to know to make informed choices. Media contact:Stacey Bender[emailprotected]973-650-1218SOURCE Adam J. Rubinstein, MD, FACS Related Links http://www.dr-rubinstein.com", "role": "user" }, { "content": "Mail Order Plastic Surgery? Plastic Surgeon, Dr. Adam J. Rubinstein Launches 'NEW ME NOW\" The Latest in the #ItsNotAllTheSame Social Media Campaign", "role": "assistant" } ]
[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WASHINGTON, Dec. 1, 2020 /PRNewswire/ --The Medicare Physician Fee Schedule (MPFS) final rule released today by the Centers for Medicare & Medicaid Services (CMS) will harm patients and further destabilize a health care system already under severe strain from the pandemic. Congress must work swiftly to reverse these devastating cuts to protect patient access to care before it recesses for the year, argues the Surgical Care Coalition. The MPFS final rule will cut Medicare payments up to nine percent for some surgical subspecialties starting on January 1, 2021. A recent survey from the Surgical Care Coalition shows these cuts will harm patients by forcing doctors to make extremely difficult decisions like reducing Medicare patient intake, laying off nurses and administrative staff, and not investing in technology. \"When CMS proposed these cuts, surgeons and their patients began raising the alarm that now is not the time to cut health care,\" said David B. Hoyt, MD, FACS, American College of Surgeons Executive Director. \"There is a bill pending in Congress right now the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, introduced by Representatives Bera and Bucshon which would stop these cuts and protect patient access to surgical care.\" The Surgical Care Coalition urges all members of Congress to join Representatives Ami Bera, MD (CA-7), Larry Bucshon, MD (IN-8) and 54 co-sponsors in support of H.R. 8702, the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, which will prevent these Medicare payment cuts for two years. This bill will stop the cuts from going into effect on January 1, 2020, protecting patients' access to surgical care and ensuring no providers experience cuts during a pandemic. \"This rule was a dangerous policy even before the pandemic, and enacting it during the worst health care crisis in a century is unconscionable. If Congress fails to act, it will further strain a health care system that's already been pushed to the brink due to the COVID-19 pandemic and undermine patient care,\" said John A. Wilson, MD, FAANS, FACS, President of the American Association of Neurological Surgeons. \"The bill introduced by Reps. Bera and Bucshon is a win for patients and a win for physicians, and I urge all members of Congress to support it,\" said Ronald Dalman, MD, DFSVS, President of the Society for Vascular Surgery. \"Our health care system is under extraordinary pressure, and now is the time for Congress to act and protect our patients.\" \"Following the publication of this rule, it is more important now than ever that Congress step up and protect patients from these cuts,\" said David Glasser, MD, Academy Secretary for Federal Affairs of the American Academy of Ophthalmology. \"Especially during a historic pandemic, there should be no cuts to healthcare providers.\" \"Congress must now act to protect patients, both now and when the pandemic is over,\" said Joseph Dearani, MD, President of The Society of Thoracic Surgeons. \"Surgeons around the country want nothing more than to care for their patients, and patients deserve access to that care when and where they need it. These cuts undermine their ability to do so.\" \"The issuance of the final rule shows that CMS failed to act, and now Congress must act,\" said Eugene Laveroni, D.O., FACOS, President of the American College of Osteopathic Surgeons. \"The bill introduced by Reps. Bera and Bucshon takes a holistic approach to protect patients' access to care and protects surgeons from unnecessary payment cuts during a pandemic.\" Time is running out because Congress needs to take action by the end of the year. In these final days, the Surgical Care Coalition will continue to advocate that Congress stop the Medicare payment cuts and protect patients' access to surgical care. About the Surgical Care Coalition The Surgical Care Coalition advocates for access to quality surgical care for all Americans. The Surgical Care Coalition is comprised of 12 surgical professional associations that proudly represent more than 150,000 surgeons working across the country with a common goal of improving the quality of care, and quality of life, for all patients. The founding members have worked together for nearly three decades to promote sound policy solutions to the U.S. Congress and federal regulatory agencies to solve the biggest challenges in health care. [emailprotected] SOURCE Surgical Care Coalition", "role": "user" }, { "content": "Medicare Cuts Jeopardize Patient Care and Ignore Impacts of Pandemic Congress must take immediate action and stop the cuts to protect patient access to care", "role": "assistant" } ]